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Abstract 
DMRT1 (doublesex and maleabnormal-3 related transcription factor-1) is a transcription 
regulator that is expressed in Sertoli cells and germ cells of the testis, where it directs 
mammalian postnatal testis differentiation. It is currently the only mammalian gene within the 
sex determination and sex differentiation genetic pathways that is evolutionary conserved and 
shares a cysteine-rich DNA binding motif (DM-domain) with doublesex in the fruit fly and 
maleabnormal-3 in the roundworm. The work presented in this dissertation revealed numerous 
novel roles of DMRT1, including Sertoli cell-specific rescue, structural function in the testis, 
cell-specific pathways and targets, and a probable regulation by NANOS2 in germ cells; thus 
providing important insight into how DMRT1 regulates testis development. Recombinogenic 
engineering was invaluable in the generation of a novel Sertoli cell-rescue (Dmrt1
-/-;tg
) mouse 
model, which is a DMRT1-deficient germ cell model that was produced by breeding Dmrt1-null 
(Dmrt1
-/-
) mice with Wt1-Dmrt1 transgenic mice. The Wt1-Dmrt1 transgenic mice express a rat 
Dmrt1 cDNA in gonadal supporting cells by directing it from the Wilms' tumor locus carried on 
a yeast artificial chromosome transgene. Characterization of the Sertoli cell rescue mice revealed 
Sertoli cell-specific function of DMRT1 in the maintenance of seminiferous tubule morphology, 
autonomous and non-autonomous dose-dependent gene regulation, Sertoli cell differentiation, 
maintenance of testis size and sperm progressive motility, organization of testis-specific 
adherens junctions and maturation of Leydig cells and thus regulation of testosterone production. 
Furthermore, cell-specific direct and indirect pathways and targets regulated by DMRT1 in 
Sertoli cells and germ cells were identified using global gene expression profiles combined with 
ChIP-Seq. Analyses of the gene profiles identified potential functions for DMRT1 in vesicular 
transport, ubiquitination and RNA binding. Similarly, analysis of ChIP-Seq data identified 150 
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targets with the majority of DMRT1 binding sites located in introns, indicating that DMRT1 
preferentially binds to distal regulatory regions. Finally, direct protein-protein interaction was 
shown between DMRT1 and NANOS2, an evolutionary conserved RNA-binding protein that 
plays a key role in male germ cell differentiation, by inhibiting entry into meiosis. NANOS2 was 
shown to act upstream, interact, partially co-localize and repress the in vitro transcriptional 
activity of DMRT1 in germ cells. Overall, these experiments uncovered several questions and 
new cell-specific roles of DMRT1 in testis differentiation. These findings and their implications 
are discussed further in this dissertation within the general scope of reproductive biology and the 
more defined scope of postnatal testis differentiation. 
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Introduction 
 This section provides reviews on reproduction, sex determination and differentiation, 
germ cell and Sertoli cell development, DMRT1 and DM family, hypothesis, specific aims and 
biological significance of the current study. 
Reproduction 
Reproduction is a fundamental biological process that ensures propagation of extant 
organisms. Asexual and sexual reproduction are the two main mechanisms of procreation. In 
asexual reproduction, an organism divides into one or more analogous or identical copies of 
itself with no genetic input from another organism. This method of propagation predominates 
within single cell organisms like bacteria and is exemplified by parthenogenesis in lower plant 
species. In sexual reproduction, an organism produces an offspring that inherits a combination of 
genetic material contributed by two members of the species. Sexual reproduction is limited to 
higher plants, higher invertebrates and all vertebrates, and always entails special male and female 
reproductive structures and gametes. This requires sex determination, which refers to the 
decision of restricting the development of an offspring to either a male or a female pathway, and 
sex differentiation, which consists in the development of a male or female phenotype (Figure 1). 
 Types of sex determination systems 
Different sex determination systems have been documented for various phylogenetic 
groups that can be classified into two main categories namely, genetic (chromosomal) and non-
genetic (environmental factors) [1] .  
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Environmental sex determination (ESD) 
This occurs when there is direct correlation between specific environmental conditions 
(temperature, nutrients) and the sex of a progeny. This suggests that the sex of the embryo is not 
predetermined at fertilization, but arises later, based on specific external conditions during the 
critical sex determination stage, as the zygote develops. In certain species, like fish, turtles, 
lizards and crocodiles, the females and males have identical genetic composition and sex 
determination is controlled by external factors like environmental hormones, visual signals and 
hatching temperatures [2, 3]. For instance, in crocodilians and most turtles, the temperature at 
which the egg is incubated determines sex. In the European pond turtle, an incubation 
temperature below 28
o
C produces phenotypic males, whereas an incubation temperature above 
29.5
o
C produces phenotypic females [4, 5]. Other environmental factors that influence sex 
determination include the proximity of related species and the duration of daylight (photoperiod). 
Proximity to related species was observed to determine sex in the echiurid marine worm 
(Bonellia spp), whereby isolated planktonic larvae developed into females while larvae that 
dwell near females developed into males. In the brackish water shrimp (Gammarus spp), long 
and short days produce males and females, respectively [5, 6]. 
Genetic sex determination (GSD) 
In genetic or chromosomal sex determination, genes inherited from donors (parents) at 
fertilization determine the sex of the embryo. This suggests that there is a preexisting 
commitment to a specific sex that cannot be normally reversed subsequently by environmental 
factors. In groups like mammals, insects, birds, snakes and amphibians, differences in male and 
female genetic makeup result in a dominant gene that drives sex determination. Genetic sex 
determination in these species generally uses chromosome combinations of XY, ZW, XO or 
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haplodiploid. After sex is determined at insemination, sex differentiation is directed to the male 
or female pathway by sex determining genes [2, 3, 5, 6]. 
In fruit flies (Drosophila melanogaster), sex is determined by the X chromosomes to 
autosomes (X/A) ratio. In Drosophila, each cell in the embryo senses the X/A ratio through the 
activity of a master regulator that drives sexual dimorphism [7]. Early transient expression of the 
sex-lethal (sxl) splicing regulator is observed in XX embryo, and permanent expression of 
functional sxl eventually activates synthesis of the female-determining variant of doublesex (dsx) 
through a sex-specific alternative mRNA splicing mechanism [5]. Expression of sxl is lower in 
XY embryos that results in the synthesis of the male-specific spliced isoform of dsx. The Y 
chromosome in fruit flies is dispensable during sex determination but contains genes that are 
indispensable for male fertility. Thus, an XO fruit fly has a male phenotype, but it is infertile [5]. 
Among species that propagate by genetic sex determination, the mechanism of this 
biologic process has been extensively studied in birds (chicken) and placental mammals (humans 
and mice) (Figure 1), which display heterogametic sex and are capable of producing two types of 
gametes. Birds (Gallus gallus) use a ZZ/ZW system, where animals that inherit two Z 
chromosomes (homogametic) become male, and those that inherit both a Z and a W chromosome 
(heterogametic) become female. The W chromosome is smaller, has few bona fide genes while 
the Z chromosome is larger, and carries the key candidate testis-determining factor, DMRT1. 
The Z chromosome shares extensive conserved syntenic segments with human chromosome 9, 
where its human ortholog resides [8]. DMRT1 dosage was higher in ZZ embryos than in ZW 
embryos; and it was suggested that higher doses of DMRT1 in avian embryo direct male 
development, whereas lower doses promote female development [8, 9]. 
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Mammals use the XX/XY system (Figure 1), where males are heterogametic; carrying an 
X and a Y chromosome, and females are homogametic; carrying two X chromosomes [2]. In 
mammals, sex determination is typically categorized by three sequential steps [2]. First, genetic 
or chromosomal sex is established by the presence or absence of the Y chromosome in the 
fertilized oocyte. Thus, the genetic sex determines the sex of the developing gonad, such that the 
presence of the Y chromosome directs development of the testes, while its absence commits the 
gonad to the ovarian fate. Second, the gonadal sex or primary sex determination along the 
testicular pathway requires the presence of the testis determining factor or Sry (Sex determining 
Region of the Y chromosome) on the Y chromosome (Figure 1). The absence of Sry on the Y 
chromosome results in progenies that genetically are males, but have ovaries. Thus, the presence 
or absence of Sry determines gonadal fate. Third, phenotypic sex or secondary sex differentiation 
is determined by the sex of the gonad, which provides the embryo’s hormonal environment 
necessary to develop male or female sexual characteristics, respectively [10].  
Other genes implicated in mammalian sex determination 
SRY is expressed in the gonad precursor and it is limited to the period in which testes 
begin to form. Unlike sxl, the master regulator in Drosophila that mediates sexual dimorphism in 
every cell, SRY is confined only to gonadal tissue and does not required germ cells to be present. 
Thus, Sry is all that is needed from the Y chromosome to form a testis and the expression of SRY 
in a XX background induces male development [11-14]. In addition to Sry, many other 
components of mammalian sex determination and /or gonadal development have been identified, 
mostly from gene knockout experiments in mice, and evaluation of human patients with sexual 
disorders or sex-reversed phenotypes. These studies revealed a repertoire of genes that include 
Dosage-sensitive sex reversal, congenital adrenal hypoplasia, on the X chromosome, gene 1 
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(Dax1), Dmrt1, Emx2, Fgf9, Gata4/Fog2, Lhx1, Lhx9, Nr5a1 (Sf1), Wt1, Sox9, Wnt4 and insulin 
family genes. The majority of these genes encode for transcription regulators that influence key 
steps during gonad development. But, genes like Wnt4, Fgf9 and the insulin family genes are 
signaling molecules, which are vital in the recruitment and differentiation of different cell types 
[15-17]. Functional studies of the expression profiles of these genes revealed various steps in the 
development of the gonad, which are regulated in a hierarchical manner.  
Sexual differentiation in Mammals 
Sexual differentiation depends on the hormonal environment and can be divided into two 
phases. Primary sexual differentiation refers to differentiation events that occur during 
embryonic development such as development of the internal reproductive organs and external 
genitalia. Secondary sexual differentiation is the response of multiple tissues to the hormones 
(Figure 1) produced by the functioning gonads to complete the sexual phenotype, for example 
the secondary sexual characteristics that occur with puberty. In mammals, expression of Sry in 
the undifferentiated gonad directs development to the testicular pathway (Figures 1 and 2). The 
supporting cells in the testis start synthesizing two hormones, anti-Müllerian hormone (AMH) 
produced by Sertoli cells, and testosterone produced by Leydig cells. AMH causes regression of 
the Müllerian duct, while testosterone and its derivative, dihydrotestosterone, induce formation 
of ancillary male reproductive organs. In the absence of Sry in females, the ovarian pathway is 
activated by a different set of master regulators and the supporting cells (granulosa and theca 
cells) in the ovary produce estrogen, which upholds development of the uterus, oviducts, and 
cervix from the Müllerian duct [6, 15, 18-20]. 
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Gonad development  
The indifferent gonads 
In mammals and birds, the gonads of each sex begin as a common precursor known as 
the bipotential gonad or undifferentiated genital ridge (Figure 2). Prior to sex determination in 
mice and during the first two days, the expanding gonadal ridge is composed of undifferentiated 
cells derived from the coelomic epithelium that proliferate and migrate to the mesenchyme 
derived from the mesonephros. Blood vessels develop from the mesonephros, and the gonadal 
ridge becomes vascularized more in the male than in the female. At approximately 9 days post 
coitus (dpc) in the mouse embryo, indifferent or bipotential gonads (genital ridges) are first noted 
as thickenings in the mid-portion of the intermediate mesoderm (i.e. ventrolateral surface of the 
mesonephroi), consisting of germ cells in both XX and XY embryos (Figure 2) [21, 22]. The 
somatic components are derived from layers of cells that proliferate and expand from the 
underlying mesonephroi and coelomic epithelium [22]. Overall, the supporting, steriodogenic 
and the partial connective cell lineages of the indifferent gonad have a dual potential and follow 
a dimorphic fate once gonadal sex is determined [23, 24].  
Unlike the somatic components, the germ cells originate from the proximal epiblast 
(primary ectoderm) and, whereas, the male germ cells are not required for testis formation, their 
female counterparts are needed for ovarian differentiation since their absence elicits 
masculinization of the ovaries [25-31]. The Wolffian duct (mesonephric duct), mesonephric 
tubules, adrenal glands and the urinary system are also derived from the mesonephroi. Murine 
studies revealed Lhx1, Emx2 and Pax2 genes are essential for stabilization of the intermediate 
mesoderm and formation of the urinogentital ridge; while Sf1 and Wt1 are required for the 
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differentiation of the gonadal ridge. Gene knockout studies in mice revealed that animals with 
deletions in the Wt1 or Sf1 gene lacked gonads and kidneys or lacked gonads and adrenals, 
respectively [32, 33]. As the gonad develops, the induction of male or female-specific factors 
drive the undifferentiated genital ridge to differentiate along the path of the testis or ovary 
(Figure 2) [32-37]. Overall, sex determination in the mammalian germ line is reduced to choose 
to enter meiosis, which leads to the ovarian pathway, or arrest in mitosis, which favors the 
testicular pathway. During this developmental process, the formation of primordial somatic and 
germ cell components are equally important as genetic makeup and sex-specific differentiation 
aspects in the establishment of an ovary or testis.  
The Testis 
The discovery of Sry provides important insight on the genes involved in testis 
development. Thus, a transient wave of SRY expression increases expression of SOX9, which 
directs the gender-specific regulation that culminates with the development of Sertoli cells in the 
male gonadal ridge and the development of the testis [11, 12, 27, 38-40]. Sertoli cells also 
produce AMH and Inhibin B. AMH induces regression of Müllerian ducts and inhibits formation 
of the fallopian tubes, uterus and vagina. Inhibin B selectively suppresses follicle stimulating 
hormone (FSH) secreted by the pituitary. After Sertoli cells are formed, they coalesce with 
peritubular myoid cells that migrate from the mesonephros to form the testis cords, which are the 
precursors of seminiferous tubules, at 12 days post coitus (dpc) in mice [41]. Formation of testis 
cords coincides with the block to meiotic entry in the male gonadal ridge. Also, male germ cells 
(prospermatogonia) are arrested in the G0/G1 phase of the cell cycle at about 12.5 and 13.5 dpc, 
but resume proliferation a few days after birth. Leydig cells appear in the interstitial region, are 
derived from mesenchymal-like stem cell [42], and secrete testosterone required for the 
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development of Wolffian structures including epididymis, vas deferens and seminal vesicles. 
Dihydrotestosterone is a byproduct of testosterone that induces virilization of the external 
genitalia [43, 44]. After the sex is determined, genes including Dhh, Insl3, Hoxa10, Hoxa11, 
Dmrt1, Fgf9, Gata4/Fog2, Sf1, Sox9 and Wt1 stay on to promote testicular development [15, 17, 
45-51].  
The ovary 
Not much is known about differentiation into the female pathway and it is thought to be 
the default pathway of gonad development. Thus in the absence of Sry, an ovary develops, likely 
due to the innate ability of germ cells to enter meiosis in the absence of an inhibiting signal from 
Sertoli cells or the lack of stabilization of the Wolffian duct. After formation of the ovary, genes 
including Gdf9, Foxl2 and Fshr are required to ensure female germ cell survival and normal 
follicle development. The supporting cells derived from cells of the underlying mesonephroi 
differentiate into granulosa cells. Like the interstitial cell population in the males, the cells in the 
interstitial compartment in the females differentiate into the theca and stromal cells that form a 
steriodogenic sheath external to the basement membrane of the primordial follicle. These 
supporting cells in the ovary produce estrogen and inhibin α and β required to maintain 
development of the female pathway. Genetic studies in mice showed that Dax1, Wnt4, Foxl2, 
Rspo1 and β-catenin are predominantly ovary-promoting genes [15, 17, 45-51]. At 13.5 dpc, 
female germ cells enter meiotic prophase and pass through leptotene, zygotene and pachytene 
before entering quiescence at the diplotene stage, where they are surrounded by a single layer of 
flattened granulosa cells to form primordial follicles just before birth [42, 52]. Meiotic entry of 
female germ cells is critical for the somatic components to commit to the ovarian fate [26-28]. 
This observation is supported by studies that showed that the XX gonad readily 
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transdifferentiated into a testis when germ cells were absent and that meiotic female germ cells 
inhibited testis differentiation and cord formation when introduced into an XY gonad, after 12.5 
dpc [26]. The meiotic inhibitors are thought to originate from Sertoli cells [53]. Entry into 
meiosis is regulated by meiotic preventing substance (MPS) and meiotic inducing substance 
(MIS) [54]. Current views indicate that retinoic acid (RA) made in the mesonephros exerts MIS 
action in the fetal ovary, whereas the P450 enzyme (Cyp26b1), produced in somatic cells of the 
embryonic male testis, degrades RA and delays meiotic entry by male germ cells [54, 55]. Stra8 
is induced by RA and regulates the G1 mitotic to meiotic transition in female primordial germ 
cells [56]. 
Germ cell development 
Early specification of primordial germ cells 
The laboratory mouse has been an invaluable tool in our understanding of sex differences 
and origins of mammalian gonads. In mice, primordial germ cells (PGCs) are induced in the 
pluripotent epiblast by signals from bone morphogenetic proteins (Bmp4 and Bmp8b), which 
originate in the extraembryonic tissues and visceral endoderm [57-61]. The ability of PGCs to 
respond to BMPs occurs at a time-point coincident with the expression of Wnt3 [62]. BMP 
signals are transduced by Smad5/8, which translocate into the nucleus with Smad4 and induce 
expression of Fragilis (Ifitm3), a member of the interferon-inducible family gene, in the epiblast 
and Prdm1 (Blimp1) in PGC precursor cells at one end of the short axis before gastrulation [63, 
64]. After gastrulation, the PGC precursors locate to the posterior proximal region, where they 
undergo specification to form the founder population of Stella-positive PGCs. The pluripotent 
proximal epiblast cells respond to signals from the extraembryonic tissues and begin to express 
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Fragilis as they acquire the ability to form PGCs, although only a small minority of them will 
become germ cells. At 6.25 dpc, about six cells in the prospective posterior proximal site of the 
embryo belonging to the Fragilis-positive cell population and that are in direct contact with the 
overlying extraembryonic endoderm start expressing Blimp1 and Prdm14, which are 
transcriptional repressors of histone methyltansferase belonging to PR-domain proteins and are 
considered to be PGC determining factors [65, 66]. These cells are recognized as being restricted 
to the germ cell lineage. Prdm1 is partially accountable for inhibiting the somatic program in 
primordial germ cells while promoting the formation of germ cell features. In the Prdm1-and-
Prdm14-expressing germ cells, genes derived from the mesoderm such as Fgf8, Brachyury and 
Snail are down-regulated, whereas genes associated with pluripotency, including Stella (Dppa3), 
Lin28, Oct4, Tnap, c-Kit, Ssea-1, Sox2 and Nanog are up-regulated [64, 67-70]. Overall, the 
transcriptional programs directed by Prdm1 and Prdm14 inhibit primordial germ cells from 
taking on the somatic fate through a successful epigenetic reprogramming mechanism that favors 
reactivation of pluripotency marker genes [70, 71]. 
Primordial germ cell maintenance and migration 
By 7-7.5 dpc, midway through gastrulation, PGCs can be observed from their intrinsic 
and elevated activity level of alkaline phosphatase (Tnap)( Figure 3A) [72]. Also, the Pou 
transcription factor and pluripotent stem cell marker, Oct4, is expressed in the epiblast at this 
time but is restricted to the germ cell lineage at about 8 dpc [73]. It is well established that the 
precursors of the PGCs are the proximal epiblast cells that are adjacent to the extraembryonic 
ectoderm rather than cells of the extraembryonic lineage. The germ cell lineage is established 
only after the precursor epiblast cells have migrated through the primitive streak (from primary 
endoderm to extraembryonic endoderm) giving rise to the extraembryonic mesoderm, allantois 
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and about 40 PGCs [43, 74-76]. Briefly, just before the end of gastrulation and 24 hours after 
establishing PGCs (8-8.5 dpc), the endoderm is invaginated to form the hindgut and, in the 
process, it carries the PGCs. These cells invade the allantois and the hindgut endoderm, with the 
fastest PGC arriving the hindgut endoderm at 8.5dpc (Figure 3A). The primordial germ cells 
become transcriptionally silent at about 8.5 dpc and undergo an elaborate reprogramming of their 
genome that consists of histone modification, the elimination of dimethylation (H3K9me2) 
signatures and the augmentation of trimethylation (H3K27me3) marks [77]. By 9-9.5 dpc, PGCs 
migrate from the ventral to the dorsal side of the hindgut, up the dorsal mesentery and towards 
the developing genital ridges. Entry of germ cells into the nascent genital ridges continues 
between 10-11 dpc but by 11.5 dpc (Figure 3B), a distinction between the genital ridges and the 
mesonephros is formed which blocks subsequent entry of germ cells [43, 75, 76, 78]. Until about 
13.5 dpc after entry into the genital ridge, mitotic proliferation continues. At the end of the 2-3 
days proliferation period, about 20,000 germ cells are present in the genital ridge, which are 
derived from an initial pool of 40 PGCs that underwent 12 successive mitotic divisions [43, 75, 
76, 78].  
Migration of primordial germ cells is complete in about four days (7.5-11.5 dpc) (Figure 
3B). Although active migration of primordial germ cells towards the gonadal ridge occurs after 
8.5 dpc, the molecular mechanisms that regulate migration and ensure germ cell survival during 
migration are only partially understood. Murine ablation studies revealed that genes, such as 
Fgf8 and β1-Integrin, are important for germ cell migration, while genes such as Dnd, Bax, Bcl2, 
c-Kit/Steel and Nanos3 are vital for PGC survival [79-84].  
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The postnatal testis 
Postnatal Sertoli cell development 
The daily sperm production in the adult testis determines the efficiency of 
spermatogenesis both of which rely on the total number of functional Sertoli cells [85-88]. The 
number of Sertoli cells available after the developmental perinatal period is critical for 
establishing both the adult testis size and quantitative daily sperm production [88]. This 
association exists because each Sertoli cell has a predetermined ability for the number of germ 
cells it can nurture [88]. Since only immature Sertoli cells proliferate, the final number of Sertoli 
cells is decided before maturity. Prepubertal, pubertal and adult are the three populations of 
Sertoli cells that have been characterized, which overlaps with the temporal development of the 
postnatal mammalian testis.  
After the testicular cords are formed, the number of fetal Sertoli cells increase rapidly just 
prior to birth. After birth, the fetal Sertoli cell, now prepubertal Sertoli cells continue to divide 
mitotically and stop after the first spermatogonia enters meiosis (at about postnatal day 5 (P5) in 
mice) [86, 89, 90]. In mice, studies using 
3
H-thymidine incorporation showed that Sertoli cell 
proliferation stopped after the cells acquire their mature appearance at P12 [91]. The presence of 
meiotic and postmeiotic germ cells causes the undifferentiated pre-Sertoli cells to develop into a 
differentiated and functional Sertoli cells. The transition from the immature proliferative state to 
the mature non-proliferative state, termed terminal differentiation or maturation, is characterized 
by: i) the presence of an enlarged tripartite nucleus with a protuberant nucleolus, ii) formation of 
tight junctions between adjacent Sertoli cells and iii) formation of the adluminal compartment 
and a fluid-filled lumen [86]. These post-mitotic highly differentiated and complicated 
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morphological structures are characteristics of adult Sertoli cells. Existing evidence links thyroid 
hormone (T3), follicle stimulating hormone (FSH), androgen receptor (AR), AMH, and 
testosterone to the final maturation of Sertoli cells [86]. Furthermore, the absence of meiotic and 
postmeiotic germ cells were shown to induce secondary changes in the function of Sertoli cells 
that were similar to those of immature Sertoli cells or features of dedifferentiation of adult 
Sertoli cells [89, 92-97]. However, in human and murine studies the absence of these 
differentiated germ cells did not automatically lead to maturation failure by Sertoli cells, but led 
to temporal delays such as the formation of inter-Sertoli cell tight junctions [86, 98].  
Postnatal germ cell development 
Male primordial germ cells arrested in mitotic G0/G1 phase are called gonocytes; which 
are evenly spherical, centrally positioned in the seminiferous tubules and detached from the 
basement membrane [99-101]. Spermatogenesis begins soon after birth and at about postnatal 
day 0.5 (P0.5) in mice, gonocytes resume mitosis, extend their cytoplasmic processes and 
radially migrate to the basement membrane [99]. Radial migration is completed between P3 and 
P6 and is thought to be important for survival of gonocytes, since failure to migrate has been 
associated with degeneration of germ cells centrally located within the testis cords [102, 103]. 
Germ cells provide the genetic link between lineages. To fulfill this function, mammalian germ 
cells self-renew by mitosis to expand and maintain the pluripotent stem cell population, which 
maintains spermatogenesis in the adult testis [102, 104]. Specifically, the production of haploid 
gametes in the mammalian testis originates from a small population of stem cells belonging to 
the undifferentiated spermatogonia (Figure 4). The undifferentiated spermatogonia consist of 
types Asingle (As, isolated single cells), Apaired (Apr, chain of two cells) and Aaligned (Aal, chain of 
4,8,16 or 32 cells) [105-109]. Type A1 differentiated spermatogonia are derived from Aal 
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population after a series of cyclical events that varies across species [104, 105]. After five 
successive mitotic divisions, type B-spermatogonia are derived from A1 spermatogonia. The type 
B spermatogonia can be detected in the mouse testis by the start of the second postnatal week 
and their morphology is analogous to those of adult intermediate (In) or B spermatogonia. The B 
spermatogonia in turn undergo one mitotic and two successive reduction divisions to form the 
primary spermatocytes and round spermatids, respectively [102, 104]. The round spermatids 
mature and form sperm cells [108]. In the mouse, spermatozoa are first observed during the first 
wave of mouse spermatogenesis, at approximately P35. Contrary to normal spermatogenesis 
which is derived from Neurogenin 3 (Ngn3)-positive undifferentiated spermatogonia, the first 
wave of mouse spermatogenesis originates directly from gonocytes without going through the 
Ngn3-expressing stage [110]. 
To date, the biologic processes occurring in embryonic gonadal development have 
received more attention than the events occurring in the developing immature testis, even though 
the latter have the potential to provide invaluable information on regulatory pathways or events 
relevant to germ cell development, Sertoli cell maturation and male fertility. More precisely, the 
events occurring during the first postnatal week in mice testis are not well characterized. This 
dissertation focuses on characterizing the events occurring during this time point with special 
emphasis on the regulatory influence by a key evolutionary-conserved transcription factor, 
DMRT1; which is present only in the testis and expressed both in germ cells and Sertoli cells.  
DMRT1 and DM FAMILY 
DMRT1 is a transcriptional regulator that shares an evolutionary conserved cysteine-rich 
DNA binding motif (DM-domain) with doublesex (dsx) in the fruit-fly, Drosophila 
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melanogaster, and male abnormal-3 (mab-3) in the transparent nematode, Caenorhabditis 
elegans; both of which were shown to regulate sex-specific neuroblast differentiation and yolk 
protein gene transcription [111-114]. The revelation that the male-specific isoform of dsx (dsx
M
) 
regulated male-specific neuroblast differentiation in Caenorhabditis elegans illustrated that these 
two phylogenetically diverse proteins shared not only structural similarity but functional 
similarity as well, and suggested a common ancient origin of at least some features of sexual 
regulation [112]. Given that molecular mechanisms of sex determination are highly variable 
across species, the above findings revealed the unique situation in which orthologous genes from 
different phyla retain the same function in sex determination and differentiation. This showed for 
the first time that pathways for sex determination and differentiation are evolutionary conserved 
across phyla and suggested that DMRT1, the mammalian ortholog of dsx and mab3, would 
similarly exhibit conserved functions in sex determination and differentiation. 
Function of DMRT1 in humans 
The protein characteristics, testis-specific expression and chromosome location of 
DMRT1 strongly suggested that this protein plays an essential role in testis development [50, 
112, 115, 116]. The DM genes in humans were mapped to three distinct loci on chromosomes 1 
(1p32-34, containing DMRTB1 and DMRT1A2), 9 (9p21-p24.3 containing DMRTA1, DMRT2, 
DMRT3 (DMRT1A3) and DMRT1) and 19 (19p13 and 19q13 containing DMRTC2 and its closest 
paralog, DMRTC1, on chromosome Xq13) [117]. The 9p21-p24.3 locus in the human genome is 
considered to be evolutionary conserved because it shares extensive syntenic segments with 
regions on the X chromosome from Platypus (Ornithorhynchus anatinus) and regions on the Z 
chromosome in chicken (Gallus gallus) [8, 118]. Also, DMRTB1, DMRTC2/DMRTC1 and 
DMRT1 carry only a portion of the original sequences of the ancient vertebrate DM gene and are 
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thus considered to be derivatives that retain roles in sex differentiation [116, 119-121]. 
Furthermore, XY individuals carrying just one copy of the distal chromosome 9p locus had a 
greater incidence of reproductive abnormalities with features ranging from indistinct genitalia to 
complete XY sex reversal, indicating that two copies of the locus are required for ordinary testis 
differentiation [122, 123]. However, DMRT1 was mapped outside the missing 9p interval 
approximately 30kb from the breakpoint identified from two 46, XY female human patients 
[116]. Further characterization narrowed the deleted region to the most distal portion of 9p and 
adjacent to 9p24.3, which contains DMRT1 [119, 124-127]. These findings together with the 
testis-specific expression of DMRT1 suggested that haploinsufficiency for DMRT1 may be 
responsible for the defective testis determination and differentiation [128]. Surprisingly, 
sequence analysis of transcripts collected from sex-reversed patients failed to identify any 
mutation or deletion in DMRT1 [119], suggesting that the testis abnormalities associated with 9p 
deletions are caused by the loss of other gene(s). A likely candidate gene that could be deleted 
and associated with testicular abnormalities in 9p deletion would be DMRT3, which is located 
directly downstream of DMRT1. The total intergenic sequence of DMRT3 is less that 4kb and it 
is plausible that it shares some upstream regulatory sequences with DMRT1 [116, 129]. 
Function of DMRT1 in mice 
Studies in wild type and mutant mice have contributed significantly to our understanding 
of DMRT1’s expression profile and its requirement for postnatal testis development [50, 119, 
130]. During the early stages of gonadogenesis (between 10.5 and 11.5 dpc), DMRT1 is 
expressed in germ cells and supporting cells of XX and XY gonads (Figure 2A-C), at levels that 
are sexually indistinguishable [130]. However, by 12.5 dpc, DMRT1 is expressed in a sexually 
dimorphic manner, with testicular expression predominating in supporting cells and ovarian 
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expression predominating in germ cells [130]. By 13.5 dpc, DMRT1 expression was absent from 
pre-granulosa cells of the ovary, while it was robustly maintained in Sertoli cells of the testis. 
Immediately after birth, at approximately P0.5, DMRT1 was still expressed in Sertoli cells but 
absent from most germ cells with peak levels attained between P6 and P9 [130].  
Functional studies revealed that fetal gonad development was normal in the absence of 
DMRT1 [50]. In addition, no ectopic structures of the ovary or Müllerian duct-derived structures 
were identified in Dmrt1-null mice. However, postnatal testis development was significantly 
impaired in Dmrt1-null mice, which presented with testicular hypoplasia, disorganization of 
seminiferous tubules, abnormal Sertoli cell proliferation (failure to differentiate), no radial 
migration by germ cells, germ cell depletion by P10, and male infertility [50]. Conditional 
deletions to evaluate DMRT1 cell-specific roles validated many of its earlier-identified functions 
in addition to providing new insights on DMRT1 in postnatal testis development that indicated 
Sertoli cells and germ cells have independent requirements for DMRT1, whereas the survival of 
germ cells is dependent on DMRT1 in Sertoli cells [131]. Thus, DMRT1 in Sertoli cells assists 
with the cell’s differentiation, germ line maintenance, meiotic progression and radial migration 
[50, 131-136]. Furthermore, DMRT1 was suggested to regulate the mitotic to meiotic transition 
of spermatogonia by its repression of Stra8, which restricts spermatogonial responsiveness to 
retinoic acid (RA) and consequently meiotic entry, and by its regulation of Sohlh1, which 
implicated DMRT1 as a positive regulator of spermatogonial development [134]. In contrast, 
Dmrt1-null germ cells expressed less STRA8 in the fetal ovary and caused a reduction in the 
number of primordial follicles in the immature ovary, without any detriment to fertility [137]. 
Thus, these findings revealed a sex-specific function for DMRT1, whereby it activates Stra8 in 
the ovary and represses Stra8 in the testis. Moreover, conditional deletion of Dmrt1 in Sertoli 
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cells demonstrated its role in maintaining Sertoli cell differentiation, as its deletion resulted in 
the transdifferentiation of Sertoli cells into FOXL2-expressing cells with granulosa cell-like 
morphology [135]. Finally, about 1400 genes were identified as targets of DMRT1 using 
promoter arrays [136].  
Overall, studies to date support a conserved role of DM genes in sex differentiation and 
the importance of DMRT1 for the postnatal testis differentiation of mice. However, the studies 
also raise many additional questions. For example, unlike humans, where deletion at the tip of 
chromosome 9 resulted in sex reversal, Dmrt1 deletion or forced expression in female mice 
produced normal embryonic gonadal development and no sex reversal. The postnatal testicular 
defect observed might be due to gene redundancy effect provided by other DM gene(s) that are 
unaffected in the Dmrt1-null mice. It may also be attributed to differences in genetic 
backgrounds across species and a likely deviation of gene function during evolution. 
Regulation of Dmrt1’s activity 
DMRT1’s command over spermatogenesis and male fertility underscores the value of 
understanding the mechanisms that control its expression. While knowledge in this area is far 
from complete, several excellent studies identified important features of Dmrt1 transcriptional 
regulation. Initial analysis of the rat Dmrt1 gene employed a region of Dmrt1 that contained its 
transcriptional start site (TSS) and 5000bp of the 5′- flanking sequence, which was 
transcriptionally active when transfected into primary Sertoli cell cultures [138]. Mutational 
analysis of this region identified two regions (between -3280 & -2000 and Dmrt1 proximal 
promoter region (-150/+75)) that were important for Dmrt1’s transcriptional activity [138]. 
Further analysis of the first 150bp promoter region identified two elements that activated and two 
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elements that repressed Dmrt1’s transcription. The regulatory regions that activated transcription 
of Dmrt1 were bound by three transcription factors namely: Early growth response 1 (Egr1), 
Trans-acting transcription factor 1(Sp1) and Trans-acting transcription factor 3 (Sp3) [138]. In 
addition, GATA4 was found to bind three of several regulatory elements identified in the distal 
promoter region (between -3280 & -2000) and coupled with the expression of DMRT1 in Fog2-
null mice bolstered a regulatory role for GATA4 in the transcriptional machinery controlled by 
DMRT1 that’s required in the testis, especially during Sertoli cell differentiation [139]. 
Furthermore, transgenic expression studies, employing transcription regulatory regions of 
varying length, were used to identify the requirements for cell-specific expression by DMRT1. 
Transgene evaluation in Sertoli cells and germ cells concluded that distinct Dmrt1 promoter 
regions directed expression to Sertoli cells and germ cells [140]. The study also showed that 
Forkhead box L2 (FOXL2), a known regulator of ovarian differentiation, repressed Dmrt1 
promoter activity via regulatory elements located between the -3.2kb/+2.8kb region [140]. 
Although these transcription factors contribute to DMRT1’s expression, their extensive 
expression patterns suggest additional, unidentified factors also contribute to the specific 
expression patterns of DMRT1. 
Conclusion 
The role of DMRT1 in postnatal testis differentiation is well-established but its cell-
specific functions require further investigation [50, 116, 141]. Sertoli cells and germ cells in the 
testis interact closely, with each mutually affecting the other’s development and function. For 
example, a defect in Sertoli cells severely affects the development and function of germ cells; 
and likewise, the absence of germ cells negatively affects the differentiation of Sertoli cells. 
Thus, the functional inferences obtained from the Dmrt1-null and the partial deletion of Dmrt1 in 
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the conditional knockout studies are confounded by these associations, and attributing 
phenotypes to Sertoli cells or germ cells become difficult. Therefore, cell-specific assessment of 
Sertoli cell or germ cell morphology and transcriptome patterns derived from conditional Dmrt1 
mutants compared to Dmrt1-null mutants provided an incomplete picture of the activity of 
DMRT1 on Sertoli cell differentiation or germ cell development. The characterization of cell-
specific pathways, biologic processes, gene transcription regulators and mechanism(s) involved 
in Sertoli cell differentiation and germ cell development require extra methodologies like cell-
specific rescues; and this dissertation characterizes a novel mouse model to study the cell-
specific function of DMRT1 in the postnatal testis. 
Hypotheses and specific aims 
The mechanism(s) associated with DMRT1 and the pathways it regulates are unresolved. Thus, 
the overall hypothesis was to elucidate pathways critical for Sertoli cell differentiation and germ 
cell growth and maintenance regulated by DMRT1 and its protein-binding partners using mouse 
models with different cell-specific expression of DMRT1. To investigate this hypothesis, 
specific aims were proposed to identify biological pathways regulated by DMRT1 that were 
unique to Sertoli cells and germ cells. This goal relied on the identification of gene expression 
differences, direct targets and their associated biological processes. In addition, identification of 
a germ cell-specific partner protein of DMRT1 was the last objective of this project. 
Significance 
The realization of these goals provide answers for some patients with male infertility, 
which accounts for 40-50% of human infertility cases with half of the causes unknown [142]. 
Sterile men are frequently misdiagnosed and their options for treatment are limited to assisted 
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reproductive technologies (ARTs), which do not require knowledge of the underlying cause. 
Regrettably, the search for new causes of infertility and treatments has been hindered by the use 
of ART to avoid diagnosis, but trigger new worries of possible health risks due to inadequate 
understanding of the causes of male infertility and the lasting impact of such procedures 
including but not restricted to propagation of genetic defects to offspring. Although genetic 
factors account for a considerable fraction of male infertility, little progress has been made to 
untangle the basis of male infertility and highlights the need to encourage research to identify 
causes of idiopathic male infertility [143]. Therefore, investigation for such causes can be 
accelerated by widening the number of identified factors and pathways essential for Sertoli cell 
development, germ cell growth and fertility to facilitate investigation of the cause of the human 
disease. This project uses murine models and tissues to offer new knowledge on the fundamental 
biological processes required for optimal testicular environment, fertility and male contraception 
by identifying factors controlled by DMRT1. The underlying rationale is that, since DMRT1 is 
indispensable for Sertoli cell maturation, germ cell development and male fertility, and as a 
transcriptional regulator, it sits at the top of essential biological pathways. Identified downstream 
targets of DMRT1 probably contribute to the process of sperm production, and since humans and 
mice share the cascade of downstream genes responsible for testis differentiation, combined with 
the evolutionary conserved nature of DMRT1, will increase the usefulness of newly uncovered 
factors to facilitate research on possible causes of human male infertility. 
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Figure 1: Schematic representation of mammalian sex determination and sex differentiation. 
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Figure 2: Development of the bipotential gonad. Gonadal primordia develop as paired thickenings 
of the epithelial layer that lines the body cavity (the ceolomic epithelium), specifically in the region that 
overlays the ventral–medial surface of the mesonephros. The signals that specify this regional 
thickening of the coelomic epithelium are unknown, but experiments in mice have identified 
several genes that have roles in the early growth and maintenance of the gonad in both sexes. A-
C. Shows expression of DMRT1 in the undifferentiated gonadal ridge at 10.5. D. Schematic 
representation of development of undifferentiated gonad and subsequent sex determination. 
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Figure 3: Specification of primordial germ cells and migration. A. Primodial germ cells at 
the base of the allantois enter the hindgut. Primordial germ cells derive from epiblast during 
gastrulation (endoderm of the yolk sac) in response to signals from adjacent tissues. Founder pool of 
mouse germ cells consists of some 40 cells at about 7.25 dpc, located within a cluster of cells 
expressing high levels of alkaline phosphatase. The cluster lies in the extraembryonic mesoderm 
at the posterior end of the primitive streak. These founding cells express germ-cell-specific 
markers such as Stella and exhibit the characteristic pattern of TNAP activity that has been used 
to characterize the germ-cell lineage. These events constitute PGC specification. B. Primordial 
germs migrate from the hindgut into the genital ridges. Complete migration of PGCs takes about 
4 days (7.5 dpc to 11.5 dpc) in mice. 
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Figure 4: Schematic representation of spermatogenesis. Depicts formation of haploid sperm cells 
derived from a diploid undifferentiated spermatogonia through successive transformation, mitotic and 
meiotic processes. Shown also are the cell-specific markers expressed by the undifferentiated and 
differentiated spermatogonia. The depicted proteins are non-hormonal factors known to modulate the 
differentiation of  germ cells and Sertoli cells in the testis SC = Sertoli cell 
 
 
 
 
27 
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Abstract  
DMRT1 is an evolutionary-conserved transcription factor expressed only in the testis, where it is 
produced in Sertoli cells (SCs) and germ cells (GCs). While deletion of Dmrt1 in mice 
demonstrated it is required for postnatal testis development and fertility, much is still unknown 
about its temporal- and cell-specific functions. This study characterized a novel mouse model of 
DMRT1-deficient germ cells (rescue (Dmrt1
-/-;tg
)) that was generated by breeding Dmrt1 null 
mice with Wt1-Dmrt1 transgenic mice, which express a rat Dmrt1 cDNA in gonadal supporting 
cells by directing it from the Wilms' tumor locus carried on a yeast artificial chromosome 
transgene. Like Dmrt1
-/-
 mice, male Dmrt1
-/-;tg
 mice were infertile, while female mice were 
fertile. Expression analyses by qPCR, immunohistochemistry and Western blot showed that 
exogenous DMRT1 was present in supporting cells of the embryonic gonads of both sex and in 
Sertoli cells of the testis after birth. Functional analyses of the transgene on a Dmrt1
-/-
 
background showed that it exhibited copy-number dosage effect on specific genes and could not 
rescue testis size. However, it did maintain testis size and enhanced sperm progressive motility 
when expressed on a Dmrt1
+/+
 background. Seminal vesicles were absent from Dmrt1
-/-;tg
 and 
Dmrt1
-/-
 mice at P42, which was consistent with the low serum testosterone levels observed in 
these mice. In addition, the seminal vesicles were well-developed in Dmrt1
-/-;tg
 mice at P131, 
suggesting that the development of the reproductive system in these mice was delayed. 
Morphological analysis of adult testes showed that, compared to Dmrt1
-/-
 mice, Dmrt1
-/-;tg
 mice 
have improved seminiferous tubule structure, with lumens present in many cross-sectioned 
tubules. Features of Sertoli cell maturation were evaluated by electron microscopy, revealing that 
Dmrt1
-/-;tg
 Sertoli cells have not reached complete maturation.  
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Introduction 
Dmrt1 encodes Doublesex and Mab-3 related transcription factor 1, a required regulator 
of testis differentiation and spermatogenesis that shares homology with D. melanogaster 
Doublesex and C. elegans Mab-3 through its DM domain, a highly conserved, cysteine-rich 
DNA-binding motif featured in proteins involved in sex determination and differentiation [3, 
112-114, 131, 133, 134, 141, 144-154]. In vertebrates, DMRT1 expression is gonad-specific and 
favors the testis in a manner that depends on the species and developmental stage, reflecting its 
diverse roles in sexual development [50, 128, 131-133, 144, 151, 155-158]. In mammals, just 
prior to birth, DMRT1 expression becomes testis-specific, where it is restricted to 
undifferentiated spermatogonia and Sertoli cells (SCs) [50, 130-133, 159]. Its dynamic and 
highly restricted expression profile and similarity to conserved sexual regulators suggested, early 
on, that DMRT1 played an important role in male reproduction.  
In humans, the chromosomal location of DMRT1 (9p24.3) is associated with a wide 
spectrum of disorders that suggested DMRT1 haploinsufficiency causes defects in testis 
development, but no direct evidence exists connecting human DMRT1 to testis function [160-
167]. However, studies from many other species argue strongly for its importance to human 
fertility, as they demonstrate extensive evolutionary constraints on DMRT1 and its requirement 
for male reproduction [3, 112, 128, 131-133, 141, 144, 146-155, 157-159, 168-172]. To date, 
most of our knowledge on DMRT1 comes from studies in mice. Dmrt1 deletion in mice revealed 
its requirement for male fertility and important roles in establishment and maintenance of Sertoli 
cell differentiation and germ cell (GC) expansion and development [131, 133, 135, 173]. The 
predominant phenotype of Dmrt1
-/- 
mice was postnatal male infertility, associated with 
significantly hypoplastic testes [50, 132]. In contrast, fertility was normal in Dmrt1
-/- 
female mice 
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[50, 173]. In male Dmrt1
-/- 
mice, testicular morphology appeared normal through postnatal day 7 
(P7), except that, at P2-P5, the tubule centers contained GCs, which, normally have migrated to 
the periphery by this time [50, 131, 132]. Additional studies indicated DMRT1 in both SCs and 
GCs contributed to the effects on migration [131]. By P10, GC numbers were significantly 
decreased, while SC numbers increased and, by P14, GCs were absent and seminiferous tubules 
were filled with abundant immature SCs [50, 132]. Failure for germ cells to proliferate and 
differentiate led to depletion of germ cells and were characterized by reduced levels of γ-H2AX 
and P-H3, which are meiotic and mitotic marker proteins, respectively [132]. 
Conditional deletion of Dmrt1 in Sertoli cells demonstrated that DMRT1 acts 
autonomously to regulate cell maturation and non-autonomously to sustain GCs. In SC-specific 
Dmrt1 knockout model (SCDmrt1KO), GC morphology, migration and mitosis appeared normal 
through P7. However, by P9, GCs had accumulated in a disorganized pattern in the lumen and, 
by P28, they were absent [131]. Sertoli cells also appeared normal through P7, but by P9 were 
slightly disorganized, and by P14, were noticeably more disorganized. By P28, SCs were 
positioned throughout the tubule and had an immature phenotype, as indicated by a decrease in 
AR and GATA1 expression that are markers for SC maturation. More recent studies indicated 
DMRT1 is needed in SCs to maintain male sexual differentiation, as SC-specific Dmrt1 deletion 
caused postnatal loss of the male-promoting factor SOX9 and subsequent expression of the 
female-promoting factor FOXL2, suggesting DMRT1 loss caused differentiated SCs to 
reprogram into granulosa cells [135]. The delay between Dmrt1 deletion, presumably in the 
fetus, and feminization of the postnatal testis suggests that DMRT1’s involvement in maintaining 
SC differentiation occurs several weeks after birth or its embryonic effects are not erased until 
then.  
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Cell-specific effects of DMRT1 in germ cells, indicated that, in males, DMRT1 promotes 
spermatogonial differentiation by direct regulation of Sohlh1 and prevents entry into meiosis by 
repressing Stra8 expression and retinoid acid signaling [134]. In the fetal ovary, DMRT1 directly 
activated STRA8 expression and its loss caused improper localization of SYCP3 and γH2AX 
and reduced primordial follicles in the juvenile ovary, despite normal fertility [173].  
While conditional deletions of Dmrt1 in SCs have demonstrated its role in SC maturation 
and GC sustenance, its GC specific roles have been more difficult to decipher due to limitations 
in the models used to delete Dmrt1 to assess its GC-specific roles. In the Dmrt1-deficient germ 
cell model (GCDmrt1KO), a significant number of GCs were positive for DMRT1 due to poor 
Cre recombinase penetrance of TNAP-Cre; and Dmrt1was ectopically deleted in some SCs 
[131]. Furthermore, another cell-specific deletion model using Ngn3-Cre transgene showed that 
spermatogonia expressing DMRT1 did not express the transgene until several weeks postpartum 
[110, 174]. Overall, the available cell-specific deletion models provide an ineffective deletion of 
Dmrt1 at early postnatal ages, such as P5-P7, when the spermatogonia stem cell niche is being 
established. Thus, there is still a need for accurate analysis of DMRT1-deficient germ cells, at 
times when DMRT1 is implicated in testicular function. 
To assess DMRT1 germ cell functions, we employed a transgenic rescue approach that 
bypasses problems of inefficient gene deletion incurred by poor expression or penetrance of Cre 
recombinase. DMRT1 was overexpressed in mice using the Wt1 (Wilms’ tumor suppressor gene 
1) locus in a yeast artificial chromosome (YAC), which directed expression to supporting cells 
(pre granulosa and pre Sertoli) of the gonad; and mice expressing DMRT1 only in Sertoli cells 
(DMRT1 Sertoli cell rescue or DMRT1-deficient germ cells) were derived by breeding Dmrt1 
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transgenic with Dmrt1 null mice. Characterization of the transgene revealed it was expressed 
only in supportive cell of the gonads from early postnatal stages to adulthood. Dmrt1 transgene 
showed dose-dependent regulation for a select group of transcripts in prepubertal mouse testis, 
maintained testis size and enhanced sperm progressive motility in aging transgenic mice. 
Seminal vesicles were absent in P42 Sertoli cell rescues which was attributed to a block in 
Leydig cell function. Finally, the transgene partially rescued the seminiferous tubule morphology 
and induced a partial maturation state for Sertoli cells in the rescue mice.  
Materials and Method 
Generation of Wt1-Dmrt1 transgene.  
A 620kb YAC containing at least 100kb of the mouse Wt1 locus was purchased from 
Research Genetics (YAC620mWt1, address YAC-90-A1, Whitehead I mouse YAC library). A 
schematic of YAC620mWt1 is shown in Figure 1A (top). Saccharomyces cerevisiae yeast strain 
AB1380 (MATa, ura3-52, trp1, ade2–1, his5, lys2–1, can1–100) was grown in Yeast Peptone 
Dextrose medium and used to propagate the 620-kb YAC containing the mouse Wt1 gene. YAC-
containing yeasts were grown in selective media lacking uracil and tryptophan to maintain the 
YAC. Propagation was followed as described elsewhere [175].  
The targeting vector (pBKS-Wt1 5′-Dmrt1-HPRT1-LYS2-Wt1 3′) generated using PCR-
amplified DNA inserts and standard cloning methodology, is depicted in Figure 1A (middle). 
The vector contains a rat Dmrt1 cDNA flanked on its 3′ side by the hypoxanthine phosphoribosyl 
transferase 1 gene (HPRT1) containing a region of exon 8, exon 9 (contains a polyadenylation 
site) and intervening sequence, the yeast Lysine 2 gene (LYS2; selectable marker) and 776bp of 
Wt1 extending 3′ from its translational start codon. An 825bp fragment encompassing sequences 
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5′ to the Wt1 translational start codon was placed upstream of the Dmrt1 cDNA in the targeting 
vector. Primers used to PCR-amplify components of the targeting vector are shown in Table 1. 
HPRT1 and LYS2 inserts were PCR amplified from vectors provided by Dr. Kenneth Peterson 
and Dr. Alan Godwin, respectively, and are described elsewhere [176, 177]. Accuracy of the 
targeting vector was confirmed by DNA sequencing.  
The targeting vector, pBKS-Wt1 5′-Dmrt1-HPRT1-LYS2-Wt1 3′, was linearized by 
digestion with ClaI and introduced into YAC 620mWt1-containing yeast (AB1380 strain) by 
spheroplast transformation [178]. Since AB1380 is auxotrophic for lysine, yeast containing the 
targeting vector was selected for by growth in the absence of lysine. Restriction endonuclease 
mapping, pulse field gel electrophoresis and Southern blot analysis were used to identify 
targeting vectors that integrated correctly (data not shown). Homologous recombination between 
YAC and targeting vector was confirmed by PCR amplification and DNA sequence analysis, 
using Wt1-355 and Dmrt1.16A primers that spanned the 5′ integration site. The resulting YAC, 
Wt1-Dmrt1, contains an in-frame insertion of the Dmrt1 cDNA with Wt1 coding sequences 
(Figure 1A, bottom).  
Wt1-Dmrt1 and Dmrt1
+/-;tg
 mice 
Wt1-Dmrt1 YAC DNA was isolated by PFGE, concentrated by two-dimensional gel 
electrophoresis, released from the gel slice by agarase digestion, and filtered through a 0.22 μm 
filter as described elsewhere [179, 180]. Transgenic mice were generated through the Transgenic 
and Gene-targeting Institutional Facility at the University of Kansas Medical Center, using 
freshly prepared YAC DNA for pronuclear injection into C57B6/SJL F1 zygotes. Two female 
founders (#s 30 and 37) and one male founder (#13) were obtained and used to generate lines for 
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the production of transgenic offspring by mating to C57BL/6 mice. Wt1-Dmrt1 transgenic 
female mice (lines 30 and 37) were crossed with Dmrt1
+/-
 mice (obtained from Dr. David 
Zarkower and are described elsewhere [50], to create heterozygous transgenic animals (Dmrt1
+/-
;tg
), which were mated to generate Wt1-Dmrt1 transgenic mice homozygous for the Dmrt1 null 
allele (Dmrt1
-/-;tg
). Animals with different transgene copies were generated by crossbreeding 
lines 30 and 37. However, because transgenic Line 37 had the highest transgene expression, it 
was predominantly used to generate the data in this study. Genotypes of interest followed typical 
Mendelian genetics. Mice employed in the studies were of mixed background (primarily 
129/SvEv and C57BL/6) and cared for in accordance with National Institutes of Health 
guidelines; and experimental procedures approved by Laboratory Animal Research Committee at 
the University of Kansas Medical Center. Mice were maintained on a 12-hour light-dark cycle 
and given food and water ad libitum. 
 Mice were genotyped using genomic DNA isolated from mouse tail biopsies, as 
described elsewhere [181]. Sequences of primers used for genotyping are provided in Table 2. 
Mice positive for the transgene were identified by PCR of genomic DNA, using either Wt1-355 
and Dmrt1.16A or TGIF0088 and TGIF0090 primer pairs. Dmrt1 alleles were identified using 
primers TGIF0105 and TGIF0106 for detection of the Dmrt1
+
 allele, TGIF0105 and TGIF0107 
for detection of the Dmrt1
- 
allele. Southern blot analysis was also used for genotyping and 
transgene copy number determination. In this case, DNA digested with EcoRI was resolved by 
agarose gel electrophoresis, transferred to nylon membrane and hybridized with a probe 
corresponding to 165bp from exon 5 of Dmrt1 (generated by PCR using Dmrt1 exon 5 forward 
and reverse primer pairs). Embryonic sex was deduced from the presence or absence of Sry, 
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identified by PCR-amplification of genomic DNA (Sry forward and Sry reverse primers). All 
procedures were as described elsewhere [182] .  
Analysis of testis weights and sperm function 
Reproductive organs were collected from Dmrt1
-/-
, Dmrt1
-/-;tg
, Dmrt1
+/+
, Dmrt1
+/+;tg
 
(wild type mice with 1 copy of the transgene) and Dmrt1
+/+;tg+tg
 (wild type mice with 2 copies of 
the transgene) mice. Mice were euthanized by CO2 anesthesia followed by cervical dislocation. 
For each genotype, body and testes weights were determined from at least six male mice, ranging 
in age from P2 to 18 months. Spermatozoa obtained from the cauda of the epididymis from 6-
and-12 month old Dmrt1
+/+
, Dmrt1
+/+;tg
 and Dmrt1
+/+;tg+tg
 mice epididymis, were collected in 
Tyrode’s medium, counted, and approximately, 3x10
6
 cells were used for assessment of total and 
progressive motility by computer assisted semen analysis (CASA), as described elsewhere [183]. 
Statistical evaluations of changes in testis weight to body weight ratio (TW/BW), total and 
progressive motility between groups were done by Student T-test (p<0.05).  
Histology 
One testis from postnatal day 7 (P7), 15 (P15), 20 (P20) and 42 (P42) mice were fixed in 
Bouin’s solution at room temperature for 4-24 hr, depending on size. Testes were rinsed twice 
with 50% and 70% alcohol, cut in half at the sagittal plane, processed and embedded in paraffin 
according to standard procedures. Five micron (5μm) sections were cut and mounted on slides, 
cleared in xylene, rehydrated through graded alcohol series and stained with periodic acid 
Schiff’s (PAS) reagent and counterstained with hematoxylin. Testis morphology was analyzed 
using the Nikon Eclipse 80i microscope (Nikon Inc., Instrument Group, Melville, NY) and 
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digital images (x200 and x400) collected using Retiga 2000R fast camera and QCapture software 
(QIMAGING, Surrey, BC, Canada).  
Transmission Electron Microscopy.  
Testes of Dmrt1
+/+
, Dmrt1
-/-
 and Dmrt1
-/-;tg
 P42 mice were fixed in 2% glutaraldehyde in 
0.1M cacodylate buffer, postfixed in 1% osmium tetroxide/0.8% potassium ferrocyanide, stained 
in uranyl acetate, and embedded in Epoxy-araldite block. Semi-thin, 1μm sections were prepared 
from each wedge and stained with toluidine blue for examination of tubule morphology by light 
microscopy. Ultra-thin sections (80nm) were examined at 80 kV using a transmission electron 
microscope (JEOL 1400EX II; JEOL, Tokyo, Japan) for examination of germ cell and Sertoli 
cell morphology. 
Immunohistochemistry.  
Five micron (5μm) sections were cleared in xylene, rehydrated through graded alcohol 
solutions, and heated in 10mM sodium citrate buffer (pH 6.0) with microwaves (14 min at full 
power) for antigen retrieval. Sections were blocked using 10% normal goat serum (Zymed 
Laboratories Inc.) for 60 min at room temperature. For co-staining, primary antibody incubations 
were carried-out overnight at 4°C in blocking solution using the following dilutions: 1:400 of 
rabbit anti-DMRT1 antibody; 1:4 of rat antiserum to germ cell nuclear antigen 1 (GCNA1, 
kindly provided by Dr. G. C. Enders); 1:2000 of mouse anti-Proliferating cell nuclear 
antigen(PCNA)(PC10, SC56, Lot#G1006); 1:100 goat anti-GATA binding protein 4 (GATA4) 
(C20, SC-1237X, Lot#J1090); 1:100 goat anti-Androgen receptor (AR); and 1:200 rabbit anti-
Cytochrome 450, family 11, subfamily A, Polypeptide 1 (P450SCC). Incubation of the 
secondary antibody was performed at room temperature for 1 hour with a 1:200 dilution of 
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fluorophor-conjugated secondary antibodies (Alexa FluorR 488 goat anti-rabbit IgG, Molecular 
Probes Inc., Eugene; Alexa FluorR 568 donkey anti-rabbit IgG, Molecular Probes Inc., Eugene; 
Alexa FluorR 488 donkey anti-goat IgG, Molecular Probes Inc., Eugene; Cy™3-conjugated 
AffiniPure goat anti-rabbit IgG, Jackson ImmunoResearch Laboratories and Cy™3-conjugated 
AffiniPure goat anti-rat IgG, Jackson ImmunoResearch Laboratories). Samples were then 
washed 3 times in Phosphate buffer saline-tween20 (PBST) (5 min. each) and glass cover slides 
mounted using Fluoromount-G (Southern Biotechnology Associates Inc., Birmingham, AL). 
Digital images were collected as above, using fluorescent filters: DAPI (blue), FITC (green) and 
TRITC (red). Images were processed using Adobe Photoshop 
Serum collection and assay. 
Blood was collected, allowed to coagulate for 1hr at room temperature, and centrifuged at 
2000 × g for 15 min. Serum was transferred to a fresh tube and stored at −80
o
C. Randomized 
sera samples were sent to the University of Virginia Center for Research in Reproduction Ligand 
Assay and Analysis Core, which performed the assays for testosterone, using a mouse 
testosterone radioimmunoassay (RIA), mouse estradiol, by CalBiotech enzyme immunoassay 
and Luteinizing hormone (LH), by sandwich immunoradiometric assay (IRMA). Group analyses 
were performed using one-way ANOVA followed by Tukey’s comparisons to detect significant 
differences between groups (P < 0.05). 
RT-PCR analysis of transgene expression in transgenic mice 
F1 offspring were sacrificed and total RNA isolated from various tissues using TRIZOL 
reagent, according to manufacturer’s procedures (Life Technologies, Gaithersburg, MD) and 
tissue-specific transgene expression evaluated by RT-PCR, as described elsewhere [184]. One 
microliter of a 20uL cDNA prep generated from 2ug RNA was used as template in PCR with 
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primers (listed in Table 2) located in the Dmrt1 cDNA (Dmrt1 3′) and exon 9 of HPRT1 
(HPRT1), which span the HPRT1 intron and allowed differentiation between the expressed 
transgene and contaminating genomic DNA. Amplified products were examined by agarose gel 
electrophoresis, with that from the transgene’s cDNA yielding a 434bp product and that from 
genomic DNA yielding a 1102bp product. 
Quantitative real-time PCR 
Real-time reactions were carried out, as described, using a 7900HT Sequence Detection 
real time analyzer (Applied Biosystems, Foster City, CA)[185]. Testis RNA was isolated as 
above from Dmrt1
-/-
, Dmrt1
-/-;tg
 and Dmrt1
+/+
 P7 mice. First-strand cDNA synthesis was 
performed using 2ug RNA with MMLV reverse transcriptase, following manufacturer’s 
instructions (Invitrogen, Carlsbad, CA). A 1:10 dilution of cDNA was assayed using a SYBR
®
 
Green PCR master mix (Applied Biosystems, Foster City, CA) and primers listed in Table 3. 
Samples and negative control (water) were run in triplicate. Ct melting curves for endogenous 
RNA ribosomal L7 (Rpl7) was used to calculate Ct values for each sample. Rpl7 Ct values did 
not vary across genotype and the melting curves for Rpl7 and the genes assayed gave only a 
single, unique peak for each primer set. Ct values were calculated by subtracting the mean P7 
wild type Ct. Fold change was calculated using the Ct method [186].  
Results 
Generation of Wt1-Dmrt1 transgenic mice 
To establish a mouse model that ectopically expresses DMRT1 in supporting cells of the 
gonads, a YAC transgene was used to direct expression of DMRT1 to pre-Sertoli and pre-
granulosa cells in the embryo. The transgene was generated using a ‘knock-in’ strategy that 
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inserted a rat Dmrt1 cDNA into the mouse Wilms’ tumor 1 gene (Wt1) located within 620mWt1, 
a YAC, when previously used as a transgene, expressed only in kidney and gonads (Figure 1, top 
and [39, 187]). Notably, gonadal expression was restricted to supporting cells and began at a 
time prior to sex determination. A targeting vector (Figure. 1A middle) was used to insert the 
Dmrt1 cDNA into Wt1 at a specified site in 620mWt1, via homologous recombination. The 
resulting Wt1-Dmrt1 transgene contains Dmrt1’s cDNA (beginning with the DMRT1 AUG start 
codon) inserted in-frame with WT1’s start codon in 620mWt1 (Figure. 1A bottom). Expression 
of the Dmrt1 cDNA within Wt1-Dmrt1 is therefore directed by Wt1 regulatory sequences. Three 
founders were obtained and used to develop transgenic lines 13, 30, and 37, all of which 
produced pups with the correct chromosomal sex. RT-PCR of multiple tissues from newborn and 
postnatal day 15 (P15) mice showed transgenic Dmrt1 expressed only in kidneys and gonads, 
confirming the expected spatial expression of the transgene (Figure 1B-D).  
Transgenic DMRT1 is Sertoli cell-specific in Dmrt1
-/-;tg
 testes 
Mice with DMRT1 expressed only in Sertoli cells were created by mating transgenic 
male mice with Dmrt1
-/- 
female mice, which are fertile. To confirm proper cellular expression of 
the transgene, immunofluorescence staining was performed for DMRT1 (green) and the specific 
germ cell marker GCNA1 (red), using testis sections from P7 mice. In Dmrt1
+/+
 mice, DMRT1 
was observed in testicular Sertoli cells and germ cells, the latter of which, when merged, 
appeared primarily yellow, indicating DMRT1 is present in most P7 germ cells (Figure 2A-C). 
As expected, no DMRT1-positive cells were seen in Dmrt1
-/-
 testes (Figure 2D-F) or in Dmrt1
-/-
;tg
 germ cells (Figure 2G-I), which stained only for GCNA1 (Figure 2I). Western blot analysis 
confirmed that DMRT1 protein was expressed in Dmrt1
-/-;tg
 but not in Dmrt1
-/-
 testes (Figure 2J). 
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Thus, DMRT1 produced from the transgene validates cell-specific expression only in Sertoli 
cells of the of Dmrt1
-/-;tg
 testes.  
Transgenic Dmrt1 partially preserves testis morphology but does not rescue testis weights.  
As previously reported during characterization of germ cell migration from P0-P7, 
defects in germ cell radial migration were observed in Dmrt1
-/-
 P7 testes. Thus, Dmrt1
-/-
 germ 
cells were confined to the lumen of the seminiferous tubule, while Dmrt1
+/+
 germ cells were 
located on the basement membrane [50, 131, 132, 188]. Notably, germ cells in Dmrt1
-/-;tg
 testes 
also showed defective migration, consistent with similar findings in DMRT1-deficient germ cells 
[131]. PAS stained P7 Dmrt1
-/-;tg
, Dmrt1
-/-
 and Dmrt1
+/+
 testis sections revealed similar tubule 
morphology between the three genotypes, with only modest differences noted in organization 
(Figure 3A-C). However, by P42 Dmrt1
-/-;tg
 testes showed notable but partial improvement in 
tubule morphology relative to Dmrt1
-/-
 testes (Figure 3D-L). Thus, histological analyses showed 
distinct differences in seminiferous tubule organization at P42 and in contrast to Dmrt1
-/-
 testes 
(Figures 3E and 3H ), Dmrt1
-/-;tg
 testes contained numerous tubules with defined lumens (Figures 
3F and 3I, arrowheads). Furthermore, no SC nuclei were observed in the lumen of the tubule in 
Dmrt1
-/-;tg
 (Figure 3I, arrowheads). Because accumulation of fatty acids was difficult to evaluate 
by PAS staining, toluidine blue staining on 1µm sections (Figures 3J-L) was employed; and 
whereas the lumen in the Dmrt1
-/-
 seminiferous tubules (Figure 3K, asterisk) featured abundant 
accumulation of lipid droplets in addition to SC nuclei, the lumen of the Dmrt1
-/-;tg
 seminiferous 
tubules (Figure 3L, arrowhead) contained only lipid droplets. The partial restoration of tubule 
morphology indicated that transgene-derived DMRT1 in Sertoli cells is functional and influences 
the formation of the basal and apical compartments within the seminiferous tubules. 
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To better pinpoint the effect of transgenic DMRT1 on testis development and the timeline 
for deficiency, we compared testis weight to body weight (TW/BW) ratios of Dmrt1
+/+
, Dmrt1
-/-
, 
and Dmrt1
-/-;tg
 mice at P2, P7, P15, P20, and P42. The TW/BW ratios at P2 were similar between 
Dmrt1
+/+
, Dmrt1
-/-
 and Dmrt1
-/-;tg
. A small but significant (p<0.01) difference was first observed 
in the Dmrt1
-/-
 and Dmrt1
-/-;tg
 P7 mice and the TW/BW difference increased with each age, 
thereafter (Figure 4). No significant difference was observed between TW/BW ratios of Dmrt1
-/-
 
and Dmrt1
-/-;tg
 mice, at all-time points (Figure 4). Thus, loss of Dmrt1 caused modest changes in 
TW/BW beginning between P2 and P7 and its return to Sertoli cells, via the transgene, failed to 
rescue these changes. Given that testis weight strongly correlates to the number of germ cells, the 
inability of transgenic DMRT1 to preserve testis weights in Dmrt1
-/-;tg
 mice confirms the 
autonomous role of DMRT1 in germ cell maintenance and/or development[131]. 
Wt1-Dmrt1 copy number influenced testis gene expression.  
To determine if DMRT1 levels affect testis gene expression, specific DMRT1-regulated 
transcripts were quantified from testes carrying different copy numbers of the Wt1-Dmrt1 
transgene. Transcripts were selected from transcriptome data that identified mRNAs with altered 
expression in P7 Dmrt1
-/-
 testes (manuscript in preparation). Dmrt1 and the selected mRNAs 
were measured by qRT-PCR, using RNA prepared from Dmrt1
-/-
, Dmrt1
+/+, 
and Dmrt1
-/-;tg 
P7 
testis. For Dmrt1
-/-;tg 
samples, Southern blot analysis, followed by densitometry and phosphor 
imaging, was used to identify mice with either one or two copies of the line 37 transgene (Figure 
5A). The data revealed dose-dependent expression of transgenic Dmrt1, demonstrating that the 
number of transgenes determined the level of Dmrt1 mRNA (Figure 5B). The data also identified 
three distinct categories for responsive genes; resistant, partial and sensitive. Resistant genes 
(Mage-K1, Cidea, Rbym1a1, Stk31, and Gpr37) changed significantly in Dmrt1
-/-
 testes, with or 
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without the transgene, indicating they are regulated by DMRT1 in germ cells. Genes in the 
partial category (Lect1, Nfx2 and Tnnt2) modestly responded to added transgene, without notable 
dose-dependency, suggesting a combined requirement for germ cell and Sertoli cell DMRT1. 
Sensitive genes (Sycp1, Rarres1, Pramel3, and Trim34) showed a dose-dependent response to 
the transgene, consistent with a primary dependence on Sertoli cell DMRT1. These findings 
support using transgene sensitivity to distinguish autonomous from non-autonomous effects of 
DMRT1. 
Transgenic DMRT1 alleviates the age-dependent decrease in testis size and progressive sperm 
motility observed in wild type mice 
Because DMRT1 influences Sertoli cell differentiation, the transgene’s influence over 
age-related changes in testes size and sperm function was evaluated in wild type mice (Dmrt1
+/+
) 
and mice carrying one or two copies of the transgene (Dmrt1
+/+;tg
 and Dmrt1
+/+;tg+tg 
, 
respectively). The mean body weight (Figure 6A) and mean paired testes weight (Figure 6B) 
were evaluated at ages 3, 6, 10, 12 and 18 months. Body weights were not changing as no 
statistical significant differences (p > 0.05) were noted between genotypes at each time-point 
(Figure 6A). Similarly, there was no statistical difference in mean paired testes weights between 
genotypes at all time-points except at 18 months of age, where the testes weights of Dmrt1
+/+;tg
 
and Dmrt1
+/+;tg+tg
 mice were significantly greater (p<0.001) than those from Dmrt1
+/+
 mice 
(Figure 6B). In addition, when the paired testes weights were corrected by their respective body 
weights (TW/BW ratio), no significant differences were observed between genotypes at 3, 6 and 
10 months of age (Figure 6C). However, at 12 and 18 months, the TW/BW ratios were 
significantly higher in mice carrying the transgene. This finding suggested that Sertoli cell 
function was preserved, which also preserved the spermatogenic capacity. Thus, CASA revealed 
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that the decrease in sperm progressive motility observed naturally in 12-month-old wild type 
mice was partially restored by the presence of the transgene (Figure 6D). The data suggest that 
the additional DMRT1 in Sertoli cells helped preserve spermatogenesis and sperm function.  
Germ cell DMRT1 is needed to maintain adult testosterone levels  
To determine if Dmrt1 impacts the animal’s reproductive hormone status, serum 
testosterone (T) was measured in Dmrt1
+/+
, Dmrt1
-/-;tg
 and Dmrt1
-/-
 mice. Although the 
difference was only moderately significant (p = 0.19), Dmrt1
-/-
 mice at P15 had reduced serum T 
compared to Dmrt1
+/+
 mice (Figure 7A). In addition, comparison of Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice 
indicated the transgene improved serum testosterone levels at P15 but the increase was not 
statistically significant (p = 0.17). By P20, serum T levels had increased and, surprisingly, were 
similar in all three genotypes, indicating that the decreased testis size at P20 (Figure 4) did not 
result from reduced T. By P42, T levels were significantly lower in both Dmrt1
-/-;tg
 (p = 0.04) 
and Dmrt1
-/-
 (p = 0.03) compared to wild type. The drop in testosterone between P20 and P42 
was supported by evaluation of the seminal vesicles, which were present in P20 and P42 wild 
type mice and absent from Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice only at the P42 time point (Figure 7B). 
However, the presence of well-developed seminal vesicles at P131 only in Dmrt1
-/-;tg;37
 
compared to Dmrt1
-/-
 mice suggest that the drop in serum testosterone levels was temporary and 
the Dmrt1
-/-;tg
 mice show a delay in the development of reproductive structures (Supplementary 
Figure 1). Furthermore, the serum levels of LH (Figure 7C) and estradiol (Figure 7D) were 
examined. Between P15 and P20, T and LH levels rose in Dmrt1
-/-
 and Dmrt1
-/-;tg
, mice, while 
between P20 and P42, only T levels dropped significantly. The results suggest that LH regulates 
T production at P15 and P20 but the regulation is lost by P42. On the other hand, the addition of 
the transgene caused a rise in estradiol level in Dmrt1
-/-;tg
 mice at P15 which was not statistically 
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different when compared to estradiol levels in Dmrt1
-/-
 (p = 0.15) or wild-type (p = 0.24) mice. 
From P15 through P42, the levels of estradiol dropped in Dmrt1
-/-;tg
 and Dmrt1
+/+
 mice but 
remained constant in Dmrt1
-/- 
mice. The results suggest that LH regulates the estradiol level at 
P15 and the levels at P20 and P42 are derived from the conversion of T. 
The above data indicate that, in P15 and P20 Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice, LH controlled 
the production of T, but, by P42, despite sufficient LH, T levels dropped, indicating the problem 
arose from a defect in the testis. Therefore, the testis was examined by immunohistochemistry, 
using an antibody against CYP11A1 (P450SCC), which is the rate-limiting enzyme for 
testosterone production and a marker of the Leydig cell population. At P7 (Figure 8A-C) and P15 
(Figure 8D-F), Leydig cell numbers appeared similar between testes of each genotype. However, 
Leydig cell morphology was noticeably different in the Dmrt1
-/-
 P15 testis, with more P450SCC-
positive cells residing in groups (Figure 8E). By P20 (Figure 8G-I), the number of Leydig cells 
appeared slightly increased in Dmrt1
-/- 
(Figure 8H) and Dmrt1
-/-;tg 
(Figure 8I), an impression 
most likely due to the increased numerical density of Leydig cells (number of Leydig cells per 
testis volume), given the significantly decreased testis size in the Dmrt1
-/-;tg
 and Dmrt1
-/-
 mice. In 
Dmrt1
-/-;tg 
and Dmrt1
-/-
 P42 mice, the apparent increase was even more exaggerated (Figures 8L 
& K). In marked contrast to the Dmrt1
-/-;tg
 and Dmrt1
-/-
 testes at P42, the Leydig cells in 
Dmrt1
+/+
 were larger and accumulated in distinct regions of the interstitium (Figure 8J). These 
results indicate that the age-dependent hypogonadism resulted, not from a loss in Leydig cell 
number, but from a defect in Leydig cell function. Since the expression of transgene-derived 
DMRT1 in Sertoli cells did not correct the problem, the deficiency most likely resulted from 
DMRT1’s absence in the germline. 
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Germ cell DMRT1 influences Sertoli cell maturation  
To determine if the transgene rescues defects in Sertoli cell maturation, proliferation and 
junctional complex formation, qRT-PCR and immunocytochemistry was used to compare the expression 
of genes involved in these cellular processes between Dmrt1
+/+
, Dmrt1
-/-
, and Dmrt1
-/-;tg
 testes. To 
evaluate Sertoli cell maturation, expression of three different genes was evaluated; Ar and Gata1, which 
are prominent in mature Sertoli cells, and Krt18, which is a marker of immature cells [189, 190] . At P7, 
Ar mRNA levels were not significantly different between Dmrt1+/+ and either Dmrt1-/- or Dmrt1-/-;tg mice, 
while Gata1 mRNA was reduced (p<0.005) in both Dmrt1-/- and Dmrt1-/-;tg testes (Figure 9). In contrast, 
Krt18 was markedly elevated (p=0.0028) in Dmrt1-/-;tg and Dmrt1-/- testes relative to Dmrt1+/+(Figure 9). 
Differentiation of Sertoli cells coincides with formation of the blood-testis barrier, which contains 
various membrane- and junction-associated inter-Sertoli proteins, such as OCLN, ESPIN, CLDN11, and 
TJP1 [191-194]. Transcript levels of the cell junction markers Ocln, Espin, and Cldn11 were dramatically 
changed in Dmrt1-/-, while more modest changes were noted for Tjp1 (Figure 9). Except for Espin, 
significant changes were noted in both Dmrt1-/- and Dmrt1-/-;tg mice. Of the four cell junction genes, only 
Espin mRNA levels increased in Dmrt1-/- testes (~3 fold; p < 0.03) or returned to normal when DMRT1 
was returned to Sertoli cells (Figure 9; Dmrt1-/-;tg). In addition, mRNA levels of Gata4, a transcription 
factor that plays important roles in the development and function of fetal and postnatal Sertoli cells and 
Leydig cells [195], were significantly increased in both Dmrt1
-/-
 and Dmrt1
-/-;tg
 testes compared to 
Dmrt1+/+ (Figure 9). Notably, of the genes investigated, only Espin showed significant sensitivity to 
DMRT1 in Sertoli cells, indicating that the other genes were primarily influenced by DMRT1 in germ 
cells.  
Expression of AR was examined at a time-point before (P7) and after (P15) Sertoli cell 
maturation in wild type mice. In mouse testes of all groups, AR was observed in Sertoli cells (arrows), 
peritubular myoid cells (arrowheads), and Leydig cells (asterisks) (Figure 10). At P7, all three groups 
showed strong staining for AR in myoid and Leydig cell, while staining was absent from Sertoli cells 
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(Figure 10A-C). By P15, AR was evident in all or most Sertoli cells of wild type mice, while it was 
absent or reduced in most Sertoli cells from the Dmrt1-/- mice (Figure 10 D & E). Comparison of AR 
staining in Sertoli cells of Dmrt1-/- and Dmrt1-/-;tg mice revealed more AR-positive Sertoli cells in mice 
baring the transgene (Figures 10E & F).  
Immunohistochemistry was also used to examine P42 testes for expression of GATA4 and 
PCNA. Testes sections revealed GATA4 in both Sertoli cells (arrowheads) and Leydig cells (located in 
the intertubular spaces), while PCNA was largely restricted to germ cells and the occasional Leydig cell 
(Figure 11A). GATA4 staining was also apparent in spermatids, which, as previously reported, was 
considered nonspecific staining [189]. In Dmrt1
-/-
 testis sections, GATA4 was noted in all cells located 
within the remaining tubule-like structures and scattered throughout the interstitium. Some cells within 
the tubules and interstitium stained for both GATA4 and PCNA (Figure 11B, arrows) but most PCNA-
positive cells were GATA4 negative and located in the interstitium. In Dmrt1-/-;tg testis sections, fewer 
cells that express only PCNA appeared to partition to the interstitium and cells positive for both GATA4 
and PCNA were observed in both the tubules (Figure 11 C, arrows) and interstitium . In the Dmrt1-/-;tg 
mouse testis, two populations of GATA4-positive, PCNA-positive Sertoli cells were identified; one in 
which GATA4 and PCNA were both nuclear (arrowhead) and the other in which only PCNA was nuclear 
(asterisks). Sertoli cells co-expressing GATA4 and PCNA were considered immature and proliferating 
whereas those expressing only GATA4 were considered more mature or differentiated. Sertoli cells in 
Dmrt1-/- mice were still proliferating and thus were considered immature.  
Sertoli cell maturation was also assessed by examining nuclear ultrastructure at P7 and P42 
(Figure 12: SC and GC nuclei traced by black and white lines, respectively). At P7, Sertoli cell nuclei of 
Dmrt1+/- mice had a regular columnar contour without invaginations and were located away from the 
basement membrane (Figure 12A, insert). In P7 Dmrt1-/- mice, nuclei were more mature in appearance, 
with an irregular shape and multiple invaginations and more prominent areas of condensed chromatin 
(Figure 12 B). In P7 Dmrt1-/-;tg mice, some rounded, regular-shaped Sertoli cell nuclei, similar to that 
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observed in the wild type, were observed but the majority appeared as those in P7 Dmrt1-/- mice (Figure 
12C, arrowheads in insert). At P42, the Dmrt1+/+ nucleus was ovoid and adjacent to the basement 
membrane (Figure 12D). The nuclear membrane was irregular and invaginated (arrow in insert, Figure 12 
D), while the nucleolus formed a central granular condensed area (Figure 12D). P42 Dmrt1
-/- 
nuclei were 
predominantly round, columnar or ovoid shaped, without invaginations, and located away from the 
basement membrane of the tubule (Figure 12E). Dmrt1-/- nucleoli were found at the periphery of the 
nucleus and the chromatin was arranged in irregular granular clusters. The morphology of the nuclei in 
P42 Dmrt1-/-;tg mice appeared intermediate to that observed in wild type and Dmrt1-/- mice, comprising a 
mixture of nuclei that were either regular round or irregular ovoid (compare nuclei denoted with asterisks 
in Figures 12 E and F). Some of these nuclei had invaginations (arrows in insert, Figure 12 F) and 
nucleoli that formed a central granular condensation area (Figure 12 F, insert). However, most ovoid 
nuclei had nucleoli located at the periphery of the nuclear membrane and chromatin arranged in irregular 
granular clusters.  
Discussion 
Dmrt1 is a putative mammalian ortholog of Dsx and Mab-3, genes known to be involved in sex 
determination and differentiation in flies and worms, respectively, and its diverse roles in sex 
determination and differentiation are well established [3, 50, 112, 128, 131-133, 141, 144, 146-155, 157, 
158, 172]. In mammals, DMRT1 functions predominantly after birth, when it becomes male-and-testis-
specific and is required for male fertility [50, 131, 133]. At this time, DMRT1 is expressed only in 
spermatogonia and Sertoli cells where it acts both autonomously and nonautonomously to regulate germ 
cell proliferation and differentiation and Sertoli cell maturation [50, 130-133, 159]. While many excellent 
studies have contributed to our understanding of DMRT1’s actions in the testes, there remain numerous 
uncertainties regarding its function, particularly with respect to its cell specific roles. Here we report the 
development and characterization of a unique mouse model, to facilitate our understanding of DMRT1’s 
specific functions in Sertoli cells and germ cells.  
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Spatio-temporal expression of Wt1-Dmrt1 transgene 
The model employed the Wt1 locus within a YAC transgene to direct DMRT1 specifically to 
Sertoli cells of the testis. The use of YACs (or BACs) as transgenes have several advantages over smaller 
vectors, as they are much less subject to insertion side effects, resulting in expression that depends only 
on sequences in the transgene [196]. In addition, larger transgenes often express at levels that are copy 
number dependent, allowing one to adjust levels of expressed product. In the case of the Wt1-Dmrt1 
transgene, its tissue and cellular expression profiles adhered to that of Wt1 and it induced dose-dependent 
expression changes in several DMRT1-regulated genes. Transcript measurements of transgenic embryos, 
as well as previous reports using the original YAC, suggest transgenic DMRT1 was present prior to sex 
determination, in both male and female gonadal somatic cells, through adulthood. After birth, transgenic 
Dmrt1/DMRT1 was restricted to the kidneys and gonads of both sexes and, in the gonads was limited to 
the supporting cells [39, 187, 197-199] . Importantly, immunohistochemistry on testis sections from 
Dmrt1-/- mice carrying the transgene showed transgenic DMRT1 expressed only in Sertoli cells of the 
testis, while Western blot analysis reported levels that matched the endogenous protein. The data, 
therefore, confirmed that the spatial and temporal expression pattern of DMRT1/Dmrt1 directed by the 
YAC transgene matched that reported for endogenous Wt1[39, 197, 198].  
DMRT1 is not required for murine sex determination but preserves testis function 
Expression of exogenous DMRT1 in female mice on a Dmrt1+/+background did not cause any 
notable morphological or functional abnormalities during gonadogenesis and female-to-male sex reversal 
was not observed (data not shown). Thus, consistent with murine Dmrt1 deletion studies, continuous 
expression of DMRT1 in pre-granulosa cells did not implicate it in murine sex determination [50, 141]. 
Eventually, all female transgenic mice, regardless of the genetic background (Dmrt1+/+, Dmrt1+/- or 
Dmrt1-/-) reached sexual maturity and were fertile. Male transgenic mice (Dmrt1+/+;tg) were also fertile 
and, surprisingly, showed less of the age-related declines in testis size and sperm progressive motility, 
normally observed in wild type males. The finding suggests that, by preserving Sertoli cell function, 
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DMRT1 preserved both spermatogenic capacity and sperm function. This role in sex maintenance is 
supported by a recent study using conditional cell-specific deletion of Dmrt1 in Sertoli cells 
(SCDmrt1KO). Specifically, cell-specific deletion of Dmrt1 in Sertoli cells resulted in a normal 
morphology and SOX9 expression after birth; but by P14, Dmrt1-null Sertoli cells started expressing 
FOXL2, which is normally expressed in the ovary, and by P28, the majority of cells expressing SOX9 
were lost while the number of cells that were FOXL2-positive were increased in the seminiferous tubule. 
Also, similar changes were observed four weeks after the cell-specific deletion of Dmrt1 in adult mice, 
leading to the conclusion that loss of Dmrt1 causes Sertoli cells to be reprogrammed into cells with a 
granulosa-like or theca-like morphology[135]. Overall, it is still unclear if Dmrt1 regulates murine 
primary sex determination but unquestionable that it is vital for postnatal testis differentiation and gonadal 
sex maintenance.  
Dmrt1
-/-;tg
 ( or Sertoli cell rescue or germ cell deficiency) mouse model complements existing 
Dmrt1 cell-specific deletion models. 
The Dmrt1-/-;tg (or Sertoli cell rescue or Dmrt1-deficient germ cell) mouse is a Sertoli cell-specific 
expression model generated by expressing DMRT1 in Dmrt1-null Sertoli cells unlike the existing 
GCDmrt1KO models generated by CRE-mediated Dmrt1 deletion [131, 133, 134]. The Dmrt1
-/-;tg
 mouse 
model has the potential to provide novel insight to cell-specific actions of DMRT1 that are impossible to 
examine using current models, which fail to capture germ cell specific events at early ages afterbirth. For 
example, existing models cannot precisely evaluate the role of DMRT1 in establishing the germ cell 
lineage, if the process involves loss of DMRT1 in all germ cells (e.g. expression profiling). Likewise, 
they cannot assess its specific function in gonocytes prior to puberty, consequently primary processes, 
like re-activation of DMRT1 in the germ line (P0-P2) and the early events that lead to testis defects (P2-
P10), cannot be evaluated [50, 131-133]. More specifically, Dmrt1 was conditionally deleted from germ 
cells in previous models using the Cre-LoxP system that employed either TNAP-Cre or Ngn3-Cre [131, 
133, 134, 200]. The TNAP-Cre employed was limited by its poor Cre penetrance that resulted in partial 
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deletion with a portion of germ cells positive for DMRT1. Furthermore, immunohistological analysis 
showed that deletion using the TNAP-Cre was leaky and nonspecific as DMRT1 was ectopically ablated 
in some Sertoli cells. Thus, TNAP-Cre cannot be used to correctly profile the cells without accounting for 
the effective deletion. Likewise, a significant number of spermatogonia that were DMRT1-positive were 
negative for the Ngn3-Cre transgene until several weeks after birth, which prevented analysis of early 
germ cell specific events [110, 174]. The restricted co-expression of DMRT1 and NGN3 in prepubertal 
mice can be appreciated by immunofluorescence of the two proteins in P7 testes, which shows few dual-
stained yellow cells [130]. Consequently, the mechanistic, morphological and molecular changes directed 
by DMRT1 in the germline remains unexploited. In Dmrt1
-/-;tg
 mice, DMRT1 is expressed from the Wt1-
Dmrt1 transgene in pre-Sertoli and pre-granulosa cells of the developing gonad and the cells are rescued 
from DMRT1 deficiency prior to sex determination in the embryo . Thus, complete loss of DMRT1 
expression in GCs begins at the onset of gonadogenesis and continues through maturity. Overall, the 
Dmrt1-/-;tg model complements and extends our knowledge of the conditional deletion models by 
providing understanding from a cell-specific expression perspective that is different from cell-specific 
deletion standpoint. 
Germ cell depletion and abnormal hormonal levels contribute to the hypoplastic testis phenotype 
in Dmrt1
-/-;tg
 (rescue) mouse model.  
Like the previously described male Dmrt1-/- mice, male Dmrt1-/-;tg mice were sterile and 
characterized by testicular hypoplasia [50]. This phenotype was substantiated in the adult (P42) Dmrt1-/- 
and Dmrt1-/-;tg mice by significant reduction in testis weights and serum testosterone levels; and 
estimation of the timeline for the onset of the testicular defect in Dmrt1-/-;tg mice like in Dmrt1-/- mice 
suggested it may begin as early as P3. The progressive loss of germ cells noted at P7 which resulted in 
complete germ cell depletion by P15 (data not shown) in Dmrt1-/-;tg like the complete depletion by P10 in 
the testis of Dmrt1-/- mice, most likely contributed to the reduced testis weights [50]. Furthermore, the 
trends of serum T, LH and estradiol levels in Dmrt1-/- and Dmrt1-/-;tg mice compared to controls also 
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suggested strong hormonal influence on the hypoplastic testis phenotype. Specifically, the serum T and 
LH levels rose between P15 and P20 in all three groups but serum T dropped between P20 and P42 in 
Dmrt1-/- and Dmrt1-/-;tg mice while serum LH was similar in all three groups. Although the drop in serum 
T was substantiated by the absence of seminal vesicles in Dmrt1
-/- 
and Dmrt1
-/-;tg
 mice at P42, the lack of a 
significant increase in serum LH as a feedback response to loss of T was likely confounded by the large 
variability in the LH data. And an obvious increase in serum LH was observed in Dmrt1-/- and Dmrt1-/-;tg 
mice when the high values were removed during subsequent data analyses (data not shown). In addition, 
because Sertoli cells have been shown to transdifferentiate into apparent granulosa cells in Dmrt1 null 
mice [135], the serum levels of the female sex hormone, estradiol; produced by granulosa cells and as an 
active metabolic product of testosterone, was evaluated. At P15, the addition of the transgene in Dmrt1-/-;tg 
mice caused a significant rise in estradiol levels that was not sustained as the mutant mice aged. Thus, 
because there was an apparent rise in LH between P15 and P20 it appears the rise in T and estradiol was 
driven by LH, but between P20 and P42, the drop in T is not dependent on LH. This finding that 
testosterone levels was maintained only in wild type P42 mice, suggests that DMRT1 activity in germ 
cells may regulate the development of interstitial Leydig cells which produces testosterone required for 
the growth of male reproductive organs.  
DMRT1 in Sertoli cells maintains tubule integrity  
Further evaluation of Dmrt1-/-;tg mice reveals Sertoli cell-specific function of DMRT1 in maintaining 
integrity of seminiferous tubules. The histology of tubule had discernible differences between the Dmrt1-/-
;tg
 and Dmrt1-/- mice when compared to the wild type controls. Although the seminiferous tubule 
morphology at P7 was similar across groups as was previously reported [50], the morphology of the 
seminiferous tubules in the adult Dmrt1-/-;tg mouse testes unlike those in Dmrt1-/- mice were partially 
restored. The incomplete restoration of seminiferous tubule morphology when DMRT1 is present in 
Sertoli cells of Dmrt1-/-;tg mice suggest that DMRT1 in germ cells or germ cells themselves are required 
for total tubule integrity. However, since models devoid of germ cells like W
(v)
/W
(v)
 mice show good 
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tubule morphology, it suggests it is not just the absence of germ cells [201]. Thus, it is either that there 
was not enough DMRT1 provided by the transgene (in this evaluation) or that a conflict arises because 
DMRT1 is regulated like Wt1, not Dmrt1, or some other tubule disruption occurs when DMRT1 is 
present in Sertoli cells or absent in germ cells. This role in tubule integrity is supported by the previous 
evaluation of Sertoli cells in SCDmrt1KO model, generated by DHH-CRE-mediated deletion of Dmrt1, 
which appeared normal through P7, slightly disorganized by P9, and notably disorganized by P14. By 
P28, SCs were positioned throughout the tubule and seminiferous tubules were disorganized and lacked 
defined lumens [50, 131]. 
Wt1-Dmrt1 transgene can be used to demonstrate autonomous and non-autonomous effects of 
DMRT1.  
Expression analysis of DMRT1-regulated genes provided further evidence on the functional 
effect of the Wt1-Dmrt1 transgene. In the case of the Wt1-Dmrt1 transgene, it revealed gene sensitivity 
derived from different levels of DMRT1 in Sertoli cells. It was demonstrated that exogenous DMRT1 
directs dose-dependent gene expression. Three expression groups were identified. The “resistant” (Mage-
K1, Cidea, Rbym1a1, Stk31and Gpr37) category included genes that responded to Dmrt1 loss but did not 
change with addition of any amount of transgene. Genes in the “partial” (Lect1, Nxf2 and Tnnt2) category 
showed modest improvement over the null mice with added transgene, but the response was not dose-
dependent. The “sensitive” (Sycp1, Rarres1, Pramel3, and Trim34) category represented genes that 
showed significant improvement with transgene addition and, in many cases, a response that was dose-
dependent. Rarres1 was partially restored with one copy, completely restored with two, and further 
compromised by the addition of more copies. Unlike Rarres1, Trim34 was best restored with a single 
copy of the transgene and additional copies further compromised expression. Pramel3 and Scyp1 showed 
similar expression patterns as Rarres1, but, all of them only approached full recovery. Lect1, Nxf2 and 
Tnnt2 showed a partial response but failed further recovery with different transgene copies. The genes 
that responded to each DMRT1 dose indicate Dmrt1's activity in the SC is the only influence on that 
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gene. While those that change partially suggest there is input from Dmrt1 from both cell types and those 
that are resistant are dependent on Dmrt1's activity in the germ cells. Interestingly, this study identified 
genes (e.g. Sycp1) that are present only in germ cells and are directed by DMRT1's actions in Sertoli cells. 
The responding gene changes confirmed that there are differences presumably due to Dmrt1 dosage and 
to Sertoli cells versus germ cells. These results validate the role of DMRT1 as a dose-sensitive regulator; 
as was previously shown that it behaves genetically as a dose-sensitive tumor suppressor gene on a 129Sv 
mouse background, and normal changes in its activity confers vulnerability to malignant cell growth 
[133]. The gene expression data demonstrate that transgenic DMRT1 is functional and can fully rescue a 
subset of genes, presumably those directed by Sertoli cell DMRT1, either autonomously or non-
autonomously. Overall, the histological and gene expression results show that the Dmrt1-/-;tg mice uphold 
several key requirements that support their use to delineate DMRT1 function and identify the specific 
effects of DMRT1 in germ cells. First, transgenic DMRT1 is produced only in testicular Sertoli cells and 
not germ cells. Second, the dosage of exogenous DMRT1 can be managed to match that of the 
endogenous gene. Lastly, transgenic DMRT1 activity mimics that of the endogenous protein.  
Wt1-Dmrt1 transgene influences maturation state of Dmrt1-null Sertoli cells 
Sertoli cells are specialized testicular somatic cell that nurtures developing germ cells and are 
considered to be terminally differentiated after puberty. Terminal differentiation involves loss of 
proliferative ability, formation of functional inter-Sertoli cell tight junctions, and expression of functions 
or proteins not present in immature Sertoli cells [86]. In humans, nuclear and general morphology of 
Sertoli cells coupled with weak or absence of AR expression has been associated with failure to mature 
[86, 202]. Assessment of markers of Sertoli cell maturation (Ar and Gata1) and an immature cell marker 
(Krt18) at a prepubertal age showed that development of Sertoli cells in Dmrt1-/-;tg and Dmrt1-/- mice was 
compromised [86, 189, 190, 203-207]. In rodents, AR is expressed in peritubular myoid cells and Leydig 
cells at all stages while its expression is elevated in Sertoli cells prior to their maturation [85]. In this 
study the transcript and protein levels of Ar were similar at P7 in all three groups, whereas at P15 the 
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expression of AR was reduced in Dmrt1-/- and Dmrt1-/-;tg compared to Dmrt1+/+ mice. A similar pattern of 
expression was previously reported for the SCDmrt1KO mice compared to controls whereby up-
regulation of AR expression was absent between P5 and P9 but present by P21 [131]. Furthermore, the 
message for Gata1 was significantly reduced in Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice at P7. This is supported by 
earlier characterization of Dmrt1-null mice showing that GATA1 expression was delayed but present in 
the mutant testes [50]. Likewise, the message for Krt18 was significantly up-regulated in Dmrt1-/-;tg and 
Dmrt1-/- mice relative to Dmrt1+/+ mice. An impact on Sertoli cell maturation was observable as early as 
P7 based on the elevated transcript expression of Krt18 and reduced expression of Gata1. Thus, 
evaluation of these markers suggest that relative to the controls (Dmrt1
+/+
 and Dmrt1
-/-
), the maturation of 
Sertoli cells in Dmrt1-/-;tg mice is delayed.  
In addition, examination of junctional complex proteins revealed that except for Espin that was 
almost normally expressed in Dmrt1-/-;tg mice, Ocln, Cldn11 and Tjp were reduced in both Dmrt1-/- and 
Dmrt1-/-;tg relative to Dmrt1+/+ mice. Only Espin showed significant sensitivity to DMRT1 in Sertoli cells 
and the other genes are primarily influenced by DMRT1 in germ cells.  
Dual staining using Sertoli cell/Leydig cell marker, GATA4, and the proliferation marker, PCNA, 
was performed to validate the maturation states of Sertoli cells. Sertoli cells in the Dmrt1+/+ mice did not 
co-express GATA4 and PCNA, which was indicative of terminal differentiation or acquisition of a mature 
state. Many Sertoli cells in Dmrt1-/- mouse testes co-expressed PCNA and GATA4, which was indicative 
of an immature or proliferating state. A small number of Sertoli cells in Dmrt1-/-;tg mouse testes did not 
co-express, whereas the majority of Sertoli cells did co-expressed GATA4 and PCNA, which was 
indicative of an intermediate or partial maturation state.GATA4 expression was persistent and elevated in 
Dmrt1-/- and Dmrt1-/-;tg mouse testes as was previously reported elsewhere in the Dmrt1-null mice [50]. 
Interestingly, there were a few Sertoli cells in the Dmrt1-/-;tg mouse testes which had GATA4 in the 
cytoplasm that did not co-localize with PCNA in the nucleus (Figure 11C, asterisks). GATA4 is a 
transcription factor important in cellular differentiation and their function is believed to reside in the 
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nucleus. The loss of nuclear localization for GATA proteins was reported in ovarian cancer cells and 
linked to dedifferentiation [208]. It is likely that the few Sertoli cells located in the lumen that had this 
cytoplasmic mislocalization were dedifferentiating. .  
The above observations were validated by further morphological and ultrastructural analyses 
using light and electron microscopy, respectively. Sertoli cells display significant structural changes that 
are linked to pubertal and postnatal developmental processes. They start as small round or oval cells with 
inconstant contour immediately after birth to complex elongated cells spreading from the basement 
membrane to the lumen as they age. For example, alterations in the nucleus from birth to puberty show 
increasing size and complexity. Early in life, Sertoli cells have a regular round or oval nuclei with 
negligible indentation, finely granular chromatin and small, unremarkable nucleoli. As they age, the 
nucleus changes into an ovoid to elongated topology that is commonly observed close to the basement 
membrane. The nuclear contour becomes more irregular with prominent indentations and contains a 
nucleolus that includes a central condensation area .The nucleolus in mouse is composed of three parts, 
one central part and two satellite parts. The nuclear matrix is made up of fine particulate matter of many 
forms namely; granular, fibrillar and fibrous [209]. The Sertoli cell nucleus at P7 in Dmrt1+/+ mice testis 
were columnar in shape and immature while those in Dmrt1-/- and Dmrt1-/-;tg mice were multi-lobulated, 
had irregular contours, indentations and seems mature. At P42, the SC nucleus in Dmrt1+/+ was ovoid 
with irregular indentations and contained a central condensation area. Most of the Dmrt1-/- Sertoli cell 
nuclei were round with regular topology and all the nucleoli lacked a central condensation area but had 
granular clusters with coarse particulate matter at the periphery of the nuclear envelope. This phenotype is 
similar to the human condition of long-term estrogen treatment of Sertoli cells but without any germ cells. 
These defective human Sertoli cells were characterized by round or oval nuclei with most having dense 
homogenously disturbed chromatin and peripherally located nucleoli. The chromatin appears in irregular 
granular clusters and in a less condensed state[210]. Nuclei from Dmrt1-/-;tg Sertoli cells had a 
combination of regular ovoid and irregular ovoid topology, with a few nucleoli forming a central granular 
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condensation area and most carrying fibrillar satellite centers and lacked coarse particulate matter at the 
nuclear envelope. This suggests that Sertoli cells in Dmrt1-/- were reprogrammed with the prepubertal SCs 
exhibiting mature nuclear characteristics and the postpubertal SCs expressing immature nuclear 
phenotype. However, the Dmrt1
-/-;tg
 mice had a small population of SCs that were normal and a large 
population of SCs that were also reprogrammed. The above characteristics demonstrated that Sertoli cells 
in Dmrt1-/-;tg mice maintained an intermediate maturation state as they showed partial signs of maturation 
that were absent in Dmrt1-/- mice. 
Dmrt1-rescue model shares characteristics with existing human models of male infertility 
The phenotype of Dmrt1-/-;tg mice resembles that of two mouse models (male 41, XXY and the 
41, XX
Y
*) of human Klinefelter’s syndrome (47 XXY) [211-215]. Common phenotypic features include 
significant germ cell depletion by P7, small testes in adult mice with reduced seminiferous tubule 
diameter, Sertoli cell-only tubules, Leydig cell hyperplasia and reduced serum testosterone levels. This 
raises the possibility that the return of DMRT1 to Dmrt1 null Sertoli cells generates a mouse model that 
mimics the Klinefelter’s phenotype; characterized by the presence of a supernumerary X chromosome, 
certain endocrine and testicular alterations. However, more experiments are required to further 
characterize and determine if Dmrt1
-/-;tg
 mice exhibit any cognitive and behavioral defects like the 
Klinefelter’s patients. 
In conclusion, the Sertoli cell-specific rescue mouse model provides a unique model to identify 
the role of DMRT1 in the germline if the method requires loss of DMRT1 in germ cells. The present 
study validates that murine DMRT1 alone is not required for sex determination. However, this study 
demonstrates that development of Sertoli cell requires DMRT1 from within and DMRT1 in germ cells or 
just the presence of germ cells to undergo complete differentiation. The DMRT1-deficient germ cells 
mouse model provides a novel model to study existing phenotypes of idiopathic male infertility. 
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Figure 1: Generation and tissue-specific expression of the Wt1-Dmrt1 transgene.  
A. Generation of the Wt1-Dmrt1 transgene. The rat Dmrt1 cDNA was inserted in-frame with the 
translational start ATG of mouse Wilms’ Tumor Gene 1 within the yeast artificial chromosome 
YAC 620mWt1. Top: YAC 620mWt1; exons = boxed with numbers, URA/Acentric and 
TRP/Centric = the pYAC4 acentric vector arms with uracil and tryptophan selectable markers, 
respectively. Middle: targeting vector, pBKS-Wt1-Dmrt1-HPRT1-LYS2. Dmrt1 = rat Dmrt1 
cDNA; HPRT1 = exons 8 & 9, intron 8 and polyadenylation site of HPRT1; LYS2 = lysine 2 
selectable marker. Wt1 5′ = 825bp Wt1 5′ untranslated region; Wt13′= 776bp of Wt13′ 
untranslated region. Bottom: Wt1-Dmrt1 transgene after homologous recombination in yeast 
(AB1380). B-D. RT-PCR of RNA prepared from different organs from male and female 
transgenic mice. PCR templates comprised of cDNA synthesized in the presence (+) or absence 
(-) of reverse transcriptase-superscript II. cDNA of the transgene: bottom bands (~450bp) 
amplified from the template of processed RNA. Genomic DNA: top bands (~1,105 bp) amplified 
from the template of contaminating genomic DNA. B. Transgene expression in the kidneys and 
gonads of newborn male and female littermates. Tissues examined are: newborn male and female 
kidney (KM & KF), ovary (O), testis (T) and postnatal day 15 (P15) transgenic testis (T+) C. 
Expression in P15 male transgenic and wild type littermates. Tissues examined in the transgenic 
male are: testis (T), brain (B), heart (H), spleen (Sp), Stomach (St), lung (Lu), kidney (K) and 
liver (Li). Tissues examine in wild-type male are: testis (T-) and kidney (K-). D. Positive and 
negative controls. The plasmid, pBKS-Wt15′-Dmrt1-HPRT1-LYS2-Wt13′ (P), was used as the 
positive control for genomic signal, the P15 transgenic testis (T+) previously determined to 
express Dmrt1-Wt1 transgene was used as a positive control for transgene expression and water 
(H2O) used as a negative control for PCR reaction.  
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Figure 2: Immunohistochemical analysis of Dmrt1
+/+
, Dmrt1
-/-
, and Dmrt1
-/-;tg
 at postnatal 
day 7. Testis sections from P7 wild type (A-C), Dmrt1 
-/-
 (D-F) and Dmrt1
-/-;tg 
(G-I)
 
mice were 
evaluated using fluorescently labeled antibodies against DMRT1 (A, D and G) and GCNA1 (B, 
E and H). Individual panels for DMRT1 (Green) and GCNA1 (Red) staining, as well as merged 
panels (C, F, and I), are shown. Yellow stained cells, indicating co-expressed DMRT1 and 
GCNA1 in germ cells, are observed only in wild type mice (C). DMRT1 expression by western 
blot (J) from mouse testes from Dmrt1
+/+
, Dmrt1
-/-
, Dmrt1
-/-;tg
, Dmrt1
+/-
 and Dmrt1
+/+;tg
 mice.  
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Figure 3: Morphological analysis of testis sections. Periodic Acid Schiff (PAS) staining of 
P7 & P42 testis section from wild type, Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice. Return of DMRT1 to 
Sertoli cells in Dmrt1
-/-;tg 
(or SC rescue) mice partially restores seminiferous tubule morphology 
(C, F and I). A, B and C; P7 testes from wild type, Dmrt1 
-/-
 and Dmrt1
-/-;tg 
mice (20X 
magnification). D, E, and F; P42 testes from wild type, Dmrt1 
-/-
 and Dmrt1
-/-;tg 
mice (20X 
magnification). G, H, and I represent higher magnification of boxed regions in G, H, and I (40X 
magnification). Arrowheads and arrows show the presence of a defined lumen and basal lamina, 
respectively, in wild type (G) and Dmrt1
-/-;tg 
(I) that are absent in the Dmrt1 
-/-
(H). J, K, and L; 
P42 testes from wild type, Dmrt1 
-/-
 and Dmrt1
-/-;tg 
mice (40X magnification) stained with 
toluidine blue. Arrowheads and arrows show the presence of a defined lumen in Dmrt1
+/+
 (J) 
and Dmrt1
-/-;tg 
(K) that are absent in the Dmrt1 
-/-
(L). Seminiferous tubules in Dmrt1
-/-
 (K) and 
Dmrt1
-/-;tg
 (L) have a remarkable number of interstitial Leydig cells and lipid droplets.  
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Figure 4: Effect of exogenous DMRT1 on testis size in Dmrt1
-/-tg
 mice. Ratios of paired testes 
to total body weight for Dmrt1
+/+
 (black bar), Dmrt1
-/-
 (stipple bar), and Dmrt1
-/-;tg
 (stripe bar) 
mice at postnatal days (P): 2 (P2), 7 (P7), 15 (P15), 20 (P20), and 42 (P42). Minimum of three 
animals were used for each genotype at each time point. Bars represent mean ± SEM of three to 
20 animals. *** = p<0.0001 (Two tail Student T-Test). 
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Figure 5: Dosage effects of Dmrt1 transgene. A. Southern blot analysis to determine transgene 
copy number for samples used. Analysis of expression of exogenous Dmrt1 compared to wild 
type. B. Gene expression profiles in mouse testis with different levels of Dmrt1 expressed in 
Sertoli cells. The data show dose-dependent increases in Dmrt1 with increased transgene copies. 
It also shows 3 distinct expression profiles: 1) genes that don not respond to Dmrt1 expressed in 
Sertoli cells (resistant), 2) genes that respond partially to Sertoli cell Dmrt1 (Partial), and 3) 
genes that respond in a dose dependent manner to increasing amounts of Dmrt1 (sensitive). 
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Figure 6: Effect of exogenous Dmrt1 on testes weights and sperm motility. A. Average body 
weights for Dmrt1
+/+
 (black bar), one copy transgenic (Dmrt1
+/+;tg
 )(stipple bar), and two copy 
transgenic (Dmrt1
+/+;tg+tg
) (stripe bar) at 3, 6, 10, 12, and 18 months of age. B. Average paired 
testes weights for Dmrt1
+/+
 (black bar), one copy transgenic (Dmrt1
+/+;tg
 )(stipple bar), and two 
copy transgenic (Dmrt1
+/+;tg+tg
) (stripe bar) at 3, 6, 10, 12, and 18 months of age. C. Ratios of 
paired testes to total body weight for Dmrt1
+/+
 (black bar), one copy transgenic (Dmrt1
+/+;tg
 
)(stipple bar), and two copy transgenic (Dmrt1
+/+;tg+tg
) (stripe bar) at 3, 6, 10, 12, and 18 months 
of age. D. Total and progressive motility of sperm from Dmrt1
+/+ 
and Dmrt1
+/+;tg
 at 6 and 12 
months of age. Minimum of three animals were used for each genotype at each time point. Bars 
represent mean ± SEM of three to 20 animals. *** = p<0.0001 (Two tail Student T-Test). 
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Figure 7: Sex hormone levels and effect on secondary sex organs. A. Serum testosterone 
levels at P15, P20 and P42 in wild type (black bar), Dmrt1
-/-
 (stipple bar), and Dmrt1
-/-;tg
 (stripe 
bar). B. Effect of serum testosterone levels on development of seminal vesicles at P20 and P42 in 
Dmrt1
+/-;tg 
, Dmrt1
-/-
 and Dmrt1
-/-;tg
. C. Serum LH levels at P15, P20 and P42 in wild type (black 
bar), Dmrt1
-/-
 (stipple bar), and Dmrt1
-/-;tg
 (stripe bar). Bars represent mean ± SEM of three to 10 
animals. D. Serum Estradiol levels at P15, P20 and P42 in wild type (black bar), Dmrt1
-/-
 (stipple 
bar), and Dmrt1
-/-;tg
 (stripe bar). Bars represent mean ± SEM of three to 10 animals. Table below 
C and D shows pooling of samples used for Serum LH and Estradiol assays. 
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Figure 8: Immunohistochemical analysis of adult Leydig cell marker (P450 SCC). Dmrt1
+/+
 
(A, D, G & J), Dmrt1
-/-
(B, E, H & K), and Dmrt1
-/-; tg
 (C, F, L & I) at P7 (A-C), P15 (D-F), P20 
(G-I) and P42 (J-L). Testis sections from mice were evaluated using fluorescently labeled 
antibodies against P450 SCC. The number of Leydig cells at P42 in the Dmrt1
-/- 
(K) and Dmrt1
-/-; 
tg 
(L) may be attributed to the shrinking size of the testis and hyperplasia. 
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Figure 9: Genes involved in testis function. Quantitative PCR was used to analyze the 
expression of 10 genes vital for testis function using P7 whole testis mRNA. These included: 
Gata1, Ar, and Krt18 important for SC maturation; Gata4 important for SC proliferation.Gata1 
was significantly reduced in both Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice (p<0.005). Ar was not 
significantly different in all groups. Krt18 was significantly elevated in Dmrt1
-/- 
and Dmrt1
-/-;tg
 
mice (p=0.0028). Gata4 was significantly elevated in Dmrt1
-/- 
(p=0.0032) but not in Dmrt1
-/-;tg
 
mice. Espin, Ocln, Cldn11 and Tjp are necessary for the formation of the blood-testis barrier . 
Ocln, Cldn11, and Tjp1 were significantly reduced in both Dmrt1
-/-
 and Dmrt1
-/-;tg
 
mice(p=0.0078, p<0.0001 and p<0.0001, respectively). Espin was significantly elevated in 
Dmrt1
-/-
 mice (p<0.03) but not significant in Dmrt1
-/-;tg
 mice. 
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Figure 10: Expression pattern of a protein marker for Sertoli cell maturity. Dmrt1
+/+
 (A & 
D), Dmrt1
-/-
(B & E), and Dmrt1
-/-; tg
 (C & F) at P7 and P15. Testis sections from mice were 
evaluated using fluorescently labeled antibodies against AR (green) and DAPI (blue) for nuclei 
stains. Myoid cells are predominantly expressing AR at P7 (arrowheads) in all three groups. The 
intensity of AR and number of Sertoli cells expressing AR (arrows) in the Dmrt1
-/- 
(E) and 
Dmrt1
-/-; tg 
(F) is lower at P15 compared to AR expression in the control (D). 
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Figure 11: Immunohistochemical analysis of Sertoli cell proliferation in Dmrt1
+/+
, Dmrt1
-/-
, 
and Dmrt1
-/-;tg
 at postnatal day 42. Testis sections from P42 Dmrt1
+/+
 (A-D), Dmrt1 
-/-
 (E-H) 
and Dmrt1
-/-;tg
 (I-L)
 
mice were evaluated using fluorescently labeled antibodies against GATA4 
(A, E and I), PCNA (B, F and J) and DAPI (C,G and K). Individual panels for GATA4 (Green), 
PCNA (Red), DAPI (blue) and merged panels (D, H, and L), are shown. Arrowheads show the 
presence of mature Sertoli cells in Dmrt1
+/+
 (D) staining green and negative for PCNA that are 
absent in Dmrt1 
-/-
 (H) but present in a few Sertoli cell nuclei in Dmrt1
-/-;tg
 (L). 
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Figure 12: Electron microscopy of Sertoli cell nuclei at P7 and P42. A. Portion of a 
seminiferous tubule from P7 Dmrt1
+/-
 showing normal ultrastructure of Sertoli cell nucleus 
(insert). Germ cell nuclei have white outlines and Sertoli nuclei have black outlines. The Sertoli 
cell nucleus is columnar in shape with regular contours and no indentations Magnification 
x3040; scale bar, 2 μm. B. Portion of a seminiferous tubule from P7 Dmrt1
-/-
 mice showing 
abnormal Sertoli cell nuclei. The Sertoli cell nuclei are irregular shaped and multi-lobulated with 
indentations (arrowheads). Magnification x3040; scale bar, 2 μm. C. Portion of a seminiferous 
tubule from P7
 
Dmrt1
-/-;tg
 mice showing a mixed population of normal and abnormal Sertoli cell 
nuclei. The normal and abnormal nuclei shared characteristics with Dmrt1
+/+
 and Dmrt1
-/-
 mice, 
respectively. Magnification x2280; scale bar, 2 μm. D. Portion of a seminiferous tubule from P42 
Dmrt1
+/+
 mice showing normal ultrastructure of Sertoli cell and germ cells. The Sertoli cell is 
large and shows considerable amount of perinuclear cytoplasm, an irregular ovoid nucleus with 
indentation (arrow) and interacting with a spermatogonium and several primary spermatocytes. 
Nucleolus formed a central condensation area. Magnification x2280; scale bar, 2 μm. E. Sertoli 
cell-only tubule from P42 Dmrt1
-/-
 mice showing Sertoli cells with many regular round nuclei 
scanty amount of cytoplasm (insert). Magnification, x1900; scale bar, 10 μm. F. Sertoli cell-only 
tubule from P42 Dmrt1
-/-;tg
 mice showing Sertoli cells with many regular round nuclei and few 
irregular nuclei with indentations (arrows) and scanty amount of cytoplasm. Nucleolus formed a 
central condensation area. Magnification, x3040; scale bar, 2 μm. 
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Supplementary Figure 1: Effect of exogenous DMRT1 on secondary sex organs. A. 
Reproductive organs of Dmrt1
+/+
 mice at about 19 weeks after birth B. Reproductive organs of 
Dmrt1
-/-
 mice at about 19 weeks after birth C. Reproductive organs of Dmrt1
-/-;tg;30
 mice at about 
19 weeks after birth D. Reproductive organs of Dmrt1
-/-;tg;37
 mice at about 19 weeks after birth. T 
= testis, E = epididymis, SV = seminal vesicle, VD = vas deferens 
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Table 1: Primers used for cloning transgene 
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Table 2: Primers used for genotyping 
 
 
 
 
 
 
 
73 
 
Table 3: Primers used for gene expression analysis by quantitative PCR 
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Chapter 3: DMRT1 in Sertoli cells regulates the organization and formation 
of ectoplasmic specialization 
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Abstract 
Ectoplasmic specializations (ES) are testis-specific adherens junctions formed between the 
cytoplasm of adjacent Sertoli cells or between Sertoli cells and maturing spermatids. Since these 
junctions are a sign of maturation and the evolutionary conserved transcription factor, DMRT1, 
is known to facilitate and maintain Sertoli cell differentiation, it was hypothesized that DMRT1 
perhaps may participate in the organization and maintenance of these junctions. In this study, 
electron microscopy and immunohistological localization of known ES-associated proteins 
(ESPIN, NECTIN-2 and NECTIN-3) were used to evaluate Sertoli cell ESs in 42-day-old mice 
expressing different levels of DMRT1 (wild types, Dmrt1
+/+
; Dmrt1-null, Dmrt1
-/-
; and Sertoli 
cell rescue, Dmrt1
-/-;tg
). In the Dmrt1
-/- 
seminiferous tubules, the ES proteins, ESPIN, NECTIN-2 
and NECTIN-3 were observed in poorly organized patches and electron micrographs indicated 
that gap junctions were the predominant junctions present. Notably, transgenic expression of 
DMRT1 to Sertoli cells of Dmrt1
-/-
 mice (Dmrt1
-/-;tg
) restored ES organization as revealed by 
expression of ESPIN, NECTIN-2 and NECTIN-3. In addition, electron micrographs of Dmrt1
-/-;tg
 
testis sections showed both adherens and gap junctions similarly represented within the 
seminiferous epithelium. Taken together, the findings indicate that DMRT1 in Sertoli cells is 
needed for the formation and regulation of the ESs. 
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Introduction 
Double-sex and male abnormal-3 (mab3) related transcription factor 1 (DMRT1) is an 
evolutionary conserved transcription factor that shares homology with double-sex (dsx) in 
Drosophila melanogaster and male abnormal-3 (mab3) in Caenorhabditis elegans [112-114]. 
DMRT1 in mammals is required for male fertility and produced only in the testes, where it is 
expressed both in Sertoli cells (SC) and germ cells (GC) [115, 119, 128, 145, 150, 159, 216-
218]. In mice, its role is associated with postnatal Sertoli cell differentiation and the growth and 
maintenance of germ cells [50, 130, 131, 133, 159, 219]; whereas in humans, it is implicated in 
prenatal testis development and sex determination [163-167].  
Conditional deletions and cellular expression profiles in mice have provided important 
mechanistic insight on DMRT1’s cell-specific functions. In Sertoli cell-specific Dmrt1 knockout 
mice (SCDmrt1KO), Sertoli cells over-proliferated and failed to polarize, while germ cell 
meiosis was incomplete [131]. However, unlike Dmrt1
-/-
 mice, radial migration, re-initiation of 
mitosis and initiation of meiosis were not hampered. In contrast, to studies with SCDmrt1KO 
mice, studies in mice with conditional germ cell deletions of Dmrt1 (GCDmrt1KO) have been 
less informative, primarily due to features of Cre recombinase transgene method employed. In 
particular, the initial transgene directed by TNAP showed poor penetrance and ectopic 
expression in Sertoli cells, while another captures only events associated with the second wave 
of spermatogenesis [131, 134]. Notably, we previously reported the characterization of a new 
mouse model, which is functionally comparable to conditional deletion of Dmrt1 in germ cells 
and does not depend on the efficacy of Cre recombinase (Chapter 2). Characterization of these 
mice (i.e. Sertoli cell rescue, Dmrt1
-/-;tg
), which express DMRT1 from a transgene in Sertoli cells 
of Dmrt1
-/-
 mice, revealed new roles for DMRT1 in tubule integrity, maintenance of testis size 
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and sperm progressive motility and supported its previous known role in Sertoli cell maturation 
(Chapter 2). The studies presented here employed these mice to further explore the role of 
DMRT1 in Sertoli cell differentiation, by examining how DMRT1 affects a specific feature of 
Sertoli cell maturation, namely junctional complex formation and/or organization [220-223]. 
 Cell-cell adhesion is vital to the formation and maintenance of multicellular structures 
complex organisms. A cohort of cell adhesion molecules has evolved to assist in the growing 
complexity and specialization of cell-cell interactions in higher eukaryotes. The interaction 
between three main types of junctions (desmosomes, tight junctions, adherens junctions), located 
at the apical lateral surfaces of adjacent epithelial cells, forms junction complexes that contribute 
to cell polarity, maintain epithelial cell integrity and control paracellular diffusion [223]. In the 
testis, Sertoli cells, which are epithelial in origin, and germ cells, are the two principal cell types 
of the seminiferous epithelium, a tubule-like structure that is the site of germ cell development 
[224-227]. These testicular epithelial cells are large asymmetrical structures that extend from the 
base to the center of the tubule and define the overall structure of the seminiferous epithelium, 
which is divided into basal and adluminal compartments by a barrier (the blood-testis barrier, 
BTB) formed between adjacent Sertoli cells near the base of the epithelium [224, 227]. The BTB 
is a specialized structure comprised of tight junctions, basal tubulobulbar complexed, 
desmosome-like junctions, and one of two testis-specific adherens junctions known as 
ectoplasmic specialization (ES) [191, 226, 228]. Ectoplasmic specializations are characterized by 
the presence of actin filament bundles sandwiched between the Sertoli cell plasma membrane 
and the cisternae of smooth endoplasmic reticulum [225, 228]. Proper formation and function of 
the BTB is essential for normal spermatogenesis to occur, as it establishes Sertoli cell polarity, 
creates the specialized milieu necessary for germ cell development and provides an 
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immunological barrier that isolates post-meiotic antigens from the systematic circulation [229, 
230]. In addition to the BTB-associated basal ES formed between adjacent Sertoli cells, a second 
testis-specific adherens junction, the apical ES, exists between Sertoli cells and developing 
spermatids [191, 226, 228]. The role of the apical ES is unknown but it has been implicated in 
several functions such as sperm head shaping, spermatid-Sertoli cell attachment stabilization, 
sperm release, spermatid orientation, and providing a scaffold for microtubules [231-234].  
There is considerable evidence documenting the ultrastructure of ESs in the testis, but 
little molecular knowledge is available on how these intercellular junctions are regulated. In the 
current study, various mouse models, having different expression levels and cellular distribution 
of DMRT1 (Dmrt1
+/+
, Dmrt1
-/-
 and Dmrt1
-/-;tg
), demonstrated that DMRT1 is needed in Sertoli 
cells to regulate and establish ES. NECTIN-2, which normally localizes to Sertoli cell- Sertoli 
cell ES, was greatly reduced or absent from the ES of Dmrt1
-/-
 mice, while its expression 
returned with the transgenic addition of DMRT1 to Sertoli cells of Dmrt1
-/-
 mice. Furthermore, 
we report here that NECTIN-3, known to be expressed only at apical ES was strongly induced 
with transgenic addition of DMRT1 to Sertoli cells of Dmrt1
-/- 
mice, which were devoid of germ 
cells by 14-days of age (Chapter 2). 
Materials and Methods 
Animals and antibodies 
Dmrt1
-/-
 mice, provided by Dr. David Zarkower and Dmrt1
-/- 
mice carrying the Wt1-
Dmrt1 transgene (Dmrt1
-/-;tg
) are reported elsewhere ([112], Chapter 2). All animal procedures 
were approved by the Laboratory Animal Research Committee at the University of Kansas 
Medical Center and performed in accordance with National Institutes of Health guidelines.  
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Immunohistochemistry 
Six-week old testis samples from Dmrt1
+/+
, Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice (three samples 
per genotype) were immersions fixed in Bouin’s solution at room temperature for 24 h. Tissues 
were rinsed twice with 50% and 70% alcohol and fixed testes cut in half at the sagittal plane, 
processed and embedded in paraffin according to standard procedures. Five-micron (5 μm) 
sections were cut and mounted on slides, cleared in xylene, rehydrated through graded alcohol 
series and heated in 10 mM sodium citrate buffer (pH 6.0) with microwaves (14 min at full 
power) for antigen retrieval. Sections were blocked using 10% normal goat or donkey serum 
(Zymed Laboratories Inc.) for 60 min at room temperature. Five sections were analyzed per 
mouse. 
Primary antibody incubations were carried out overnight at 4°C in blocking solution. The 
sections were probed with: anti-ESPIN, anti-NECTIN-2, anti-NECTIN-3, anti-DMRT1, anti-
GCNA1 serum or anti-ACTIN antibody. Anti-ESPIN antibody was a rabbit polyclonal and a gift 
from Dr. Rajendra Kumar. Rabbit anti-NECTIN-2 antibody (AB87220) and rabbit anti-
NECTIN-3 antibody (AB63931) were gifts from Dr. Joseph Tash. Goat anti-Actin (L19) 
antibody (sc1616) was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). 
Rabbit anti-DMRT1 antibody was custom made by Covance Inc. (Denver, PA, USA) using a C-
terminal peptide of DMRT1 [130]. Rat anti-GCNA1 serum was kindly provided by Dr. George. 
C. Enders.  
After washing with PBST, sections were incubated with fluorescently labeled secondary 
antibody for 1 hour at room temperature. The secondary antibodies employed were Alexa FluorR 
488 goat anti-rabbit IgG (Molecular Probes Inc., Eugene), Alexa FluorR 568 donkey anti-rabbit 
IgG (Molecular Probes Inc., Eugene), Alexa FluorR 488 donkey anti-goat IgG (Molecular 
80 
 
Probes Inc., Eugene), Cy™3-conjugated AffiniPure goat anti-rabbit IgG (Jackson 
ImmunoResearch Laboratories) or Cy™3-conjugated AffiniPure goat anti-rat IgG (Jackson 
ImmunoResearch Laboratories). Samples were washed 3 times in PBST (5 min. each) and glass 
cover slides mounted using Fluoromount-G (Southern Biotechnology Associates Inc., 
Birmingham, AL). Digital images were collected using a 20x or 40x objective lens and 
fluorescent filters (FITC, TRITC and DAPI) on a Nikon Eclipse 80i microscope (Nikon Inc., 
Instrument Group, Melville, NY), a Retiga 2000R fast camera and a QCapture software program 
(QIMAGING, Surrey, BC, Canada) and processed using Adobe Photoshop. 
Transmission Electron Microscopy 
The testes of Dmrt1
+/+
, Dmrt1
-/-
 and Dmrt1
-/-;tg
 P42 mice were immersion fixed with 2% 
glutaraldehyde in 0.1 M cacodylate buffer, postfixed in 1% osmium tetroxide/0.8% potassium 
ferrocyanide, stained in uranyl acetate, and embedded in epon –araldite blocks. Ultra-thin 
(80nm) sections were examined at 80 kV using a JEOL 1400EX II (JEOL, Tokyo, Japan) 
transmission electron microscope. For electron microscopic analysis, ES structures were 
identified as actin bundles sandwiched between Sertoli cell plasma membrane and smooth 
endoplasmic reticulum [229, 235, 236]. Low magnification (x1200–8000) was used to examine 
the basal and adluminal ES in various testes sections.  
Results 
Immunolocalization of exogenous DMRT1 in Sertoli cells of Dmrt1
-/-;tg
 mice 
We previously described the construction and generation of a DMRT1-deficient germ 
cell mouse model, which is Dmrt1
-/- 
with a transgene (Wt1-Dmrt1) that expresses DMRT1 in 
Sertoli cells (Dmrt1
-/-;tg
;Chapter 2). Initial characterization of DMRT1 expression and testis 
81 
 
morphology was performed on P7 testes. To establish that transgenic expression of DMRT1 was 
sustained in Sertoli cells of Dmrt1
-/-;tg
 mice, immunohistological evaluation was performed on 
P42 testis sections using antibodies to DMRT1 (green), the germ cell marker GCNA1 (red) and a 
DAPI counterstain for nuclei. DMRT1 was expressed in both Sertoli cells (green) and 
spermatogonia (white/yellow) of Dmrt1
+/+
 animals, while meiotic and postmeiotic germ cells 
were negative for DMRT1 (Figure 1A-D). As expected, no DMRT1-positive cells were observed 
in Dmrt1
-/- 
testes (Figures 1E-H), while Dmrt1
-/-;tg
 testes (Figures 1I-L) continued to express 
DMRT1 in Sertoli cells (Figure 1L, arrowhead). Both Dmrt1
-/- 
and Dmrt1
-/-;tg
 P42 testes were 
depleted of germ cells (Figures 1F and J).  
Colocalization of ESPIN and ACTIN in DMRT1-deficient mouse testes 
To evaluate organization and formation of ESs, ESPIN immunohistochemistry was 
performed. ESPIN is an actin-binding/bundling protein and adaptor protein of apical and basal 
ESs. Immunolocalization of ESPIN (Figure 2 A, E and I) and actin (Figure 2; B, F and J), with 
DAPI counterstaining for nuclei (Figure 2; C, G, K), was performed in P42 testes from Dmrt1
+/+
 
(Figure 2 A-D), Dmrt1
-/- 
(Figure 2 E-H) and Dmrt1
-/-;tg
 (Figure 2 I-L) mice. In Dmrt1
+/+
 testes, 
ESPIN was observed as curvilinear and arching structures at the basal aspect of the seminiferous 
epithelium, representing its association with specialized tight junctions (Figure 2A, arrowhead). 
In addition, ESPIN staining was observed amid groups of elongating spermatids that are 
arranged in columns within seminiferous epithelium (Figure 2A, asterisk). The co-localization of 
ESPIN and ACTIN at the basal aspect and in the columns established ESPIN at adherens 
junctions (Figure 2 D, arrowhead). The reactivity at the basal aspect represents basal ES (Figure 
2A, arrowhead) and those in the lumen represent apical ESs (Figure 2A, asterisk). ESPIN 
expression in Dmrt1
-/-
 mice
 
(Figures 2 E) appeared in irregular patches, without any recognizable 
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polarity, in the adlumen compartment of the seminiferous tubule and was absent at the basal 
aspect and colocalized partially with ACTIN (Figure 2 H). ESPIN was also absent at the basal 
aspect in Dmrt1
-/-;tg
 testes but the adlumenal staining appeared more regular than that of Dmrt1
-/- 
mice and stretched in a neuron-like manner (Figure 2 I) with notable co-localization with ACTIN 
(Figure 2 H, arrowhead), which was consistent with their presence at adherens junctions. 
However, no ESPIN immunolocalization was present at the basement membrane of Dmrt1
-/-;tg
 
testes, suggesting that complete polarization of basal ES require the expression of DMRT1 in 
germ cells or general presence of germ cells in the seminiferous tubules while the 
polarity/structure of apical ES require DMRT1 expression in Sertoli cells.  
Localization of NECTIN-2 and NECTIN-3 in DMRT1-deficient testes 
To further characterize the role of DMRT1 in the formation and organization of the ES, 
expression was examined for NECTIN-2 and NECTIN-3, two proteins associated with ES [223, 
237-241]. Localization of NECTIN-2 (Figure 3; A, D, G), NECTIN-3 (Figure 4; A, D, G) and 
counterstain with DAPI for nuclei (Figures 3 and 4; B, E, H) in P42 mouse testes from Dmrt1
+/+
 
(Figures 3 and 4; A-C), Dmrt1
-/- 
(Figures 3 and 4; D-F) and Dmrt1
-/-;tg
 mice (Figures 3 and 4; G-
I) were determined by immunofluorescence.  
NECTIN-2 is expressed at basal and apical ESs and was used to validate the expression 
of ESPIN. Similar to ESPIN, NECTIN-2 immunoreactivity showed the presence of the ES 
protein was present at the inter-Sertoli cell junctions of Dmrt1
+/+
 mouse testis, as curvilinear 
structures associated with tight junctions at the basal compartment of the seminiferous 
epithelium (Figures 3A & 3C, arrowhead). In addition, NECTIN-2 staining was observed as dots 
at the luminal edge of the seminiferous tubules, where round and elongating spermatids interact 
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tightly with the plasma membrane of Sertoli cells (Figure 3A, asterisk). In the testis of Dmrt1
-/-
 
mice, NECTIN-2 expression was lost from the adlumenal and basal compartments (Figures 2F). 
However, in Dmrt1
-/-;tg
 testes, NECTIN-2 expression was significantly present and collected 
towards the center of the tubule similar to that observed for ESPIN in these mice (compare 
Figures 3G and 2I). Its absence from the basal compartment suggested that DMRT1 in Sertoli 
cells was not sufficient to localize NECTIN-2 to the basement membrane but could maintain 
NECTIN-2 expression in the adluminal compartment (Figure 3I). This result confirms that 
Sertoli cell DMRT1 partially regulates organization of ES within the seminiferous tubules. 
NECTIN-3 is expressed only at apical ESs and between Sertoli cells and elongating 
spermatid. NECTIN-3 immunoreactivity was absent at the basal aspects of Dmrt1
+/+
 mouse testis 
(Figure 4A-C). However, NECTIN-3 staining was observed amongst a group of elongating 
spermatids arranged in columns near the lumen of the seminiferous tubule (Figure 4C, 
arrowhead). Unlike NECTIN-2 and ESPIN, NECTIN-3 expression was absent in Dmrt1
-/- 
mice 
(Figures 4D-F), suggesting a difference in background. However, similar to ESPIN and 
NECTIN-2, NECTIN-3 expression in Dmrt1
-/-;tg
 mice appeared elevated along the luminal side 
of the tubule and lost from the basement membrane (Figure 4G-I). The result further supports a 
role of Sertoli cell DMRT1 in the formation and organization of ESs in the testis.  
Electron Microscopic Analysis of Sertoli cell ectoplasmic specialization 
To further evaluate the role of DMRT1 in regulating ESs, ultrastructural analysis was 
performed to compare structures of this testis-specific adherens junction in seminiferous tubules 
of Dmrt1
+/+
, Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice. In Dmrt1
+/+
 testis, basal ESs were identified by actin 
filament bundles sandwiched between the Sertoli cell membrane and a cistern of the endoplasmic 
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reticulum and their association with neighboring tight junctions of the blood-testis barrier (Figure 
5A). Similarly, apical ESs were observed between elongating spermatids and its supporting 
Sertoli cells by the presence of actin filament bundles sandwiched between an engorged cistern 
of endoplasmic reticulum and the membrane of a Sertoli cell (Figure 5B). Thus, the 
ultrastructural of Dmrt1
+/+ 
testes indicated the presence of an intact and highly selective blood-
testis barriers that conferred polarity to the seminiferous tubule. In contrast, ESs and tight 
junctions were not observed between adjacent Sertoli cells of Dmrt1
-/- 
mice (Figure 6A). 
However, abundant desmosomes were noted between adjacent Sertoli cells (Figure 6 B), 
suggesting that the blood-testis barrier is comprised largely of desmosome and their selectivity is 
speculated to be low, with cell polarity completely absent. In the Dmrt1
-/-;tg
 mice, tight junctions 
were absent but ESs that formed in the adlumen were abundant between adjacent Sertoli cells 
and formed away from the basal (Figure 7A) but around the apical (Figure 7B) sites of the 
seminiferous tubules. This suggest that the blood-testis barrier is comprised of adherens 
junctions and desmosomes (not shown), attributing cell polarity and selectivity that we speculate 
will be intermediate between that of Dmrt1
+/+
 and Dmrt1
-/-
 mice. 
Discussion 
Spermatogenesis, the generation of haploid spermatozoa from diploid spermatogonia, 
represents one of the best-studied differentiation processes in biology. This transfiguration of the 
germline relies on numerous complex interactions between Sertoli cells and differentiating germ 
cells, which take place within the seminiferous epithelium and requires its integrity and 
polarization. Proper function and structure of the epithelium depend on its integrity and 
polarization and, in turn, on the junctional complexes that form between the apical-lateral 
surfaces of adjacent cells. Cellular junctions consists of multiprotein complexes of which three 
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major types exist in vertebrates including anchoring junctions (adhesion junctions, desmosomes, 
hemidesmosomes), communicating junctions (gap junctions) and occluding junctions (tight 
junctions) [223]. In the testicular seminiferous epithelium, a distinct actin-associated adhesion 
junctions, ESs, have been characterized between adjacent Sertoli cells and between a Sertoli cell 
and a developing spermatid, each type referred to as the basal and the apical ESs, respectively 
[226, 235]. 
In this study, the role of DMRT1 in the formation and organization of ES was evaluated 
by examining the junctions in the seminiferous tubules of mice with different cellular 
complements of DMRT1. Our previous studies showed that DMRT1 expression from a Wt1-
Dmrt1 transgene was restricted to Sertoli cells on a Dmrt1-null background (Dmrt1
-/-;tg
 mice or 
Dmrt1 rescue) at P7. This Dmrt1 rescue mouse model revealed Sertoli cell-specific functions for 
DMRT1 in the maintenance of seminiferous tubule integrity, testis size and progressive sperm 
motility, as well as validation of its role in Sertoli cell maturation (Chapter 2). Our current study 
shows that DMRT1 from the transgene is maintained in Sertoli cells of P42 Dmrt1
-/-;tg 
mouse 
testes and maintained seminiferous tubule structure but not germ cells. Our model is an 
alternative to the conditional deletion of Dmrt1 in germ cells in GCDmrt1KO mouse model and 
does not depend on the Cre-LoxP technology (using either TNAP-Cre (Tissue Non-specific 
Alkaline Phosphatase-Cre) or Ngn3-Cre (Neurogenin3 Cre)) but rather on the return of DMRT1 
to a single cell type [131, 133, 134, 200]. In contrast to our current model, the Cre-LoxP 
technology employed in the conditional models showed poor Cre penetrance and DMRT1 was 
not deleted in all germ cells. While characterization of the occluding junctions in Dmrt1-null 
mice revealed that Dmrt1 mutant testes fail to form Sertoli cell tight junctions [132], no data is 
available on the formation of anchoring or communicating junctions by Sertoli cells in Dmrt1-
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null or Dmrt1 conditional deletion mouse models. Thus, the current study is the first of its kind 
to examine associations between Sertoli cell-specific expression of DMRT1 and 
formation/organization of ES.  
The ESs are testis-specific adherens junction, which are components of the blood-testis 
barrier and required for spermatid maturation. The current study showed that DMRT1 is required 
for proper expression and localization of these adherens junctions, as, in its absence, constituents 
of the ESs were significantly reduced or lost from the seminiferous epithelium. However, when 
DMRT1 was returned to Sertoli cells of Dmrt1
-/-
 mice, i.e. absent only from germ cells, 
expression of the junction proteins returned but was distributed differently from that observed in 
wild type mice. Expression of NECTIN-2, NECTIN-3 and ESPIN together with electron 
micrographs revealed that these ES proteins returned and were abundant in the seminiferous 
epithelium of Dmrt1
-/-;tg
 mouse testes. The extensive ES proteins in the Dmrt1
-/-;tg
 mouse testes 
epithelium accumulated in the adluminal compartment of the seminiferous tubule and formed 
between adjoining Sertoli cells (Figure 2I, 3G, 4G). This observation of ES protein accumulating 
in the lumen of Dmrt1
-/-;tg
 mice testes in the absence of germ cells, may be attributed to the 
continuous interaction between the cell membrane processes of neighboring Sertoli cells that 
forms the required framework for the deposition of these multiprotein complexes. NECTIN-3 
was shown to be expressed in spermatids [241, 242], but considerable expression of NECTIN-3 
was observed in the absence of elongating spermatids in the seminiferous epithelium of Dmrt1
-/-
;tg
 mouse testes suggesting that either NECTIN-3 is also expressed in Sertoli cells or NECTIN-3 
can be ectopically expressed in the absence of elongating spermatid. In addition, except for 
ESPIN, which was expressed in irregular patches, the Dmrt1
-/-
 mice testes showed weak 
NECTIN-2 expression and no NECTIN-3 expression. Since it was difficult to differentiate 
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between weak and no NECTIN-2 expression, it is likely that the weak NECTIN-2 expressions 
observed in Dmrt1
-/- 
mouse seminiferous tubules were non-specific. The expression of all three 
ES proteins depends on DMRT1 as they were either completely absent of significantly reduced 
in Dmrt1-null mouse testes. In addition, it appears that the apical localization is intact but the 
basal localization is not or maybe the apical localization is the default in the absence of a basal 
ES. Thus, failure to localize at basal ES due to the lost tight junction formation favors apical 
localization of ES proteins. Overall, the phenotype of the Dmrt1
-/-
 mice is similar to the absence 
of fully organized Sertoli cell junctional complexes in hpg Sertoli cells, incompletely formed 
Sertoli cell junctional complexes in the 12–14-day-old mouse and in the diethylstilbestrol-treated 
mouse testis [220, 243, 244]. The junctional specialization formed in the Dmrt1
-/-;tg
 mice 
technically can be referred to as basal ES; since, they are formed between adjoining Sertoli cells 
even though they are localized apically. 
Tight junctions are an important component of the BTB and a vital indicator of Sertoli 
cell polarization and maturation [193]. Tight junctions and adherens junctions play vital roles in 
determining polarity of a cell [132, 245]. The absence or presence of tight junctions was 
examined using immunofluorescence and electron microscopy. Similar curvilinear profiles for 
ESPIN and NECTIN-2 were observed at the basal aspect that contributed to adult Sertoli cell 
junctional complexes in P42 Dmrt1
+/+
 mice that were absent in P42 Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice. 
Also, staining for ZO-1, a marker for tight junctions, formed curvilinear structures at the basal 
aspect of seminiferous tubules in Dmrt1
+/+
 mice that were absent in tubules from Dmrt1
-/-
 and 
Dmrt1
-/-;tg
 mice; indicating absence of tight junctions (data not shown). These results were 
supported by the identification of “kisses” of plasma membrane on electron micrographs from 
Dmrt1
+/+
 mice denoting tight junctions (Figure 5A) that were absent in micrographs of Dmrt1
-/-
 
88 
 
and Dmrt1
-/-;tg
 mice. The expression at the basal aspect is analogous to expression patterns of 
OCCLUDIN (OCLN) and CLAUDIN11 (CLDN11), two molecules associated with the 
formation of tight junctions at the BTB [246-249].  
In a similar study by Fahrioglu et al [132], the expression of tight junction proteins (ZO-
1, OCLN and CLDN11) in Dmrt1
-/- 
mice were examined immediately after birth (P2) and 
through the first wave of spermiation (P36) [132]. Previous studies showed ZO-1 was abundantly 
expressed in testes of Dmrt1
-/-
 mice from P2 through P20, but was disorganized and localized 
only to the lumen of seminiferous tubule [132]. The tight junction proteins, CLDN11 and OCLN 
were also absent from Dmrt1-null testes at P14 and P20. Our data at P42 suggest that DMRT1 is 
required for expression of all ES proteins and Sertoli cell-specific DMRT1 expression in Dmrt1
-/-
;tg
 seminiferous tubules returns expression of ES proteins but fail to localize them to tight 
junctions because they are still compromised.  
Autoimmune recognition of differentiating germ cells is avoided by their translocation 
from the basal to the immune-privileged adluminal compartment by breaking apical junctional 
complexes maintained by Sertoli cells and rejoining them at the basal end of a migrating germ 
cell without jeopardizing the blood-testis barrier. Tight junctions, ES and desmosomes are the 
three main components of the blood-testis barrier. Knowing the dependent association between 
adherens and tight junctions, our findings on the dependent action of DMRT1 on NECTIN-2 and 
ESPIN expression at basal ESs suggests that DMRT1 is essential for establishing the BTB. Like 
other studies of testis ES, we found that ESPIN and NECTIN-2 localized basal ES at the BTB 
and with the apical ES associated with spermatids [246, 250-252]. Similarly and as shown 
previously, electron micrographs of Dmrt1
+/+
 mice showed adherens junctions in association 
with tight junctions formed between adjacent Sertoli cells. However, similar to mice with 
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testicular feminization, Dmrt1
-/-
 mice had small testes, small diameter of seminiferous tubule, 
large number of lipid droplets and abundant junctional complexes (desmosomes) [253]. In 
contrast, in addition to desmosome, numerous adherens junctions were identified in Dmrt1
-/-;tg
 
mice, which also had small testes, large number of lipid droplets and reduced diameter of the 
seminiferous tubule. Overall, based on the expression of ES protein staining and identification of 
junctional structures, the blood-testis barrier in Dmrt1
+/+
 mice comprised of tight junctions, 
adherens junctions and desmosome (not shown) was speculated to be intact and highly selective, 
whereas, those in Dmrt1
-/-
 or Dmrt1
-/-;tg
 mice were made up only of desmosomes and speculated 
to be very permeable or composed of adherens junction and desmosome (not shown) and 
speculated to have an intermediate selectivity, respectively. However, junctional permeability 
experiments will be required to validate these observations. 
In conclusion, this study provides new insights into cell-specific functions for DMRT1 in 
polarization and compartmentalization within the seminiferous epithelium, phenotypes of Sertoli 
cell-only pathological condition and putative cytoskeletal regulated signaling pathway essential 
for the formation and organization of testis-specific adherens junctions. 
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Figure 1: Immunolocalization of DMRT1 and GCNA1 in postnatal day 42 (P42) mouse 
seminiferous tubule. Testis sections from Dmrt1
+/+
 (A-D), Dmrt1 
-/-
 (E-H) and Dmrt1
-/-; tg
 (I-L)
 
mice were evaluated using fluorescently labeled antibodies against DMRT1 (green; A, E and I), 
GCNA1 (red; B, F and J) and counterstained with DAPI for nuclei (blue; C, G and K). D, H and 
L shows merged images. Yellow stained cells (arrow), indicating co-expression of DMRT1 and 
GCNA1 in germ cells, are observed only in Dmrt1
+/+
 mice (D). Arrowheads show DMRT1 
expression in Sertoli cells of Dmrt1
+/+ 
(D) and Dmrt1
-/-;tg
 (L) mice. Final magnification for 
micrographs is x400. 
 
 
 
 
 
 
 
 
91 
 
Figure 2: Colocalization of ectoplasmic specialization associated protein, ESPIN. ESPIN (A, 
E and I) and ACTIN (B, F and J) on P42 testes sections from Dmrt1
+/+
 (A-D), Dmrt1 
-/-
 (E-H) 
and Dmrt1
-/-;tg
 (I-L)
 
mice. ESPIN colocalizes with ACTIN in Dmrt1
+/+
 (D, arrowhead) and 
Dmrt1
-/-;tg
 (L, arrowhead) but not in Dmrt1
-/-
 (H) mice. Final magnification for micrographs is 
x400. 
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Figure 3: Immunohistochemical localization of NECTIN2. NECTIN-2 (red; A, D and G) and 
counterstained with DAPI for nuclei (blue; B, E and H) on testes sections at P42 in Dmrt1
+/+
 (A-
C), Dmrt1 
-/-
 (D-F) and Dmrt1
-/-;tg
 (G-I)
 
mice. Arrowheads in G and I depicts NECTIN-2 
expression between adjacent Sertoli cells. Arrowhead in F shows absence of NECTIN-2 
expression. Final magnification of micrographs is x400. 
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Figure 4: Immunohistochemical localization of NECTIN-3. NECTIN-3 (red; A, D and G) and 
counterstained with DAPI for nuclei (blue; B, E and H) on testis sections at P42 in Dmrt1
+/+
 (A-
C), Dmrt1 
-/-
 (D-F) and Dmrt1
-/-;tg
 (G-I)
 
mice. Arrowheads in G or I depicts ES formation 
between Sertoli cell and developing germs or between adjacent Sertoli cells, respectively. Final 
magnification of micrographs is x400. 
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Figure 5: Electron microscopy of Sertoli cell ectoplasmic specialization in testes sections of 
P42 Dmrt1
+/+
 mice. A. Basal ES in normal testis. Actin filament bundles are sandwiched 
between cisternae of endoplasmic reticulum and cell processes of adjoining Sertoli cells, and 
together with neighboring tight junctions form the blood-testis barrier. Magnification, x30400; 
scale bar, 100 nm. B. Apical ES in normal testis. The ES is seen in the cytoplasm of a Sertoli cell 
opposite an elongating spermatid. Magnification, x38500; scale bar, 500nm. 
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Figure 6: Electron microscopy of Sertoli cell ultrastructure in testes sections of P42 Dmrt1
-/-
 
mice. A. Absence of basal ES structures between adjoining Sertoli cells in Dmrt1
-/-
 seminiferous 
tubules. Magnification, x30400; scale bar, 500nm. B. Desmosomes (arrow) were present 
between neighboring Sertoli cells in Dmrt1
-/-
 testes. Magnification, x38200; scale bar, 100nm. 
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Figure 7: Electron microscopy of Sertoli cell ectoplasmic specialization in testes of P42 
Dmrt1
-/-;tg
 mice. A. Presence of basal ES structures between adjoining Sertoli cells in Dmrt1
-/-;tg
 
at the basement membrane of seminiferous tubules. Magnification, x19500; scale bar, 500nm. B. 
Presence of basal ES structures between adjoining Sertoli cells in Dmrt1
-/-;tg
 at the lumen of the 
seminiferous tubules. Magnification, x38200; scale bar, 500nm. 
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Chapter 4: DMRT1 regulates distinct pathways and targets in Sertoli cells 
and germ cells 
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Abstract 
The Doublesex and Mab-3 related transcription factor 1 (DMRT1) is a testis-specific 
transcription factor required for germ cell development and Sertoli cell differentiation. To 
explore the functional role of DMRT1 in germ cells and Sertoli cells, genome-wide DMRT1 
binding sites, identified by ChIP-Seq, were evaluated together with testis gene expression 
profiles from different models of DMRT1-deficiency. Microarray analyses were performed on 
postnatal day 7 testes from wild type, Dmrt1
-/-
, and Sertoli cell-specific DMRT1 rescue (Dmrt1
-/-
;tg
) mice. This revealed 609 differentially expressed genes, with at least two fold change and 
p≤0.05, in Dmrt1
-/-;tg
 testes and 791 in Dmrt1
-/-
 testes. Ingenuity Pathway Analysis (IPA) 
identified top pathways and associated biological processes in differentially expressed genes that 
were shared and distinct to Dmrt1
-/-
 and Dmrt1
-/-;tg
 testes and representing changes mediated by 
DMRT1 in germ cells and Sertoli cells, respectively. Functions associated with genes directed by 
DMRT1 in germ cells include spermatogenesis, male gamete generation and sex differentiation, 
whereas functions directed in Sertoli cells included cell-cell contact, male infertility, RNA and 
kinesin binding. Further functional annotation using DAVID and ExoCarta on a select group of 
differentially expressed genes revealed potential functions for DMRT1 in ubiquitination and 
vesicular transport. ChIP-Seq and ChIP-qPCR identified and validated genome-wide DMRT1 
binding sites using P10 and, P7 and P10 mouse testes, respectively. Approximately 150 binding 
peaks were inspected manually on the UCSC Genome Browser, identifying many novel DMRT1 
binding sites with desired peak qualities. Putative target genes were designated based on 
proximity to the binding sites, which, for 87% of the genes, were located in introns. In addition, 
integration of the microarray and binding peak data identified 52 additional putative targets of 
DMRT1 and revealed indirect and direct pathways regulated by DMRT1. VDR/RXR activation 
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and pantothenate and CoA biosynthesis were direct pathways regulated by DMRT1 in germ cells 
and Sertoli cells, respectively. In summary, the study identified new cell-specific targets and 
pathways that are regulated by DMRT1 in Sertoli cells and germ cells. 
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Introduction 
Dmrt1 encodes a transcriptional regulator, DMRT1, that shares homology to dsx and 
mab3; two evolutionary conserved proteins that regulate comparable aspects of sexual 
differentiation in Drosophila Melanogaster and Caenorhabditis elegans, respectively [112-114]. 
These orthologs share a cysteine-rich DNA binding motif, the DM domain, illustrating the 
existence of a shared gene lineage and preserved molecular pathways essential for sexual 
differentiation [146]. In vertebrates, DMRT1 expression is restricted to the gonads, where it is 
expressed in both Sertoli cells and germ cells, and required for testis differentiation [115, 128, 
141, 145, 150, 159, 216-218]. Human DMRT1 has been implicated in sex determination by 
comparative genetic mapping, which associated the region of chromosome 9 containing DMRT1 
to XY sex-reversed and testicular dysgenesis [119]. In mice, neither Dmrt1 ablation nor forced 
expression studies provided evidence for DMRT1 in sex determination but the reprogramming of 
Sertoli cells to granulosa cells in Dmrt1
-/-
 testes did reveal its role in maintaining sex 
differentiation ([50, 135]; Ning et al., unpublished). In addition, evaluation of Dmrt1
-/-
 mice 
showed DMRT1 is important for germ cell migration, survival and proliferation, Sertoli cell 
differentiation, and seminiferous tubule organization [50, 131, 133].  
DMRT1 is indispensable for spermatogenesis and is an evolutionary conserved 
transcription factor, suggesting that it may sit at the top of a hierarchy of genes that control key 
spermatogenic pathways. Therefore, identifying the genes and pathways will significantly 
advance our understanding of male fertility. In order to understand how DMRT1 contributes to 
spermatogenesis, it is necessary to identify the relationship between DMRT1 and the genes 
directed within its network, which requires knowledge of DMRT1’s target genes (i.e. those under 
its direct regulation) and the various biological pathways they affect.  
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Various cell-specific Dmrt1-deletion models contributed more insight on the biological 
processes and pathways of DMRT1 in the testis. DMRT1's cell specific role is best understood 
for the Sertoli cells. The DMRT1-deficient germ cell model (Sertoli cell rescue (Dmrt1
-/-tg
)) 
showed that DMRT1 in Sertoli cells is required for the maintenance of testis size, sperm 
progressive motility and tubule integrity, regulation of Sertoli cell maturation and localization of 
ES proteins (Chapter 2). These were consistent with findings from the SCDmrt1KO conditional 
deletion mouse model, which had DMRT1 deleted only in Sertoli cells, revealing importance in 
tubule integrity and Sertoli cell maturation as DMRT1-deficient Sertoli cells fail to polarize and 
differentiate. Functions for DMRT1 in germ cells were revealed in the SCDmrt1KO mice testes 
including postnatal mitotic reentry by spermatogonia, unimpaired migration from the lumen of 
the seminiferous tubule to the periphery and meiotic entry by primary spermatocyte that was not 
completed [131]. The inability of primary spermatocyte to complete meiosis in the SCDmrt1KO 
testes suggested that DMRT1 in Sertoli cells is needed to complete meiosis, demonstrating a 
non-autonomous action of DMRT1 on germ cells. The biological processes that were impaired 
and unhindered in Sertoli cells and germ cells of SCDmrt1KO mice testes represent the 
autonomous action of DMRT1 on Sertoli cells and germ cells, respectively. While much is 
known about the biological processes regulated by DMRT1, many of the mechanistic, direct 
targets and cell-specific details are missing. 
To this end, chromatin immunoprecipitation (ChIP) and gene expression changes 
resulting from Dmrt1 deletion have been instrumental in identifying DMRT1 target genes and 
regulated pathways, respectively. DMRT1 binding peaks were identified at the proximal 
promoter regions of 1,439 genes using ChIP-chip and the associated DMRT1 binding sites 
identified using motif searches; and a limited number of these targets were differentially 
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expressed when Dmrt1 levels were perturbed after postnatal re-initiation of DMRT1 expression 
(P1 & P2) or when levels of DMRT1 are at a maximum (P9) [132, 136]. By integrating the data, 
many known testis regulators, including Claudin11, Sox2, Stra8, Ar, Vinculin, Gja3, Gfra3, and 
Sohlh1, were implicated as direct targets of DMRT1 [136]. Furthermore, network analysis 
ascribed pathways represented by the identified DMRT1 target genes, which included androgen, 
focal adhesion kinase, IL-6, phosphatase and tensin homolog (PTEN), and insulin-like growth 
factor 1 (IGF-1), FSH, retinoic acid, GDNF, eicosanoid, and tachykinin 2 pathways [132, 136]. 
However, this study probed only proximal promoter sequences thus putative DMRT1 target 
genes regulated by distal binding were not identified. Furthermore, only about 1/10th (143/1439 
targets) of the putative genes mapped close to a binding site were misregulated in microarray 
analyses supporting their regulation by DMRT1.  
The present study used previously characterized mouse models of Dmrt1 deficiency to 
examine cell-specific DMRT1-regulated pathways. In addition to Dmrt1
-/-
 mice, the study 
employed a transgenic model of germ cell DMRT1 deficiency, which expresses DMRT1 only in 
Sertoli cells in Dmrt1
-/- 
mice (i.e. Dmrt1
-/-;tg
 mice; Chapter 2) and therefore function can be 
ascribed to the entire germ cell population at times when spermatogenesis is initiated and the 
niche is formed. Pathway analysis revealed roles in VDR/RXR activation, IL-4 signaling and 
immune response enriched in germ cells, whereas cell-cell contact and RNA binding were 
enriched in Sertoli cells. Genome-wide analysis of DMRT1 binding sites by ChIP-Seq of 
chromatin from postnatal day 10 (P10) Dmrt1
+/+
 and Dmrt1
-/-
 testes identified many new 
DMRT1 target genes, which have roles in RNA transport and regulation, cell cycle, cell adhesion 
and protein transport.  
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Materials & Methods  
Animals 
Generation and characterization of Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice have been described 
elsewhere ([50]; Chapter 2). All animal procedures were approved by the Laboratory Animal 
Research Committee at the University of Kansas Medical Center and performed in accordance 
with National Institutes of Health guidelines.  
RNA isolation and Microarray analysis 
Total RNA was isolated from 12 postnatal day 7 (P7) mouse testes, four each from 
knockout (Dmrt1
-/-
), wild type (Dmrt1
+/+
) and rescue (Dmrt1
-/-;tg
), using Trizol reagent 
(Invitrogen) following the manufacturer’s guidelines. Isolated RNA was quantified using 
NanoDrop (ND-1000, Thermo Scientific) and quality checked using the Agilent 2100 
Bioanalyzer with the RNA 6000 Nano LabChip. Microarray analysis was performed by the 
Microarray and Bioinformatics core at the University of Kansas Medical Center. Briefly, five 
microgram (5µg) of total RNA was biotinylated using GeneChip Expression 3′-Amplification 
IVT labeling kit (Affymetrix, Cleveland, OH). The Mouse Genome 430 2.0 GeneChip arrays 
(Affymetrix, Cleveland, OH) were hybridized with amplified RNA (cRNA), washed in the 
Fluidics Station 400 (FS400) (Affymetrix, Cleveland, OH) using the EuKGE-WS2v5 protocol, 
and scanned, using the default settings, using the GeneChip Scanner 3000 7G Reader 
(Affymetrix, Cleveland, OH).  
Expression data analysis 
Raw data analyses were performed using Partek® genomic suite, version 6.4 (Partek Inc., 
St. Louis, MO) and pairwise comparisons performed between Dmrt1
-/-
 and Dmrt1
+/+
, Dmrt1
-/-;tg
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and Dmrt1
+/+
 or Dmrt1
-/-
 and Dmrt1
-/-;tg
 samples.
 
Background was adjusted using Robust Multi-
array Average (RMA) algorithm, data normalized using the Quantile normalization algorithm, 
and probe intensity levels summarized using the Median polish method [254-256].  
To identify differentially expressed genes, a 3-step filtering process was used for each 
comparison (Dmrt1
-/-
 / Dmrt1
+/+
, Dmrt1
-/-;tg
 / Dmrt1
+/+
 or Dmrt1
-/-
 / Dmrt1
-/-;tg
). The p-values 
were calculated using R package and functions in the ‘limma’ Bioconductor package [257]. The 
false discovery rate (FDR) was calculated using adjusted p-values corrected for multiple 
comparisons as described elsewhere[258]. Transcripts with expression fold differences less than 
2 (i.e. differences with log2 values between -1 and 1), moderate t-test p-values greater than 0.05 
or a false discovery rate (FDR) greater than 0.1 were excluded [259].  
Pathway analysis 
Functional and pathway analyses of differentially expressed genes were performed by 
Ingenuity Pathway Analysis software (IPA; Ingenuity
®
 Systems, www.ingenuity.com). Prior to 
importing the gene refseq accession numbers to IPA, germ cell and Sertoli cell-specific 
differential gene changes were identified using a parameter called the rescue factor (RF). The RF 
was calculated using the formula, RF , where Res/Wt was fold changes in Dmrt1
-/-;tg
 
probes after normalizing to the equivalent Dmrt1
+/+ 
probes and Ko/Wt was fold changes in 
Dmrt1
-/-
 probes after normalizing to the equivalent Dmrt1
+/+
 probes. An arbitrary scoring scale 
ranging from a minimum of negative one (-1) to a maximum of one (1) was utilized to categorize 
these genes. Genes with and RF > 0.5 were considered either partially (0.5<RF<1.0) or fully (RF 
= 1.0) rescued, with the latter representing genes regulated by DMRT1 only in Sertoli cells. 
Genes with an RF < 0.5 were considered to be largely or entirely regulated by DMRT1 in germ 
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cells. Functional annotation was performed using IPA, the Database for Annotation, 
Visualization and Integrated Discovery (DAVID; [260]) and ExoCarta (Exosome protein, RNA 
and Lipid data base;[261, 262]). 
Chromatin Immunoprecipitation (ChIP) 
ChIP was performed using chromatin from freshly isolated Dmrt1
+/+
 and Dmrt1
-/-
 P10 
mouse seminiferous tubules as described elsewhere [263-265]. Briefly, tubules were prepared by 
sequential treatments of collagenase, DNase I, and trypsin, followed by sedimentation and low 
speed centrifugation, resulting in a cell preparation largely consisting of Sertoli cells and 
spermatogonia. DMRT1 antibody production and characterization were reported elsewhere and 
preliminary studies confirmed DMRT1 immunoprecipitation before and after formaldehyde 
treatment ([130] and data not shown). Immunoprecipitated and input DNAs were processed and 
and analyzed by CoFactor Genomics (St. Louis, MO) using Illumina Pipeline version SCS2.8.0 
paired with OLB 1.8.062. Sequence was aligned using Novoalign version 2.07.05 (Novocraft 
Technologies, Selangor, Malaysia) and Bowtie [266] and normalized reads from both alignments 
were used with CLC Genomics Workbench (CLC Bio, Cambridge, MA) and MACS to identify 
peaks [267]. This uncovered roughly 150 peaks specific to the Dmrt1
+/+
 IP DNA, which were 
considered potential DMRT1 binding sites. Sequence tags (BAM files) from all four samples 
(Dmrt1
+/+
, Dmrt1
-/-
 IP and input) were visualized on the UCSC Genome Browser, together with 
peak annotations to mark potential binding sites, which were manually curated to assess spatial 
spread, strand symmetry and peak density enrichment of Dmrt1
+/+
 IP sample compared to 
negative controls (Dmrt1
-/- 
IP, Dmrt1
+/+
 input, Dmrt1
-/-
 input) [268-271].  
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Quantitative real-time PCR  
To validate ChIP-Seq and microarray results, real-time reactions were carried out as 
described elsewhere using a 7900HT Sequence Detection real time analyzer (Applied 
Biosystems, Foster City, CA)[185]. For microarray validation, RNA was isolated from Dmrt1
-/-
, 
Dmrt1
-/-;tg
 and Dmrt1
+/+
 P7 testes and first-strand cDNA synthesized using 2ug RNA and 
MMLV reverse transcriptase (Invitrogen (Carlsbad, CA), following the manufacturer’s 
instructions. Default cycle parameters were used to amplify a 1:10 dilution of cDNA with 
SYBR
®
 Green PCR master mix (Applied Biosystems, Foster City, CA) and primers 
(supplementary Table 1). Samples were run in triplicate and included water as negative controls. 
Ct melting curves for ribosomal L7 (Rpl7) cDNA was used to calculate Ct values for each 
sample. Rpl7 Ct values did not vary across genotype and the melting curves for Rpl7 and all 
analyzed genes gave a single peak that validated the absence of primer-dimer formation. Ct 
values were calculated by subtracting the mean P7 wild type Ct. Fold change was calculated 
using the 2
- Ct
 method [186].  
Validation was performed on forty DMRT1 binding sites identified by ChIP-Seq. 
Quantitative real-time PCR was performed as above but with chromatin as template and primers 
spanning the binding site (Supplementary Table 2). For ChIP validation chromatin was prepared 
from P7 and P10 Dmrt1
+/+ 
and Dmrt1
-/- 
testes.  
DNA motif Analysis 
Motif identification was performed on the top 5 identified DMRT1 binding sites, using 
MEME Suite sequence analysis tools [272]. MEME was run using default settings and the 
projected number of motifs was manually set to equal the number of input sequences. Similarity 
searches were performed using TOMTOM to compare the predicted binding motif to the existing 
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in vitro Dmrt1 binding sequence ([TCA][TGA]G[ACT][TA]ACA[TA]TGT[TA][GT][CTAG]) 
[273, 274].  
Integrative Analysis 
To identify direct targets of DMRT1, two separate analyses were performed to evaluate 
genes whose expression were altered in Dmrt1
-/-
 or Dmrt1
-/-;tg
 testes and contained a mapped 
DMRT1 binding peak within its proximal, distal or intronic regulatory region. Manual analysis 
was performed by integrating the differential gene expression obtained in Dmrt1
-/-
 and Dmrt1
-/-;tg
 
samples (Table 2) with either previously published DMRT1 ChIP-chip binding site data ( 
a-c
 in 
Tables 2, 3 and 4) (http://www.dmrt1.umn.edu/) or with our current ChIP-Seq data ( 
d-g
 in Tables 
2) to help predict true DMRT1 target genes [136]. In addition, ChIP-Array 
(http://jjwanglab.org/ChIP-Array), web-based free-software that integrates ChIP-Seq and 
microarray data was used as described elsewhere [275]. Briefly, 5537 peaks, with at least twenty 
tags located in binding site, were uploaded to ChIP-Array, which can identify sequences located 
within 8kb upstream and 2kb downstream of a gene’s transcription start site (TSS). In order to 
identify all potential DMRT1-targets, all genes with a fold change greater than one (fold change 
≥ 1) in Dmrt1
-/-
 and Dmrt1
-/-;tg
 testes were included in the analyses. The parameters for the ChIP-
Array were set to -8kb to +2kb for regulatory region range, p-value for position weighted matrix 
scan was 10
e-4
, p-value for conservation filtering was 0.01 and UCSC gene browser was selected 
search platform. 
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Results 
Gene expression changes in P7 testes from Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice. 
Microarray analysis was used to obtain gene expression profiles from Dmrt1-/-, Dmrt1+/+, and Dmrt1-/-;tg, 
generated by expressing DMRT1 to Dmrt1-null Sertoli cells using a Wt1-Dmrt1 transgene, mouse testes 
at postnatal day 7, a time-point when germ cell radial migration is complete, spermatogenesis is 
beginning, and cellular levels of DMRT1 are at a maximum ([130]; as published in the dataset GSE926 
[276]). Pairwise comparisons of the expression profiles from Dmrt1+/+and either Dmrt1-/- or Dmrt1-/-;tg 
identified 791 and 609 differentially expressed transcripts, i.e. with ≥ 2 fold change and p < 0.05 , in 
Dmrt1-/- and Dmrt1-/-;tg samples, respectively (Table 1). Pairwise comparison of Dmrt1-/- and Dmrt1-/-;tg 
samples identified 37 differentially expressed transcripts in Dmrt1-/- relative to Dmrt1-/-;tg. The results 
showed that transgenic return of DMRT1 to Sertoli cells restored expression of 219 transcripts whose 
expression was altered by at least 2fold or more in the testes of Dmrt1-/- mice.  
 In order to identify cell-specific gene expression changes, microarray data were 
examined for the most sensitive transcripts that were shared between or unique to the Dmrt1-null 
and Dmrt1-rescue testes. Given that the Dmrt1-null and Dmrt1-rescue testes both lacked 
DMRT1 in germ cells, gene expression changes that were identical, (or nearly so), in both groups 
were considered germ cell-specific (Figure 1), while gene expression profiles that were lost when 
DMRT1 expression was restored to Sertoli cells of Dmrt1
-/-
 mice or unique to Dmrt1
-/- 
mice, i.e. 
when DMRT1 is absent in both Sertoli cells and germ cells, were considered Sertoli cell-specific. 
After excluding duplicates from the 791 and 609 differentially expressed genes that met the 
cutoff criteria in Dmrt1
-/-
 and Dmrt1
-/-;tg
 testes samples, 704 and 516 genes were mapped to the 
IPA database, respectively. Comparative analyses on the mapped genes revealed 450 genes were 
equally changed in both Dmrt1
-/-
 and Dmrt1
-/-
 samples, indicating they were associated with 
DMRT1 actions in germ cells. In addition, 320 genes were rescued by the transgene, as they 
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were changed only in Dmrt1
-/- 
samples, and were associated with DMRT1 activity in Sertoli cells 
(Figure 1). A second more stringent method was used to evaluate cell-specificity. In this case, a 
rescue factor (RF) was assigned to 718, 15 and 37 genes with RF < 0.5, RF < 1 and RF =1, 
respectively, were considered to be germ cell-specific, shared by germ cells and Sertoli cells, and 
Sertoli cell-specific, respectively. The results suggested that manual analysis is capable of 
identifying cell-specific differences that could be missed using computer-based methods. 
To confirm gene expression profiles obtained by microarray experiments, quantitative 
PCR was performed on a subset of mRNA of genes characterized to be germ cell or Sertoli cell-
specific. Microarray and qRT-PCR results were compared for 11 downregulated and 10 
upregulated genes (Figure 2). The overall expression trend of down-regulated (Figure 2A) and 
up-regulated genes (Figure 2B) obtained in microarrays correlated with the expression trend 
observed in qPCR. For instance, Dmrt1 was reduced 10 and 5 fold, Clec12b was reduced 7 and 4 
fold, Rarres1 was reduced 4 and 1.7 fold and Lect1 was induced by 4.5 and 4 fold, in Dmrt1-null 
and Dmrt1-rescue testes, respectively. Thus, the qRT-PCR results support the microarray 
analyses and its ability to detect cell-specific gene expression changes is response to DMRT1 
loss.  
To gain insight on the temporal effects of DMRT1, gene expression profiles from this 
study were compared to those of previously reported for P1/P2 Dmrt1
-/-
 and P9 GCDmrt1KO 
testes [132, 136]. Comparison of P7 Dmrt1-null testis transcriptome to those at P1 and P2, 
revealed about 40.3%, 42% and 17.5% were absent at P1/P2 (311 out of 770), showed a similar 
(up or down; 322 out of 770) and opposite (137 out of 770) trend at P7 and P1/P2, respectively. 
This suggested that almost half of the differential gene profiles present at P7 Dmrt1-null testes 
were silent at P1/P2. Similarly, comparison of differentially expressed genes between P7 Dmrt1-
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rescue and P9 GCDmrt1KO testes revealed 72 genes were unchanged in P9 GCDmrt1KO, 2 
were unchanged in P9 GCDmrt1KO and P7 Dmrt1-rescue testes, and 35 were unchanged in P7 
Dmrt1-rescue but changed at P9 GCDmrt1KO testes. In addition, 660 changed in both P7 Dmrt1-
rescue and P9 GCDmrt1KO testes, of these, 434 changed in a similar direction of which 402-
showed change that is more robust at P7 Dmrt1-recue than P9 GCDmrt1KO testes. The results 
suggested that a significant number of transcripts in the Dmrt1-null samples at turned-on at P7 
that were off at P1/P2 and the P9 GCDmrt1KO sample, generated by Ngn3-Cre-mediated 
conditional deletion of Dmrt1 in germ cells, and P7 Dmrt1-rescue sample, generated by returning 
DMRT1 to Dmrt1-null Sertoli cells, share a significant gene expression profile.  
Characterization of DMRT1 binding sites and putative target genes 
ChIP-Seq was used to identify DMRT1 binding sites on a genome-wide scale. The UCSC 
Genome Browser (http://genome.ucsc.edu/cgi-bin/hgGateway) was used to visualize BAM and 
annotated peak files and the top scoring peaks unique to Dmrt1
+/+ 
immunoprecipitated sample 
(~150) were manually curated to assess spatial spread, strand symmetry and peak density of the 
Dmrt1
+/+
 immunoprecipitated sample relative to the negative controls (Dmrt1
-/-
 chip, Dmrt1
+/+
 
input, Dmrt1
-/-
 input). Binding site characteristics (chromosome and relation to predicted gene) 
showed that 87% of DMRT1 binding sites mapped within introns, 6.5% mapped within 3′ end 
and 6.5% within an intron and 5′ end (Table 3A). Thirty-one genes in-close proximity to the 
peaks enriched for Dmrt1
+/+
 immunoprecipitated sample were confirmed by ChIP-qPCR. All 
genes except Taok3 were found to be enriched in the Dmrt1
+/+
 immunoprecipitated DNAs 
compared to the IgG immunoprecipitated DNAs using real time quantitative PCR (*qChIP, 
Table 3B). The average binding affinity for qPCR in the Dmrt1
+/+
 immunoprecipitated DNAs 
was 11 fold over IgG immunoprecipitated DNAs and range between 4 and 20 fold (Table 3A). 
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The results suggested that the false discovery rate for peaks identified in this study was about 
3%. 
To predict putative in vivo binding motifs for DMRT1, MEME and TOMTOM analyses 
were performed on the top five DMRT1 binding site sequences[272, 273]. Using MEME, two 
motifs, logo one (CAG[AT]C[AT]G[AT]CA[CT][AG]TGT[GT]) and logo two 
(CG[GC]A[CA]T[GC]G[TA]GCGA), were identified with an elevated statistical significance 
(E-value = 3.4E
-7
). Similarities in ACA and TGT nucleotide bases were observed between the in 
vitro Dmrt1 consensus logo ([TCA][TGA]G[ACT][TA]ACA[TA]TGT[TA][GT][CTAG]) 
(Figure 3A) and logo one (CAG[AT]C[AT]G[AT]CA[CT][AG]TGT[GT])(Figure 3B) . Using 
TOMTOM to search for transcription factors similarities in binding sites to logo two 
(CG[GC]A[CA]T[GC]G[TA]GCGA) revealed the binding sites ([AGT][AT]TGTTGC[GCA] 
[ATG][ATG][TG][TGCA]) for male abnormal3 (mab3), with 77% (10 out of 13) binding site 
similarity (Figure 3C). 
Pathway comparison of P7 Testes 
To categorize the functions of genes specifically regulated by DMRT1 in germ cells and 
Sertoli cells, the RF was used to select genes for IPA. From the list of 718 genes that were 
assigned to germ cells with RF < 0.5, canonical pathway analysis using IPA revealed enrichment 
of VDR/RXR and RAR activation, ATM and FLT3 signaling, role of Nanog in pluripotency and 
immune response pathways (IL-4 and NFAT; Table 4A, upper panel). Pathways enriched in the 
37 genes with RF = 1, which were assigned to Sertoli cells included lipid (sphingolipid and 
glycerolipid) metabolism, biosynthesis (methyl group amino acids, pantothenate and CoA) and 
bladder cancer signaling (Table 4A, lower panel). Functional clustering using IPA revealed 
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enrichment of male gamete generation, apoptosis, cell adhesion, sex differentiation and 
morphogenetic processes in germ cells (Table 4B, upper panel), whereas infertility, cell-cell 
contact, cholesterol ester metabolism, RNA and kinesin binding were processes enriched in 
Sertoli cells (Table 4B, lower panel).  
DAVID was used to obtain gene ontology terms and pathways for subset of genes 
identified by comparing gene expression profiles from Dmrt1-null testes at P1/P2 and P7 or P7 
Dmrt1-rescue and P9 GCDmrt1KO testes (Table 5). For the genes absent in P1/P2 Dmrt1-null 
testes, biological processes including piRNA metabolic processes, RNA binding and nuclear 
RNA export factor complex were represented, whereas pathways including ubiquitin (Ubl) 
conjugation and axon guidance were enriched (Table 5A). Processes and pathways that were 
enriched in subset of genes with opposite or similar gene expression changes at P1/P2 and P7 
included male gamete generation, sex differentiation, regulation of protein localization, 
apoptosis, p53 signaling, cell cycle, antigen processing and presentation, and cell adhesion 
molecules pathways (Tables 5 B and C). The subset of genes absent in P7 Dmrt1-rescue sample 
were implicated in the organization of the cytoskeleton and in panthotenate and CoA 
biosynthesis, while those absent in P9 GCDmrt1KO samples were important in cell-cell junction 
and p53 signaling (Tables 5 D and E). In addition, the subsets of genes with opposite or similar 
gene expression changes in P7 Dmrt1-rescue and P9 GCDmrt1KO were represented by 
biological processes and pathways that include lipid localization, cell cycle, cell proliferation, 
lipid transport, spermatogenesis and protein localization (Tables 5 F and G). Overall, these 
results showed temporal gene regulation by DMRT1 whereby at P1/P2, DMRT1 directs male 
gamete generation, cell cycle and protein localization, which were maintained at P7 and P9. At 
P7, functions in lipid localization, lipid transport and cell-cell junction are turned on that were 
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absent at P1/P2 but sustained at P9. Apoptosis was predominant at P1/P2 and P7 but absent at 
P9. Unique functions in piRNA metabolic processes, cell-cell junction and RNA binding were 
enriched only at P7; and at P9, the regulation of cytoskeleton organization was enriched. 
To further understand and reveal potential novel functions for DMRT1, DAVID and 
ExoCarta was used to identify functional clusters within a subset of about 100 genes (Table 6). 
The functions that were enriched include cell death/survival, pluripotency marker, cell junction, 
exosomes, adhesion, meiosis, RNA binding, migration, integrin binding, cancer and 
ubiquitination (Table 6). Ubiquitination was implicated by marked changes in several genes 
encoding MAGE cancer testis antigens (MAGE11, K1, & B16) and TRIM E3 RING ubiquitin 
ligases (TRIM71, 12, & 34). Vesicle transport was implicated when it was noted that 13 genes 
misregulated in Dmrt1-null testes were previously identified components of exosomes, vesicles 
used for intercellular communication that transfer membrane components and nucleic acid 
between cells (ExoCarta). Remarkably, mRNAs for all except Foxq1, Gfra1, Rarres1, Tuba3a, 
Cadm1 and Piwil2 increased with Dmrt1 loss, and included Dppa3, Cpne8, Mid1, Aqp5, H2Aa, 
BM117570 (long ncRNA), Hspb8, Krt18, Krt8, Cfi, Rsp9, Ano4, and Fbln2 (Table 6). Return of 
DMRT1 to Sertoli cells entirely restored Cpne8, BM117570, Mid1 and Rarres1, partially 
restored Rsp9 expression and did not restore the rest. The results revealed functions relevant to 
testis biology including ubiquitination and vesicular transport that have not been associated to 
DMRT1 until now. 
 Direct targets of DMRT1 
 To identify direct targets and pathways of DMRT1, integrative analyses were performed 
using P7 testes gene expression profiles and ChIP-Seq. Two methods were used to integrate the 
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ChIP-Seq and microarray data to identify putative DMRT1 targets. The first method consists of 
manually evaluating the a subset of 770 differentially expressed genes in this study for the 
desired peak quality in the ChIP-Seq analyses. This analysis revealed 30 targets that were 
differentially expressed and contained a DMRT1 binding site (Table 7). Of these, Usp9y, 
Plekhg1 and Boll were novel targets identified by ChIP-Seq analyses (Table 7). The importance 
of these direct targets in testis development is highlighted by the roles of Boll and Usp9y in germ 
cell differentiation and male infertility, respectively [277, 278]. The basis of second method was 
the same to the first but it utilized a web-based freeware, the ChIP-Array, to integrate and query 
the gene expression (7403 probe sets) and ChIP-Seq (5537 MACS peaks) data. This analysis 
identified 58 direct targets (Figure 4) and six of these targets (Tlr7, Unc45a, Clec1a, Zfp606, 
Ccnf, Kcnh1) were previously identified as DMRT1 targets elsewhere [136]. 
Pathways and processes directly regulated by DMRT1 
The list of target genes (Table 3 B) was also evaluated for functional associations but 
because the number of functionally annotated target genes was small, limited information was 
gained from standard bioinformatics. Therefore, biological profiles were developed from 
information extracted from the literature and homology to known proteins. This identified 
several biological areas highly represented by DMRT1 target genes (Table 3B). These included 
cell adhesion/structure (Group 1), RNA processing/metabolism (Group 2; binding, transport, and 
regulation), protein modification/transport (Group 3), and DNA damage and repair (Group 4). 
Within these, cilia biogenesis, cell cycle control, and cell migration were also emphasized. Other 
areas (composite Group 5) included cell signaling/communication and lipid metabolism. These 
results favored the elucidation of pathways and processes directly influenced by DMRT1 in 
Sertoli cells and germ cells.  
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Discussion 
The mammalian testis is the primary site for spermatogenesis and is comprised of four 
main cell types that include Sertoli cells and germ cells. The development of germ cells and 
maturation of Sertoli cells are known to be regulated by the transcription factor, DMRT1 [50, 
131, 133]. Thus, studying the cell-specific roles of DMRT1 in Sertoli cells and germ cells is of 
great importance. The present study used cell-specific DMRT1 expression mouse models to 
systematically study functions of Dmrt1 in Sertoli cells and germ cells. 
Microarray identified global gene expression changes 
The expression of DMRT1 in both Sertoli cells and germ cells makes it an extraordinary 
transcription factor with cell-specific regulatory capabilities for differential expression of direct 
or indirect target genes. DMRT1 exhibits auto-regulation and its mRNA levels were reduced by 
97 and 92 fold in germ cells from Dmrt1
-/-
 and Dmrt1
-/-;tg
 testes, respectively. The gene 
expression change for Dmrt1 was assigned to germ cells for the purpose of analysis because peak 
expression of DMRT1 that occurs between P6-P9 coincides with increased expression 
contributed by the multiplying number of spermatogonia, which accounts for a significant 
amount of total DMRT1 levels ([130]; dataset GSE926 [276]). Thus, the fold difference in Dmrt1 
mRNA level in both Dmrt1-null and Dmrt1-rescue testes was not statistically significant, but the 
five-fold enrichment in the Dmrt1
-/-;tg
 testes was sufficient for translation and expression of 
DMRT1 in Sertoli cells that partially restored tubule morphology and integrity in the adult male 
mice as previously described elsewhere (Chapter 2). Furthermore, the mRNA levels of Dmrt1 
and 19 other genes were confirmed by qPCR (Figure 2). The results revealed a similar 
expression trend but the magnitude fold change obtained by qPCR was inferior in most cases to 
those obtained by microarrays. Examples of genes differentially expressed in germ cells and 
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validated by qRT-PCR include Clec12b, Lin28, Cidea Plzf, Cfi and Lect1, while that regulated in 
Sertoli cells was Rarres1. Clec12b belongs to a C-type lectin-like family and serves as a receptor 
in myeloid cell function during activation of an immune response [279]. Lect1 is a cartilage 
matrix protein shown to inhibit angiogenesis and suppress T-cell responses [280]. Rarres1 is a 
tumor suppressor gene shown to regulate differentiation and proliferation of adipose tissue-
derived mesenchymal stem cells [281].  
The pattern of cell-specific global gene expression profiles regulated by transcription 
factors like DMRT1 typically occurs through age-dependent activation or repression of the 
transcription of its target genes. Evaluation of the global gene expression profiles at P1/P2 and 
P9 revealed 118, 759 and 852 genes were misregulated in Dmrt1-null, SCDmrt1KO and 
GCDmrt1KO testes, respectively [132, 136]. Consistent with these previous studies, evaluation 
of P7 Dmrt1
-/-
 and Dmrt1
-/-;tg
 testes revealed that 791 and 608 genes were misregulated (Figure 1 
and Table 1), respectively. The trend suggest that the number of genes regulated increases from 
P1/P2 to P7 to P9 and overlaps with the increasing cellular levels of DMRT1, which peaks 
between P6 and P9 in the mouse testes ([130]; GSE926 dataset [276]). In addition, the results in 
this current study suggested that the return of DMRT1 to Dmrt1-null Sertoli cells via a Wt1-
Dmrt1 transgene reduced the number of genes that were misregulated in Sertoli cells. 
Furthermore, comparing the gene expression profiles of the Dmrt1-null testes at P1/P2 revealed 
that of the total number of genes that met the cutoff criteria in the P7 Dmrt1-null testes, 40.31 % 
and 42% were absent and misregulated at P1/P2, respectively (Table 2B). Likewise, comparison 
of the gene expression profiles of P9 GCDmrt1KO and P7 Dmrt1-rescue revealed that 5% of 
genes misregulated at P9 were absent at P7, 9% of genes misregulated at P7 were absent at P9 
and 56% of the genes were misregulated at P7 and P9 (Table 2C). Examples of genes that were 
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misregulated from P1 through P9 include the continuous increased expression of Cfi and 
decreased expression of Nkx3-1, both of which are expressed in germ cells, and thus confirms 
their role in blocking the transition of primordial germ cells to gonocytes as was previously 
observed elsewhere [132]. Overall, the various mouse models of cell-specific DMRT1 
expression share significant similarities in global gene expression profiles, despite differences in 
age of the biological samples and method used for cell-specific targeting (conditional deletion vs. 
transgene expression). 
Novel DMRT1-targets identified by ChIP-Seq 
Continuous efforts have been made to identify DMRT1-target genes and thus the 
functions of DMRT1. However, varied conclusions have been drawn using different models. 
Using ChIP-chip, 1434 targets were identified on P9 testes derived from cell-specific mouse 
models generated by Cre-mediated conditional deletion of Dmrt1 in germs cells (GCDmrt1KO or 
GC-KO; used Ngn3-Cre) and Sertoli cells (SCDmrt1KO or SC-KO; used Dhh-Cre) compared to 
Cre controls [136]. Consistent with previous findings, ChIP-Seq analyses in this study identified 
approximately two hundred binding sites that were enriched in the Dmrt1
+/+
 immunoprecipitated 
sample compared to all negative controls (Dmrt1
-/-
 chip, Dmrt1
+/+
 input, Dmrt1
-/-
 input) as 
previously described elsewhere (Figure 4 and Tables 3 and 7; [268, 269]). The three negative 
controls, while reducing the total number of peaks identified, significantly improved the quality 
of the data by eliminating false positives and thus enriching for the most promising DMRT1 
binding sites. Surprisingly, most DMRT1 binding sites were found within introns (87%) (Table 
3A), suggesting it functions predominantly through distal enhancers. Many putative targets are 
relatively uncharacterized, while others have known or implicated functions in spermatogenesis 
(e.g. Gfra1, Boll and Spag1) and neurogenesis (e.g. Gfra1, Ntm, Nlgn1) [279, 282-287]. In 
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contrast to a previous study that identified about 1400 targets, all identified binding sites in this 
current study are novel; having escaped detection by previous methods that used promoter arrays 
[136]. Further evaluation of DMRT1-associated binding sites using the top five DNA binding 
site sequences revealed a close match to the in vitro DNA-binding motif, having 40% 
conservation of the nucleotides (Figure 3B). More similarity searches using TOMTOM identified 
a second motif closely related to male abnormal-3 (mab3), which had a 77% similarity to the 
putative DMRT1 binding site (Figure 3C). These results suggest that DMRT1 interacts directly 
by binding to a defined regulatory element. These results differ but are consistent to similar 
findings that analyses of potential DMRT1 regulatory element identified atleast two regions with 
70% and 77% similarity to the characterized in vitro sequence [136]. 
Different biological processes are regulated by DMRT1  
The biological processes regulated by DMRT1 in Sertoli cells and germ cells were 
identified using IPA, DAVID and ExoCarta. Evaluation of pathways in genes misregulated in 
Dmrt1-null revealed a tendency for DMRT1 to influence the transcription of genes involved in 
pathways of pluripotency, immune response, VDR/RXR activation ATM and IL-4 signaling; and 
lipid metabolism and pantothenate and CoA biosynthesis in Sertoli cells (Table 3A). Functions 
enriched in germ cells include maturation of male gamete generation, spermatogenesis, and sex 
differentiation, whereas functions enhanced in Sertoli cells include RNA binding, infertility, cell-
cell contact and kinesin binding (Table 3B). These findings are consistent with those from 
previous studies which showed enrichment of biological processes that included antigen 
presentation, retinoic acid signaling, FSH receptor, GDNF and tachykinin 2 signaling, eicosanoid 
and nuclear receptor metabolism, immune response and pluripotency [132, 136]. However, 
although the pathways at P1/P2 were informative and deduced from pre-existing knowledge of 
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testicular targets and pathways, they were not statistically significant due to the limited number 
of focus molecules associated with each pathway. For instance, GDNF pathway was enriched 
because Ret and Gfra1 were differentially express or retinoic acid signaling was overrepresented 
due to altered expression of Crabp II. Thus, although genes like Ret, Gfra1and Crabp II were 
differentially expressed in our study, their associated pathways were not statistically significant 
in the IPA database. 
Further analyses using DAVID and ExoCarta revealed the potential role for DMRT1 in 
ubiquitination and vesicular transport. Ubiquitination was implicated by marked changes in 
several genes encoding MAGE cancer testis antigens (MAGE11, K1, & B16) and TRIM E3 
RING ubiquitin ligases (TRIM71, 12, & 34) and by the recent report showing MAGE and TRIM 
proteins interact to mediate substrate ubiquitination [288]. Vesicular transport was highlighted 
when mRNA of 13 genes found to be expressed in exosomes were misregulated in Dmrt1-null 
testes (Table 6). These results open-up more questions on the possible regulatory and 
communication mechanisms between and/or within Sertoli cells and germ cells. Thus, it is 
plausible that DMRT1 uses ubiquitination to regulate differentiation of Sertoli cells or exosomes 
for communication between Sertoli cells and germ cells. However, further experiments will be 
needed to test these hypotheses.  
In addition, biological processes enriched in DMRT1-targets and regulated genes were 
examined to help conceive a hierarchy for the DMRT1 network. This identified commonalities 
used to predict biological areas most relevant to DMRT1 function and consequently its control 
over spermatogenesis. Four areas were identified: 1) protein processing/transport, 2) cell 
adhesion/cytoskeletal regulation, 3) RNA processing, and 4) DNA recombination/repair. Protein 
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processing/transport derives from features of up-regulated genes (glycosylated, 
secreted/membrane proteins) that connect to Group 3 target genes via functions in protein 
modification (glycosylation, peptidase, thiol exchange) and vesicle-mediated transport. Cell 
adhesion/cytoskeletal regulation emerged from correlations between up-regulated gene processes 
(morphogenesis, cell junctions, cytoskeletal regulation) and Group 1 targets. Down-regulated 
genes were highly enriched for genes involved in RNA processing (binding, metabolism, 
expression) and DNA recombination/repair; two groups represented by target genes (Groups 2 
and 4, respectively).  
Integration of the gene expression profiles and binding site data followed by functional 
analyses facilitated the identification of pathways and processes directly regulated by DMRT1 in 
Sertoli cells and germ cells. For example the requirement of Bcat and Stk4 in pantothenate and 
CoA biosynthesis, makes this pathway to be directly controlled by DMRT1 in Sertoli cells. 
Whereas the involvement of Fcgrb2, Taf7, Ncoa2, and Fgfr2 in the role of NFAT in immune 
response, pluripotency and nuclear horme activation and metabolism make these pathways to be 
directly regulated by DMRT1 in germ cells. Some of these pathways are consistent with those 
previously reported [136].  
In conclusion, the present study shows that DMRT1 regulates distinct pathways and 
processes in Sertoli cells and germ cells by regulating the basal transcription of its target genes. 
In addition, expression of DMRT1 in germ cells directly regulated pathways involved in immune 
response, pluripotency, and ATM signaling; and functions in male gamete generation, 
spermatogenesis and sex differentiation. On the other hand, its expression in Sertoli cells drives 
pathways of lipid metabolism and pantothenate and CoA biosynthesis, while also influencing 
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infertility, cell-cell contact, RNA and kinesin binding. These biological processes and their 
associated genes have been inferred by in silico modeling methods using fixed database 
information and as such can only be regarded as a source of hypotheses. Most of these 
associations are acceptable in a variety of physiological and diseased states, but does not 
establish that the genes in these pathways interact in a similar fashion in vivo. Thus, functional 
testing will be needed to evaluate these individual molecular relationships directed by DMRT1 
that are essential for germ cell development and Sertoli cell differentiation. 
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Figure 1: Strategy for identifying cell-specific gene expression changes using the Ingenuity 
Pathway Analysis (IPA) software. 
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Figure 2: Validation of differentially expressed transcripts by quantitative PCR. A. Down-
regulated genes in microarray maintained a similar expression pattern by qPCR in Dmrt1
-/-
 or 
Dmrt1
-/-;tg
 relative to Dmrt1
+/+
 samples. B. Expression patterns of up-regulated genes were 
similar comparing microarray and qPCR in Dmrt1
-/-
 or Dmrt1
-/-;tg
 relative to Dmrt1
+/+
 samples. 
Stippled and striped bars are microarray expression in Dmrt1
-/-
 and Dmrt1
-/-;tg
 samples, 
respectively, relative to microarray expression in Dmrt1
+/+
 samples. Black and clear bars are 
qPCR expression in Dmrt1
-/-
 and Dmrt1
-/-;tg
 samples, respectively, relative to microarray 
expression in Dmrt1
+/+
 samples. 
 
124 
 
Figure 3: Comparison of DMRT1 in vitro identified consensus binding sequence to putative 
binding sites identified using MEME and TOM TOM. 
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Figure 4: DMRT1 targets identified using ChIP-Array. 
 
 
 
 
 
 
126 
 
Table 1: Summary of fold changes and number of differentially regulated genes by 
microarray from Dmrt1
-/-
 or Dmrt1
-/-;tg
 samples compared to Dmrt1
+/+ 
samples. 
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Table 2: Transcripts (769 genes) differentially regulated in germ cells and Sertoli cells that 
met the cutoff criteria and represents genes shared by or unique to Dmrt1
-/-
 and Dmrt1
-/-;tg
 
testes. Up or down denotes similar gene expression trend reported in previous studies. Letters a-
g denotes gene has been identified as a target of DMRT1 by ChIP-chip or ChIP-Seq. A. List of 
769 genes comparing expression of Dmrt1-null at P7 to previous results at P1/P2 and comparing 
Dmrt1-rescue expression at P7 to those of GCDmrt1KO previously published at P9. B. Summary 
of transcript expression trends at P7 and P1/P2 in Dmrt1-null testes. C. Summary of transcript 
expression trends between Dmrt1-rescue and GCDmrt1KO testes. 
 
A   
 
P7 Dmrt1 -null / Dmrt1 -
Wt 
 
P1 Dmrt1 - 
null / Dmrt1 
- Wt 
 
P2 Dmrt1 
- null / 
Dmrt1 -Wt 
 
Comparison of Dmrt1 -
null testes expression at 
P7 and P1/P2 
 
P7 Dmrt1 
- rescue / 
Dmrt1 - 
Wt 
P9 
GCDmrt1KO 
/ 
GCDmrt1KO
- Ctrl 
 
Comparison of P7 Dmrt1 
- rescue and P9 
GCDmrt1KO 
  
  
 
Symbol 
 
 
P7 Fold Change 
  P1 Fold 
Change 
(Data from 
Fahrioglu et 
al., 2007) 
 
P2 Fold 
Change 
(Data from 
Fahrioglu 
et al., 2007) 
 
 
Up, down, absent at P1/P2, 
absent at P7 
 
 
P7 Fold 
Change 
 
P9 Fold 
Change (data 
from 
Murphy et 
al., 2010) 
 
Up, down, absent at P9, 
absent at P7, absent at P7 
and P9 (compared to P7 
Dmrt1 -null) 
 
P7 Relative 
factor (RF) 
= 1- 
((Res/Wt)/ 
(Ko/Wt)) 
Comparison 
to previous 
to ChIP-chip 
(a-c) and 
current 
ChIP-Seq (d- 
g) data 
DMRT1  -97.38 -16.74 -16.79 down -91.07 -2.21 down 0.06  
CLEC12B -38.67  absent at P1/P2 -32.42 -1.79 down 0.16  
MAGEA11 -29.40  absent at P1/P2 -13.95 -1.33 down 0.53 a 
Ocln  -26.67 -7.23 -12.27 down -23.82 -1.48 down 0.11  
NKX3-1  -18.56 -5.05 -3.52 down -11.60 -1.45 down 0.38  
CYTIP  -14.26 -2.18 -2.89 down -8.26 -1.57 down 0.42  
MORC1  -12.41  absent at P1/P2 -11.94 1.22 up at P9 0.04  
CIDEA  -12.07 -5.25 -8.38 down -6.73 -1.26 down 0.44  
RARRES1 -11.50  absent at P1/P2   absent at P7 and P9 1.00  
TRIM71  -10.40  absent at P1/P2 -10.86 -1.37 down -0.04  
SH3GL2   -9.43 -3.09 -4.98 down -4.25 -1.78 down 0.55  
TEX11   -9.23   absent at P1/P2 -2.92 -1.06 down 0.68  
ZBTB16   -9.22 -2.37 -1.88 down -8.94 1.03 up at P9 0.03  
RIPK4   -8.47   absent at P1/P2 -7.06 -1.60 down 0.17 a 
NEFM   -8.47 -1.64 -1.33 down -9.03 1.18 up at P9 -0.07  
FOXQ1   -7.67 -4.03 -2.83 down -5.18 -1.59 down 0.33  
DDX4   -7.51 1.04 -1.24 up at P1 and down at P2 -4.95 1.08 up 0.34 C 
CADM1   -7.36 -1.96 -2.03 down -6.61 -1.06 down 0.10  
RNF17   -7.28   absent at P1/P2 -2.98 1.37 up 0.59  
RSPO2   -7.26 1.24 1.39 Up at P1/P2 -7.61 -1.95 down -0.05  
RBMY1A1  -7.09   absent at P1/P2 -2.63  absent at P9 0.63 e,f 
TBC1D30  -6.81   absent at P1/P2 -4.97 -1.41 down 0.27  
CLDN11   -6.71 -1.25 -1.69 down -5.27 -1.23 down 0.21 a 
VDR   -6.71 -1.55 -1.74 down -6.00 -1.29 down 0.11 b 
SCARA3   -6.54   absent at P1/P2 -5.19 -1.66 down 0.21  
HLA-A   -6.42 -1.21 -1.05 down -5.89 -1.15 down 0.08  
Acaa1b   -6.40 1.16 1.33 Up at P1/P2 -5.57 -1.02 down 0.13  
NXF3   -6.06   absent at P1/P2 -3.45 -1.78 down 0.43  
JAKMIP1  -5.98   absent at P1/P2 -5.94  absent at P9 0.01  
SALL4   -5.90 -1.20 -1.05 down -9.01  absent at P9 -0.53  
FGF13   -5.89 -2.13 -2.54 down  -1.33 absent at P7 1.00  
AFP   -5.71 1.46 2.43 Up at P1/P2 -4.86 1.16 up at P9 0.15  
TSPAN17   -5.68   absent at P1/P2 -5.23 -1.63 down 0.08  
RBM44   -5.61   absent at P1/P2 -3.54 1.31 up at P9 0.37  
STARD4   -5.61   absent at P1/P2 -4.97 -1.05 down 0.11  
IGF2BP1   -5.60 -1.26 -1.29 down -5.13 -1.19 down 0.08  
EGR2   -5.58 -1.97 -3.15 down -5.72 -1.51 down -0.02  
GFRA1   -5.50 -2.15 -2.44 down -4.86 -1.23 down 0.12  
GPR37   -5.39 1.92 1.25 Up at P1/P2 -2.65 -1.52 down 0.51  
TNNT2   -5.38 1.00 -1.53 up at P1 and down at P2 -1.53 -1.10 down 0.71  
ASB9   -5.37   absent at P1/P2 -4.97 -1.45 down 0.07  
RICTOR   -5.37   absent at P1/P2 -4.04 1.04 up at P9 0.25  
DAZ2   -5.37 -1.10 -1.06 down -3.50 1.04 up at P9 0.35  
PIP5K1B   -5.31 -1.94 -1.78 down -4.40 -1.26 down 0.17  
SYCP2   -5.30   absent at P1/P2 -1.80 1.70 up 0.66  
ACSS1   -5.20 -1.72 -1.70 down -4.43 -1.55 down 0.15  
MEIG1   -5.18 -1.43 -1.09 down -6.22 -1.11 down -0.20  
TBX22   -5.12   absent at P1/P2 -5.05 -2.30 down 0.01 b 
C20orf54   -5.11   absent at P1/P2 -3.71 -1.19 down 0.27  
TKTL1   -5.11 1.11 1.13 Up at P1/P2 -2.36 1.20 up at P9 0.54  
GLIS3   -5.09   absent at P1/P2 -4.71 1.04 up at P9 0.08 f 
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LIN28A   -5.06   absent at P1/P2 -4.83 1.22 up at P9 0.04  
TUBA3E   -5.05 -1.15 -1.47 down -4.01  absent at P9 0.21  
DDX25   -5.00 1.16 1.11 down -6.05 -1.09 down -0.21 c 
LPAR3   -4.93   absent at P1/P2 -5.25 -2.18 down -0.07  
NTN4   -4.92   absent at P1/P2 -3.56 -1.16 down 0.28  
PPHLN1   -4.88   absent at P1/P2 -4.09  absent at P9 0.16  
PIWIL2   -4.88   absent at P1/P2 -4.98 1.31 up at P9 -0.02  
WNK3   -4.83   absent at P1/P2 -4.38  absent at P9 0.09  
ENPP2   -4.82 -1.46 -2.33 down -5.28 -1.87 down -0.10  
TOX   -4.76   absent at P1/P2 -4.93 -1.37 down -0.04  
CLIC6   -4.75   absent at P1/P2 -5.90 -1.39 down -0.24 a 
BASP1   -4.70 1.09 1.14 Up at P1/P2 -4.93 -1.99 down -0.05  
TCFL5   -4.67   absent at P1/P2 -4.03 1.37 up at P9 0.14  
SLC25A31  -4.62   absent at P1/P2 -2.84 1.17 up at P9 0.38  
RAB11FIP4  -4.61   absent at P1/P2 -4.46 -1.11 down 0.03  
NMT2   -4.59 -1.21 -1.47 down -3.44 -1.01 down 0.25  
SCML2   -4.53   absent at P1/P2 -2.82 -1.11 down 0.38  
LPPR4   -4.46   absent at P1/P2 -2.61 -1.49 down 0.41  
Taf7l   -4.40   absent at P1/P2 -2.27 1.06 up at P9 0.48  
DOCK3   -4.34   absent at P1/P2 -4.52 1.86 up at P9 -0.04  
MOV10L1  -4.33   absent at P1/P2 -3.44 1.47 up at P9 0.20  
FOXC2 -4.31 -1.86 -1.70 down -5.22 -1.42 down -0.21  
CDO1 -4.27 -1.21 -1.48 down -2.92 -1.71 down 0.32  
FOXF1 -4.25 -1.11 -1.04 down -4.76 -1.41 down -0.12  
TCL1A -4.23 -1.20 -1.33 down -4.72 1.79 up at P9 -0.11  
BIK -4.20 -1.44 -1.38 down -3.59 -1.80 down 0.15  
JAKMIP2 -4.19  absent at P1/P2 -2.99 -1.01 down 0.29  
TSC22D3 -4.10  absent at P1/P2 -3.31  absent at P9 0.19  
RIMKLB -4.10 -1.15 -1.40 down -3.12 -1.08 down 0.24  
NXF2 -4.08  absent at P1/P2 -2.53  absent at P9 0.38  
FKBP6 -4.05  absent at P1/P2 -3.35 -1.06 down 0.17 b 
SLC1A6 -4.04 -4.15 -3.48 down -2.84 1.04 up at P9 0.30  
ELAVL2 -4.01 1.20 -1.10 up at P1 and down at P2 -4.17 -1.32 down -0.04  
NEUROG3 -3.99 -1.15 1.32 Down at P1 and up at P2 -4.25 -1.14 down -0.07  
FRZB -3.98 1.03 -1.01 up at P1 and down at P2 -4.16 -2.42 down -0.05  
SOX3 -3.98 -1.17 1.85 Down at P1 and up at P2 -3.86 1.09 up at P9 0.03  
CRABP1 -3.95 1.08 1.32 up -3.72 1.06 up at P9 0.06  
ADH4 -3.94 -3.25 -5.06 down -3.77 -1.73 down 0.04 a 
PCGF5 -3.93 -1.15 -1.16 down -3.84 -1.20 down 0.02  
SYT9 -3.91 -1.11 -2.06 down -5.13 -1.80 down -0.31 C 
FGD6 -3.91  absent at P1/P2 -3.41 1.11 up at P9 0.13 a 
BARD1 -3.90 1.16 -2.09 up at P1 and down at P2 -3.38 -1.34 down 0.13 a 
GMFB -3.89 1.56 1.31 up -3.33 1.19 up at P9 0.14  
ARAP2 -3.88  absent at P1/P2 -3.29 -2.20 down 0.15  
TULP2 -3.84 -2.20 -2.48 down -3.42 -1.34 down 0.11  
TSPAN8 -3.79 -1.24 -1.09 down -3.15 -1.34 down 0.17  
ID4 -3.75  absent at P1/P2 -4.87 -1.33 down -0.30  
MMD -3.75  absent at P1/P2 -4.14 -1.31 down -0.10  
DPPA4 -3.65 1.11 -1.06 up at P1 and down at P2 -3.34  absent at P9 0.09 b 
PDHA2 -3.64 -1.08 -1.31 down  2.36 absent at P7 1.00  
RHPN2 -3.63 -1.07 -1.02 down -3.45 -1.15 down 0.05  
HHEX -3.61 -1.29 -1.03 down -3.49 -1.29 down 0.03  
SUV39H2 -3.60 1.12 -1.02 up at P1 and down at P2 -2.54 -1.09 down 0.29 c 
SPINLW1 -3.59  absent at P1/P2 -2.52 -1.85 down 0.30 a 
HMGA1 -3.59 -1.27 -1.04 down -3.65 -1.07 down -0.02  
PHTF2 -3.58 1.14 -1.01 up at P1 and down at P2 -3.00 -1.00 down 0.16  
CCNB1 -3.58  absent at P1/P2 -3.21  absent at P9 0.10  
ATP11C -3.57  absent at P1/P2 -2.92 -1.04 down 0.18  
Tex19.1 -3.56 -1.06 1.26 Down at P1 and up at P2 -3.19 1.29 up at P9 0.10  
ZNF808 -3.53  absent at P1/P2 -3.30  absent at P9 0.07  
ARL5B -3.53  absent at P1/P2 -3.07 -1.34 down 0.13  
SPTA1 -3.52 -10.29 -11.56 down  -1.16 absent at P7 1.00  
TNIK -3.51  absent at P1/P2 -3.59  absent at P9 -0.02  
SOX11 -3.51 -1.08 1.18 Down at P1 and up at P2  -1.49 absent at P7 1.00  
COL4A3BP -3.50  absent at P1/P2 -2.65 -1.26 down 0.24  
TDRKH -3.49  absent at P1/P2 -2.63 1.29 up at P9 0.25  
SOHLH2 -3.44  absent at P1/P2 -2.19 1.47 up at P9 0.36 c 
EPB41L3 -3.43  absent at P1/P2 -3.27 -1.02 down 0.05 b 
ERO1L -3.43 1.10 -1.11 up at P1 and down at P2 -3.22 1.13 up at P9 0.06  
STAG3 -3.42 -1.01 2.72 Down at P1 and up at P2 -1.87 1.37 up at P9 0.45  
ZIC3 -3.41 -1.96 -1.83 down -3.20 -2.98 down 0.06 b 
API5 -3.41 1.03 -1.13 up at P1 and down at P2 -2.54 1.05 up at P9 0.25  
XPO4 -3.38  absent at P1/P2 -2.97 -1.35 down 0.12  
UPP1 -3.38 1.06 1.37 up -3.12 1.36 up at P9 0.08  
STRA8 -3.37 -2.62 -2.80 down -1.64 1.18 up at P9 0.51 b 
ADAD1 -3.35 -1.09 -1.09 down -2.22 1.61 up at P9 0.34  
DCK -3.32 1.17 -1.12 up at P1 and down at P2 -2.71 -1.09 down 0.18  
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MBP -3.32 -1.50 -1.50 down -4.10  absent at P9 -0.24  
RCC2 -3.31 -1.50 -1.16 down -3.21 -1.01 down 0.03  
FAR1 -3.31  absent at P1/P2 -2.36 1.24 up at P9 0.29  
TAF9B -3.30  absent at P1/P2 -2.38 1.01 up at P9 0.28  
ATF7IP2 -3.28  absent at P1/P2 -2.14 1.04 up at P9 0.35  
SYCP1 -3.27 1.16 -1.02 up at P1 and down at P2  1.25 absent at P7 1.00  
GDPD1 -3.27  absent at P1/P2 -1.53 1.09 up at P9 0.53  
CHTF18 -3.27  absent at P1/P2 -3.48 1.15 up at P9 -0.06  
Snhg11 -3.25 1.54 1.25 up -2.49 -1.03 down 0.24  
MGEA5 -3.25 1.06 -1.10 up at P1 and down at P2 -2.75 -1.09 down 0.15  
CTNND2 -3.25 -1.07 1.33 Down at P1 and up at P2 -3.78 -2.11 down -0.16  
KLHDC10 -3.23  absent at P1/P2 -3.90 1.14 up at P9 -0.21  
USP24 -3.21 -1.19 -1.20 down -2.59  absent at P9 0.19  
LGALS2 -3.17 1.08 1.27 up -3.04 1.29 up at P9 0.04  
MASTL -3.17  absent at P1/P2 -2.36 -1.12 down 0.26  
NNAT -3.16 -2.65 -2.54 down -3.07  absent at P9 0.03  
FLRT1 -3.16  absent at P1/P2 -2.51 -1.58 down 0.21 a 
UCHL1 -3.16 1.11 -1.12 up at P1 and down at P2 -2.74 1.26 up at P9 0.14  
Cycs/Gm10053 -3.16 -1.61 -1.94 down -2.77 -1.35 down 0.12  
PLXNC1 -3.16  absent at P1/P2 -1.72 -1.36 down 0.46  
C10orf46 -3.14 1.02 -1.03 up at P1 and down at P2 -2.95 1.08 up at P9 0.06  
ESRP1 -3.10 -1.39 -1.15 down -2.84 1.12 up at P9 0.08  
POU3F1 -3.10 -1.24 -2.12 down -3.15 1.29 up at P9 -0.02  
RNF144B -3.10  absent at P1/P2 -2.60 -1.25 down 0.16  
MTMR7 -3.09 1.44 -1.31 up at P1 and down at P2 -3.26 -1.00 down -0.05 b 
EXOSC1 -3.09  absent at P1/P2 -1.45 -1.10 down 0.53  
BCL2L11 -3.09 1.39 1.25 up -2.78 -1.11 down 0.10  
NCOA2 -3.06 -1.24 -1.90 down -2.71 -1.28 down 0.12 a 
Cyct -3.05 1.14 -1.28 up at P1 and down at P2 -2.39 1.26 up at P9 0.22  
FAM184B -3.04  absent at P1/P2 -3.64 1.10 up at P9 -0.20  
FOXJ3 -3.01  absent at P1/P2 -2.98 1.03 up at P9 0.01  
SLK -3.01 1.08 -1.03 up at P1 and down at P2 -2.80 -1.15 down 0.07  
TAF4B -3.01  absent at P1/P2 -2.39 -1.04 down 0.20  
SMG1 -2.99  absent at P1/P2 -2.51 1.40 up at P9 0.16  
SGK3 -2.98  absent at P1/P2 -2.21 -1.56 down 0.26  
NINL -2.98  absent at P1/P2 -2.72 -1.13 down 0.09  
LRP8 -2.97  absent at P1/P2 -2.90 -1.88 down 0.02  
CCDC88C -2.96  absent at P1/P2 -3.02 -1.05 down -0.02  
FAM105A -2.96 -2.16 -2.26 down -2.69 -1.67 down 0.09  
RUNDC3B -2.95  absent at P1/P2 -2.62 1.06 up at P9 0.11  
HSPA4L -2.94 -1.00 1.17 Down at P1 and up at P2 -2.36 1.06 up at P9 0.20  
DTL -2.93 -1.04 -1.24 down -2.73 1.22 up at P9 0.07  
TLE3 -2.93 -1.05 -1.06 down -2.97 -1.23 down -0.02 a 
NR0B1 -2.92 -1.76 -2.01 down -2.02 -1.55 down 0.31  
BOLL -2.92  absent at P1/P2 -2.80 1.04 up at P9 0.04 a 
PAQR8 -2.92  absent at P1/P2 -2.47 -1.64 down 0.16  
MYO1B -2.92 1.18 1.33 up -2.92 -1.15 down 0.00  
C21orf91 -2.92  absent at P1/P2 -2.88 1.02 up at P9 0.01  
POU5F1 -2.90 -1.49 1.30 Down at P1 and up at P2 -2.78 2.03 up 0.04  
GCAT -2.90 1.16 1.17 up -2.72 -1.17 down 0.06  
KBTBD8 -2.89  absent at P1/P2 -2.22 -1.32 down 0.23  
LHX1 -2.89 -1.09 -2.28 down -2.39 -1.25 down 0.17  
SKIL -2.89 -1.41 -2.21 down -2.70 1.01 up at P9 0.07  
DNER -2.89  absent at P1/P2 -2.09 -1.40 down 0.28 a 
SFMBT1 -2.88  absent at P1/P2 -2.60  absent at P9 0.10 b 
LIPA -2.87 1.04 -1.26 up at P1 and down at P2  1.26 absent at P7 1.00  
GNG12 -2.86 -1.35 -1.52 down -2.45 -1.19 down 0.14  
RET -2.85 -2.70 -7.27 down -3.10 -1.33 down -0.09  
ENAH -2.83  absent at P1/P2 -2.79  absent at P9 0.02  
C13orf27 -2.83  absent at P1/P2 -2.47 -1.00 down 0.13  
FAM40B -2.83  absent at P1/P2 -2.66 -1.16 down 0.06  
ZFP42 -2.82 1.07 1.44 up -2.33 1.54 up at P9 0.17  
4930486L24Rik -2.82  absent at P1/P2 -1.63 -1.75 down 0.42  
PITPNC1 -2.81 1.03 1.21 up -3.24 -1.39 down -0.15  
PANK1 -2.81  absent at P1/P2  1.30 absent at P7 1.00  
MXD1 -2.81 -1.10 -1.58 down -1.54 -1.14 down 0.45  
DDX21 -2.81 -1.04 -1.25 down -2.85 1.21 up at P9 -0.01 c 
CACNG5 -2.80  absent at P1/P2 -3.23 -1.23 down -0.16  
PLEKHG1 -2.79  absent at P1/P2 -2.72 -1.76 down 0.02  
KIAA0182 -2.79  absent at P1/P2 -2.82 1.16 up at P9 -0.01  
LOC284023 -2.78 -1.30 -1.31 down -2.91 -1.43 down -0.05  
ELL3 -2.78  absent at P1/P2 -2.96 1.07 up at P9 -0.06  
TOLLIP -2.78 -1.17 -1.14 down -2.56 1.18 up at P9 0.08  
Gm884 -2.77  absent at P1/P2 -2.62 1.09 up at P9 0.05  
TSC22D1 -2.77 1.13 -1.09 up at P1 and down at P2 -2.44  absent at P9 0.12  
DMC1 -2.76 -1.05 1.46 Down at P1 and up at P2  1.92 absent at P7 1.00  
RAB20 -2.76 -1.46 -2.21 down -2.08 -1.22 down 0.24  
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CHP2 -2.75  absent at P1/P2 -1.75 -1.38 down 0.37  
EIF5A2 -2.75  absent at P1/P2 -2.78 1.17 up at P9 -0.01  
CDKN2A -2.75 -1.25 1.13 Down at P1 and up at P2 -2.61 -1.45 down 0.05  
KCNG2 -2.75  absent at P1/P2 -1.97 -1.40 down 0.28  
EMB -2.74 -2.56 -4.00 down -2.39 1.14 up at P9 0.13  
SH3BGRL2 -2.72 1.09 -1.78 up at P1 and down at P2 -2.28 1.29 up at P9 0.16  
TMEM100 -2.71  absent at P1/P2 -1.55 1.31 up at P9 0.43  
ORC1 -2.71 1.03 -1.30 up at P1 and down at P2 -2.27  absent at P9 0.16  
ZSWIM5 -2.70  absent at P1/P2 -2.74 -1.29 down -0.02  
AIFM3 -2.68  absent at P1/P2 -2.52 1.09 up at P9 0.06  
RPS6KA2 -2.68 -1.90 -2.20 down -2.68 -1.02 down 0.00  
ISLR2 -2.67  absent at P1/P2 -2.68 -1.22 down 0.00  
PI4K2B -2.67  absent at P1/P2   absent at P7 and P9 1.00  
SH3D19 -2.67 -1.74 -2.20 down -2.55  absent at P9 0.05  
NAA30 -2.67 -1.13 -1.25 down -2.17  absent at P9 0.19  
MYO5B -2.67 -1.16 -1.10 down -2.41 -1.12 down 0.10  
TRIM25 -2.66 1.16 -1.09 up at P1 -2.89 -1.06 down -0.08  
PLA2G7 -2.66 -1.40 -1.38 down -2.17 -1.40 down 0.18 a 
STRA6 -2.65 -3.68 -1.85 down -2.74 -1.38 down -0.03  
WDR5 -2.64 -1.06 -1.03 down -2.41 1.24 up at P9 0.09  
PRSS12 -2.63 1.13 -1.08 up at P1 and down at P2 -2.47 -1.08 down 0.06  
GSTM2 -2.62  absent at P1/P2 -1.92  absent at P9 0.27  
ACTR1A -2.62 1.36 1.19 up  1.18 absent at P7 1.00  
ATF2 -2.61 1.14 -1.04 up at P1 and down at P2 -2.15 1.27 up at P9 0.18  
HSPBAP1 -2.61  absent at P1/P2 -2.51 -1.04 down 0.04  
KPNA3 -2.61 -1.13 -1.94 down -2.41 1.31 up at P9 0.08  
PSMA8 -2.61  absent at P1/P2 -2.15 1.43 up at P9 0.18  
ELOVL2 -2.60 -2.88 -4.56 down -1.75 -1.46 down 0.33  
AK4 -2.59 1.02 -1.05 up at P1 and down at P2 -1.98 -1.37 down 0.23  
CRLF1 -2.59 -2.62 -1.72 down -1.92 1.09 up at P9 0.26  
BZW1 -2.58 1.14 -1.17 up at P1 and down at P2 -2.19 -1.03 down 0.15  
THAP4 -2.58 -1.33 -1.07 down -2.85 -1.02 down -0.10  
LRRFIP1 -2.58  absent at P1/P2 -5.70  absent at P9 -1.21  
RNF138 -2.58 1.10 -1.10 up at P1 and down at P2 -2.00 1.26 up at P9 0.22  
HIF1AN -2.56  absent at P1/P2 -2.27 -1.03 down 0.11  
WAPAL -2.56  absent at P1/P2 -2.33 -1.00 down 0.09  
OSBPL3 -2.55  absent at P1/P2 -2.14 1.13 up at P9 0.16  
SEMA4F -2.55 1.24 -1.02 up at P1 and down at P2 -1.49 -1.08 down 0.42  
MAN2A1 -2.55 -1.11 -1.17 down -2.78 -1.21 down -0.09 a 
RORA -2.54 -1.78 -1.88 down -2.56 1.12 up at P9 -0.01  
GNG13 -2.54  absent at P1/P2 -2.78 1.30 up at P9 -0.10  
MNS1 -2.54 1.40 -1.26 up at P1 and down at P2 -2.22 -1.01 down 0.12  
PLK4 -2.54 -1.10 -1.29 down -2.01  absent at P9 0.21  
ABCB7 -2.54 1.07 -1.71 up at P1 and down at P2 -2.00  absent at P9 0.21  
PIWIL4 -2.54  absent at P1/P2 -2.42 1.03 up at P9 0.05  
Chn1 -2.53  absent at P1/P2 -2.05  absent at P9 0.19  
HINFP -2.53 1.08 -1.13 up at P1 and down at P2 -2.39 1.15 up at P9 0.05  
CTDSP2 -2.53 -1.11 1.15 Down at P1 and up at P2 -2.57 -1.03 down -0.02  
CAB39L -2.52 1.03 -1.18 up at P1 and down at P2 -2.02 1.02 up at P9 0.20  
LIN7C -2.52 1.15 -1.32 Down at P1 and up at P2 -2.15 1.26 up at P9 0.15  
SMC1B -2.52  absent at P1/P2  1.63 absent at P7 1.00  
PPAT -2.51 -1.16 -1.39 down -2.20 1.16 up at P9 0.12  
RELN -2.50 -2.35 -1.05 down -1.77 1.16 up at P9 0.29  
FAM70A -2.50  absent at P1/P2 -2.17 -1.36 down 0.13  
RIF1 -2.50  absent at P1/P2 -1.17 1.00 up at P9 0.53 a 
OBFC2A -2.49 -1.49  down -1.94 1.33 up at P9 0.22  
PRR5 -2.49 -1.27 -1.18 down -1.98 -1.03 down 0.21  
G2E3 -2.49  absent at P1/P2 -2.27 1.03 up at P9 0.09  
C10orf35 -2.49  absent at P1/P2 -2.92 1.08 up at P9 -0.17  
UGT8 -2.49 -1.44 -1.03 down  1.23 absent at P7 1.00  
DUSP9 -2.49 1.41 1.77 up -2.62 1.33 up at P9 -0.05  
Nlrp4f -2.48  absent at P1/P2 -1.98 1.33 up at P9 0.20  
RAD9B -2.48  absent at P1/P2 -1.83 1.09 up at P9 0.26  
SPATA5 -2.47 1.02 -1.06 up at P1 and down at P2 -2.13 1.29 up at P9 0.14  
SNX6 -2.47 1.00 -1.11 up at P1 and down at P2 -2.19 1.05 up at P9 0.11  
EFHC2 -2.47  absent at P1/P2 -1.85 1.47 up at P9 0.25  
CAMK1D -2.47  absent at P1/P2 -1.81 -1.36 down 0.26  
MAPK12 -2.46 -1.14 -1.15 down -2.59 1.12 up at P9 -0.05  
STAG1 -2.46 1.11 -1.36 up at P1 and down at P2 -1.94 -1.12 down 0.21 c 
MPHOSPH9 -2.46 -1.15 -1.33 down -2.14  absent at P9 0.13  
GOSR1 -2.45 -1.05 -1.07 down -2.08 1.08 up at P9 0.15  
FANCD2 -2.44  absent at P1/P2 -2.12 1.25 up at P9 0.13  
CDS2 -2.44 -1.01 -1.10 down -2.34 1.16 up at P9 0.04  
TAF7 -2.43  absent at P1/P2 -2.06  absent at P9 0.15 b 
MFSD2A -2.43  absent at P1/P2 -2.09 -1.15 down 0.14  
DAPK2 -2.42 1.04 -1.00 up at P1 and down at P2 -2.76 -1.11 down -0.14  
USP9Y -2.42  absent at P1/P2 -1.78 1.44 up at P9 0.27  
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CAPN6 -2.42 -1.76 -2.49 down -2.44 1.07 up at P9 -0.01  
CORO1C -2.42 -1.17 -1.16 down -1.91 1.18 up at P9 0.21 a 
QPCT -2.41  absent at P1/P2 -2.10  absent at P9 0.13  
EXOC6 -2.41  absent at P1/P2 -2.22 -1.40 down 0.08  
INA -2.41  absent at P1/P2 -2.66 -1.17 down -0.11  
GFPT1 -2.40  absent at P1/P2 -1.92 1.04 up at P9 0.20  
CCNG1 -2.39 1.16 -1.03 up at P1 and down at P2 -2.10 1.00 up at P9 0.12  
KIF5C -2.39 1.69 -1.05 up at P1 and down at P2 -2.71 -1.02 down -0.13  
TGFBI -2.38 2.21 -2.03 up at P1 and down at P2 -2.69 1.07 up at P9 -0.13  
RAD18 -2.38  absent at P1/P2 -2.06 1.09 up at P9 0.13  
ANKRD57 -2.38 -1.35 -1.69 down -1.91 -1.21 down 0.20  
FSD1 -2.38  absent at P1/P2 -2.44 -1.20 down -0.03  
UBE2T -2.38 1.11 -1.06 up at P1 and down at P2 -1.62 1.23 up at P9 0.32  
TRIM6 -2.37  absent at P1/P2  1.68 absent at P7 1.00 c 
PLEKHG4 -2.37  absent at P1/P2 -2.26 1.02 up at P9 0.05  
SLAIN1 -2.37 -1.49 -1.96 down -2.35 -1.29 down 0.01  
STX3 -2.36 1.93 -1.09 up at P1 and down at P2 -2.27  absent at P9 0.04  
ADORA1 -2.36 -2.36 -2.27 down -1.23 -1.23 down 0.48  
RGS17 -2.36  absent at P1/P2 -1.86 -1.82 down 0.21  
RADIL -2.36  absent at P1/P2 -2.46 -1.10 down -0.04  
WIPI2 -2.36 -1.18 -1.15 down -2.17 1.37 up at P9 0.08  
NASP -2.36 -1.03 -1.41 down -2.11 1.51 up at P9 0.11  
C15orf55 -2.35  absent at P1/P2 -2.43 -1.18 down -0.03  
ART3 -2.35 -1.10 -1.29 down -2.24 -1.21 down 0.05 b 
NEB -2.35  absent at P1/P2 -2.00 -1.10 down 0.15  
DDX3Y -2.34 -1.18 -1.23 down -1.73 1.74 up at P9 0.26  
USP31 -2.34  absent at P1/P2 -1.99 -1.21 down 0.15  
YKT6 -2.34 -1.12 -1.28 down -2.10 1.18 up at P9 0.10  
PDE4B -2.34 -1.11 -1.09 down -2.10 1.01 up at P9 0.10  
DGAT2 -2.33  absent at P1/P2 -2.11 1.46 up at P9 0.10  
FYTTD1 -2.33 -1.08 -1.17 down -1.71 1.29 up at P9 0.27  
UXS1 -2.33 -1.17 -1.26 down -1.92 -1.01 down 0.18  
TACC1 -2.32  absent at P1/P2 -1.74 -1.24 down 0.25  
FAM84A -2.32 1.02 -1.09 up at P1 and down at P2 -2.27 -1.80 down 0.02  
BRWD3 -2.32 -1.22 -1.01 down -2.18 -1.32 down 0.06  
ZRSR2 -2.32 1.35 1.28 up -2.15  absent at P9 0.07  
KCNA6 -2.31 -1.41 -1.69 down -1.81 -1.44 down 0.22  
DDAH1 -2.31  absent at P1/P2 -1.35 -1.17 down 0.41  
KIAA0895 -2.31  absent at P1/P2 -1.92 -1.35 down 0.17  
EPCAM -2.31 1.34 -1.70 up at P1 and down at P2  1.55 absent at P7 1.00  
POLR3G -2.31  absent at P1/P2 -1.89 -1.16 down 0.18  
TUBB2C -2.30 1.03 -1.04 up at P1 and down at P2 -2.15 -1.05 down 0.07  
TRPC3 -2.30  absent at P1/P2 -1.57 -1.72 down 0.32  
NUPL1 -2.30  absent at P1/P2 -1.76 1.18 up at P9 0.24  
TAF7L -2.30  absent at P1/P2  2.12 absent at P7 1.00  
ZDHHC2 -2.30  absent at P1/P2 -1.72 -1.63 down 0.25  
ZNF398 -2.30 -1.07 -2.33 down -1.23  absent at P9 0.46  
KCTD20 -2.30 -1.02 -1.04 down -2.43 -1.06 down -0.06  
RGL1 -2.30 -1.56 -2.07 down -2.11 -1.43 down 0.08  
CCND3 -2.29 1.04 -1.04 up at P1 and down at P2 -1.90 1.27 up at P9 0.17  
RAD51C -2.29  absent at P1/P2 -2.27 1.05 up at P9 0.01  
GNA14 -2.29 -1.25 -1.64 down -2.09 -1.48 down 0.09  
SPINT1 -2.29 -1.28 -1.06 down -2.59 -1.23 down -0.13  
FOXP1 -2.29 1.56 1.22 up -2.38 -1.25 down -0.04  
ABHD5 -2.29 -1.22 -1.11 down -2.05 1.11 up at P9 0.10  
Mpped2 -2.28  absent at P1/P2 -2.48  absent at P9 -0.08  
TFRC -2.28 -1.29 -1.41 down -1.79 1.52 up at P9 0.21  
PIM1 -2.28 -1.06 1.23 Down at P1 and up at P2 -2.51 -1.05 down -0.10  
SH3GL3 -2.28 -2.39 -2.16 down -2.08 -1.03 down 0.09  
RAB10 -2.27 -1.12 -1.19 down -1.94 -1.06 down 0.15  
EPAS1 -2.27 1.00 1.14 up -1.95 -1.08 down 0.14  
BRIP1 -2.27  absent at P1/P2 -1.56 2.26 up 0.31  
4933425L06Rik -2.27  absent at P1/P2 -1.77 1.70 up at P9 0.22  
SHB -2.27  absent at P1/P2 -1.98  absent at P9 0.13  
FZD3 -2.27 -1.20 -1.19 down -2.08 -1.27 down 0.08  
DOCK5 -2.27 -1.26 -1.51 down -1.88  absent at P9 0.17  
RECQL4 -2.27  absent at P1/P2 -2.19 1.01 up at P9 0.03  
DMRTB1 -2.27 1.53 -1.92 up at P1 and down at P2 -2.57 -2.20 down -0.13 b 
BNC2 -2.27  absent at P1/P2 -1.91 -1.06 down 0.16  
DDHD1 -2.26 1.02 -1.02 up at P1 and down at P2 -1.89 -1.12 down 0.16  
GABPA -2.26 -1.22 -1.57 down -1.79 1.15 up at P9 0.21  
ZMYND19 -2.26  absent at P1/P2 -2.01 -1.24 down 0.11  
PI4K2A -2.26 -1.18 1.24 Down at P1 and up at P2  1.03 absent at P7 1.00  
TDRD1 -2.26  absent at P1/P2 -2.30  absent at P9 -0.02  
C17orf79 -2.25 1.44 1.14 up -2.20 -1.06 down 0.02  
ETNK1 -2.25 1.30 -1.04 up at P1 and down at P2 -1.61 -1.00 down 0.28  
ZBED5 -2.24  absent at P1/P2 -2.11 -1.22 down 0.06  
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TRAIP -2.24 -1.25 -1.23 down -2.15 1.48 up at P9 0.04  
PTPRR -2.24 1.68 -1.36 up at P1 and down at P2 -1.98 1.07 up at P9 0.12  
MTHFD2 -2.24 1.84 -1.12 up at P1 and down at P2 -1.96 -1.06 down 0.12  
SMC5 -2.24  absent at P1/P2 -1.81 1.11 up at P9 0.19  
ASNS -2.23 -1.29 -1.45 down  -1.30 absent at P7 1.00 b 
ASCL2 -2.23 1.19 1.37 up -2.41 -1.56 down -0.08  
MYCBP -2.23 1.39 -1.48 up at P1 and down at P2 -1.96 -1.08 down 0.12  
NRAS -2.22 -1.06 1.24 Down at P1 and up at P2 -2.12 -1.04 down 0.05  
EFR3A -2.22  absent at P1/P2 -1.86 -1.07 down 0.16  
ZNF711 -2.22  absent at P1/P2 -2.12 -2.13 down 0.05  
HMGN5 -2.22 -1.15 -1.74 down -1.90 -1.60 down 0.15  
SLC31A1 -2.22 -1.54 -1.54 down -1.76 -1.22 down 0.21  
AKT3 -2.22  absent at P1/P2 -1.93 1.14 up at P9 0.13  
GSTA3 -2.22 -1.22 -1.42 down -1.95 -1.78 down 0.12  
MDN1 -2.21 -1.01 -1.02 down -2.18  absent at P9 0.01  
SALL1 -2.21  absent at P1/P2 -2.10 -1.42 down 0.05  
DCAF7 -2.21  absent at P1/P2 -2.00 1.04 up at P9 0.09  
PLEKHA8 -2.21  absent at P1/P2 -2.18 1.06 up at P9 0.01  
ZMYM3 -2.20  absent at P1/P2 -1.80 1.03 up at P9 0.18 a 
PHF17 -2.20 -1.36 -1.33 down -1.73 1.00 up at P9 0.22  
KLHL15 -2.20  absent at P1/P2 -2.01 -2.05 down 0.09  
GTF2A1 -2.20 1.03 -1.03 up at P1 and down at P2 -2.18  absent at P9 0.01 a 
GNAT2 -2.20 -1.07 -1.07 down -2.21 1.32 up at P9 -0.01  
CENPE -2.19 2.10 3.01 up -1.59 1.18 up at P9 0.28  
C6orf108 -2.19 -1.16 -1.09 down -2.22 -1.36 down -0.01  
PSME3 -2.19 -1.21 -1.20 down -2.33 1.05 up at P9 -0.06  
RNF114 -2.19 1.66 1.52 up -1.77 1.17 up at P9 0.19 c 
LMO1 -2.18 1.02 1.14 up -2.72 -1.15 down -0.24  
EHD1 -2.18 -1.09 -1.07 down -1.99 1.12 up at P9 0.09  
PDGFC -2.18  absent at P1/P2 -2.49 -1.22 down -0.14  
SHMT1 -2.18 -1.45 -1.27 down -2.49 -1.17 down -0.14  
TOX3 -2.18  absent at P1/P2 -2.48 -1.66 down -0.14  
ZBTB44 -2.17  absent at P1/P2 -2.01  absent at P9 0.07  
POLR3F -2.17  absent at P1/P2 -1.86 -1.13 down 0.15  
PLEKHF2 -2.17  absent at P1/P2 -2.21 1.06 up at P9 -0.02  
REEP1 -2.17 -1.95 -2.03 down -1.85 -1.27 down 0.15  
ARID3B -2.17 -1.07 -1.06 down -2.21 1.10 up at P9 -0.02  
SLC27A2 -2.17 1.23 1.47 up  -1.36 absent at P7 1.00  
LHX8 -2.17 1.78 -1.04 up at P1 and down at P2 -1.81 1.54 up at P9 0.17  
EXO1 -2.17 -1.08 -1.21 down -1.71 -1.06 down 0.21  
C12orf5 -2.17  absent at P1/P2 -2.18 -1.01 down -0.01  
DPYSL3 -2.16 -1.11 -1.08 down -2.23 -1.02 down -0.03 a 
HELLS -2.16 -1.13 -1.50 down -1.65 1.08 up at P9 0.24  
KIF2A -2.16 -1.03 -1.27 down -1.96 1.14 up at P9 0.09  
CBL -2.16 -1.09 -1.60 down -1.62 -1.34 down 0.25  
CA6 -2.15 -1.42 -2.77 down -1.96 1.57 up at P9 0.09  
PPRC1 -2.15 -1.23 -1.05 down -2.24 -1.13 down -0.04  
NDRG4 -2.15 1.38 1.17 up -2.17 1.13 up at P9 -0.01  
ZNF655 -2.15  absent at P1/P2 -1.95 1.05 up at P9 0.09  
NUS1 -2.15 1.18 -1.04 up at P1 and down at P2 -1.86 -1.06 down 0.13  
CCNB1IP1 -2.15 1.54 -1.05 up at P1 and down at P2 -2.62 1.18 up at P9 -0.22  
RIMKLA -2.15  absent at P1/P2 -2.30 -1.23 down -0.07  
FOXO1 -2.14  absent at P1/P2 -2.44 1.07 up at P9 -0.14  
KCNQ5 -2.14  absent at P1/P2 -1.89 -1.58 down 0.12  
AKR1B1 -2.14 -1.21 1.13 Down at P1 and up at P2 -1.84 -1.06 down 0.14  
C11orf82 -2.14  absent at P1/P2 -1.50 1.18 up at P9 0.30  
PADI3 -2.14 -1.03 1.61 Down at P1 and up at P2 -1.85 1.13 up at P9 0.13  
TERF1 -2.13 1.10 -1.41 up at P1 and down at P2 -1.70 1.22 up at P9 0.20 a 
TEX9 -2.13 1.04 -1.05 up at P1 and down at P2 -1.71 1.11 up at P9 0.20  
FBXO41 -2.13  absent at P1/P2 -2.33 1.48 up at P9 -0.09  
IP6K1 -2.13 1.48 -1.12 up at P1 and down at P2 -2.20 1.18 up at P9 -0.03 a 
BCAT2 -2.13 -1.91 -1.67 down  -1.01 absent at P7 1.00  
LRR1 -2.13  absent at P1/P2 -1.48  absent at P9 0.30  
UBFD1 -2.13 -1.17 -1.24 down -1.92 1.12 up at P9 0.10  
GJC1 -2.13 -1.37 -1.26 down -1.66 1.03 up at P9 0.22  
KIAA1468 -2.12  absent at P1/P2 -1.56 1.27 up at P9 0.26  
HDGFRP3 -2.12  absent at P1/P2 -1.63 -1.05 down 0.23  
CDCA5 -2.12 1.04 -1.09 up at P1 and down at P2 -2.11 -1.00 down 0.00  
COL4A3 -2.12 -1.04 -1.35 down -1.61 -1.01 down 0.24  
GAB3 -2.12  absent at P1/P2 -1.58 -1.26 down 0.26  
STK10 -2.12 -1.28 -1.23 down -1.73 -1.19 down 0.18  
HOOK3 -2.11  absent at P1/P2 -1.87 -1.15 down 0.11  
LATS1 -2.11  absent at P1/P2  -1.22 absent at P7 1.00  
DOCK7 -2.11 -1.30 -1.09 down -1.69 -1.23 down 0.20  
TBC1D1 -2.11 1.01 -1.02 up at P1 and down at P2 -1.92 1.13 up at P9 0.09  
MYBL2 -2.11 -1.37 -1.29 down -1.78 -1.19 down 0.15  
YWHAB -2.11 -1.07 -1.04 down -2.09 1.03 up at P9 0.01  
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CAMSAP3 -2.10  absent at P1/P2 -2.24 -1.13 down -0.07  
C1orf51 -2.10  absent at P1/P2 -1.86 -1.02 down 0.12  
CBLB -2.10  absent at P1/P2 -2.31 -1.14 down -0.10  
NRCAM -2.10 -1.76 1.85 Down at P1 and up at P2 -1.89 -1.27 down 0.10  
SAR1A -2.10 1.02 -1.05 up at P1 and down at P2 -1.85 1.31 up at P9 0.12  
LPIN2 -2.10 -1.07 -1.65 down  -1.02 absent at P7 1.00  
NNMT -2.10 -1.35 -1.26 down -1.92 1.52 up at P9 0.09  
CDR2 -2.10 1.21 -1.18 up at P1 and down at P2 -2.07 -1.03 down 0.01  
CCDC136 -2.10  absent at P1/P2 -1.65 1.03 up at P9 0.21  
HEATR1 -2.10  absent at P1/P2 -2.11 1.05 up at P9 -0.01  
Prune2 -2.09  absent at P1/P2 -1.71  absent at P9 0.18  
PMAIP1 -2.09  absent at P1/P2 -2.54  absent at P9 -0.22  
CRLF3 -2.09 -1.04 -1.20 down -1.80 -1.06 down 0.14  
RACGAP1 -2.09 -1.06 -1.28 down -1.93 1.01 up at P9 0.08 a 
RNF38 -2.09 -1.05 -1.02 down -2.18 -1.14 down -0.04 b 
CAD -2.09 -2.63 1.50 Down at P1 and up at P2 -1.75 1.02 up at P9 0.16  
MTF1 -2.09 -1.15 -1.09 down -1.96 1.03 up at P9 0.06  
GML -2.09 -1.50 -1.29 down -1.76 2.65 up at P9 0.15  
DDX46 -2.08 1.03 -1.14 Down at P1 and up at P2 -1.85 1.15 up at P9 0.11  
DICER1 -2.08 1.00 1.28 up -1.97 -1.01 down 0.06  
CHPT1 -2.08 -1.36 -1.66 down -1.59 -1.38 down 0.23  
ATP13A3 -2.08 1.03 -1.23 up at P1 and down at P2 -1.94  absent at P9 0.07  
ZBTB37 -2.08 -1.03 -1.21 down -1.63 1.32 up at P9 0.22  
KIAA1024 -2.08  absent at P1/P2 -1.97 1.15 up at P9 0.05  
TCTE3 -2.08 1.10 -1.08 up at P1 and down at P2 -1.92  absent at P9 0.08  
THAP1 -2.08  absent at P1/P2 -1.94 1.06 up at P9 0.06  
STAT1 -2.08 1.01 -1.09 up at P1 and down at P2 -1.93 -1.43 down 0.07  
RBP4 -2.07 1.15 1.14 up -1.62 -1.45 down 0.22  
CITED1 -2.07 -1.47 -1.31 Down at P1 and up at P2 -1.34 -1.23 down 0.35  
VPS13A -2.07  absent at P1/P2 -2.11 1.23 up at P9 -0.02  
ERBB3 -2.07 1.17 1.19 up -1.88 1.81 up at P9 0.09  
NFKBIA -2.07 -1.59 -1.40 down -1.80 1.07 up at P9 0.13 a 
WIPF3 -2.07  absent at P1/P2 -1.80 -1.54 down 0.13  
DISP1 -2.07  absent at P1/P2 -1.94 -1.09 down 0.06  
RUNX3 -2.06  absent at P1/P2 -2.17 -2.30 down -0.05  
ARIH1 -2.06 -1.05 1.52 Down at P1 and up at P2 -2.18 -1.12 down -0.06  
GRIK3 -2.06  absent at P1/P2 -1.99 1.03 up at P9 0.03  
KIF26A -2.06  absent at P1/P2 -2.17  absent at P9 -0.05  
CCNF -2.06 -1.08 -1.19 down -1.83 1.13 up at P9 0.11  
CPEB1 -2.06 -1.17 2.42 Down at P1 and up at P2  1.31 absent at P7 1.00  
TCEA1 -2.06 -1.05 -1.25 down -1.66 1.16 up at P9 0.19  
SLAIN2 -2.05  absent at P1/P2 -1.90 -1.15 down 0.07  
TJP2 -2.05  absent at P1/P2 -1.94 1.02 up at P9 0.06  
PRKCB -2.05 -1.05 1.19 Down at P1 and up at P2 -1.48 -1.17 down 0.28  
RTKN2 -2.05  absent at P1/P2 -1.93 1.03 up at P9 0.06  
CCNA2 -2.05 1.05 -1.08 up at P1 and down at P2 -1.89 1.17 up at P9 0.08  
DRP2 -2.04  absent at P1/P2 -1.75 -1.49 down 0.14  
BICD2 -2.04  absent at P1/P2 -1.79 1.01 up at P9 0.12  
ALDOC -2.04 1.45 1.45 up -1.72 1.08 up at P9 0.16  
NUP50 -2.04 -1.12 -1.08 down -1.95 1.06 up at P9 0.05  
MYH3 -2.04 1.59 2.38 up -1.91 1.29 up at P9 0.07  
CDCA7 -2.04  absent at P1/P2 -2.00  absent at P9 0.02  
DDX19B -2.04 1.13 -1.01 up at P1 and down at P2 -1.70 1.60 up at P9 0.17 a 
GALNT12 -2.04  absent at P1/P2 -1.91 1.15 up at P9 0.06  
VCL -2.04 -1.50 -1.72 down -1.80 -1.12 down 0.12 c 
CGN -2.04  absent at P1/P2 -1.54  absent at P9 0.24  
RYBP -2.03  absent at P1/P2 -2.02 1.02 up at P9 0.01  
CDC45 -2.03 -1.06 -1.44 down -1.76 1.17 up at P9 0.14  
PCBD1 -2.03 -1.89 -2.75 down -2.21 -1.10 down -0.09  
SRPK2 -2.03 -1.03 -1.15 down -1.74 -1.71 down 0.15  
C1orf112 -2.03  absent at P1/P2 -1.60 1.30 up at P9 0.21  
AP2A2 -2.03 -1.10 1.16 Down at P1 and up at P2 -1.99 1.18 up at P9 0.02  
LRIG2 -2.03  absent at P1/P2 -1.90 -1.24 down 0.06  
SIX4 -2.03 2.19 1.46 up -2.18 -1.11 down -0.07  
Bc1 -2.03  absent at P1/P2 -1.78  absent at P9 0.13 b 
RAD51 -2.03 -1.60 -1.57 down -1.79 1.15 up at P9 0.12  
WIPF2 -2.03  absent at P1/P2 -1.88 1.13 up at P9 0.07  
ING5 -2.03  absent at P1/P2 -1.95 1.10 up at P9 0.04  
ARHGAP44 -2.03  absent at P1/P2 -1.88 1.12 up at P9 0.07  
ZNF264 -2.02  absent at P1/P2 -2.19  absent at P9 -0.08  
MXI1 -2.02 -1.09 -1.30 down -1.90 -1.15 down 0.06  
RIPK3 -2.02  absent at P1/P2 -2.10 1.27 up at P9 -0.04  
CUL4B -2.02  absent at P1/P2 -1.82 -1.04 down 0.10  
RND2 -2.02 -1.87 -2.00 down -1.62 1.02 up at P9 0.20  
BNC1 -2.02 1.14 1.56 up -1.81 1.58 up at P9 0.10  
MREG -2.02  absent at P1/P2 -1.75 -1.41 down 0.13  
C6orf1 -2.02 -1.10 1.11 Down at P1 and up at P2 -1.79 1.00 up at P9 0.11  
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ESCO2 -2.02  absent at P1/P2 -1.47 1.18 up at P9 0.27  
C11orf70 -2.02  absent at P1/P2 -1.45 -1.18 down 0.28  
STK4 -2.02  absent at P1/P2 -1.99 1.04 up at P9 0.01 a 
MECR -2.02 1.14 1.32 up  1.13 absent at P7 1.00  
BRSK2 -2.01  absent at P1/P2 -2.02  absent at P9 0.00  
RAB11FIP3 -2.01  absent at P1/P2 -1.94 -1.24 down 0.04  
TMEM87B -2.01  absent at P1/P2 -1.84 1.20 up at P9 0.09  
MPP6 -2.01  absent at P1/P2 -2.10  absent at P9 -0.04  
TACR3 -2.01  absent at P1/P2 -1.73 -1.07 down 0.14  
SDAD1 -2.01  absent at P1/P2 -2.02 -1.20 down -0.01  
LRBA -2.01 -1.39 -1.53 down -1.78 -1.33 down 0.12  
GABPB1 -2.01 1.25 -1.19 up at P1 and down at P2 -1.68  absent at P9 0.16  
DYRK3 -2.01  absent at P1/P2 -2.07 1.20 up at P9 -0.03 b 
CDCA7L -2.01 -1.07 -1.30 down -1.91 1.04 up at P9 0.05  
STK38L -2.01  absent at P1/P2 -1.81 1.13 up at P9 0.10  
INTS6 -2.00 1.13 -1.01 up at P1 and down at P2 -1.62 2.01 up 0.19  
DTNA -2.00 -1.64 -2.10 down -1.57  absent at P9 0.22  
MYNN -2.00 1.12 -1.01 up at P1 and down at P2 -1.50 -1.03 down 0.25  
DUSP6 -2.00 -1.72 -2.11 down -1.95 -1.16 down 0.03  
PKD2L1 -2.00  absent at P1/P2 -1.73 1.65 up at P9 0.13  
PDK1 -2.00 -1.09 -1.06 down -1.95 -1.36 down 0.03  
TTK -2.00 -1.01 -1.40 down -1.80 -1.08 down 0.10  
MEX3C 2.00  absent at P1/P2 1.79 1.08 up 0.11  
COL25A1 2.00  absent at P1/P2 1.57  absent at P9 0.22  
SPHK1 2.01 -1.18 -1.07 down 2.07  absent at P9 -0.03  
MIOX 2.01 -2.05 -1.51 down 1.94 2.24 up 0.03  
SESN3 2.01  absent at P1/P2 1.78 1.04 up 0.12  
HRK 2.02 -1.11 -1.92 down 1.74 1.27 up 0.14  
FAM107A 2.02  absent at P1/P2 1.88 -1.17 down 0.07  
STAR 2.02 1.53 -1.04 up at P1 and down at P2 1.96 -1.04 down at P9 0.03  
GNMT 2.02 2.04 1.39 up 1.46 1.51 up 0.28  
ELOVL6 2.03 1.22 1.54 up 1.67 1.48 up 0.17 a 
B3GNT2 2.03 -1.12 -1.17 down 2.05 1.37 up -0.01  
GRAMD1B 2.03  absent at P1/P2 1.64 1.20 up 0.19  
NAV1 2.03 1.01 -1.10 up at P1 and down at P2 1.82 1.21 up 0.10  
KHDRBS3 2.03  absent at P1/P2 2.13 -1.08 down at P9 -0.05  
SLC24A2 2.03  absent at P1/P2 1.79 -1.31 down 0.12  
TOR3A 2.03 1.40 1.35 up 1.71 1.39 up 0.16  
FABP7 2.03 1.45 2.12 up 1.87 1.22 up 0.08 c 
AK1 2.04 1.47 2.22 up 1.73 1.44 up 0.15  
ADAM12 2.04 1.12 1.14 up 1.75 1.06 up 0.14  
PLEKHA2 2.04  absent at P1/P2 1.92 1.48 up 0.06  
PLEKHA7 2.04 -1.07 1.42 Down at P1 and up at P2 2.04 1.33 up 0.00  
CYP4V2 2.05 1.50 1.29 up 1.87 -1.09 down at P9 0.08 b 
ATP1A2 2.05 1.31 1.33 up 1.47 -1.06 down 0.28  
MAPK13 2.05 1.01 1.50 up 1.66 1.31 up 0.19  
MMP2 2.05 -1.32 -1.72 Down at P1 and up at P2 1.57 1.22 up 0.23  
LRP2 2.05 1.09 1.32 up 1.79 5.22 up 0.12  
MATN2 2.05 1.26 1.15 up 2.45 1.45 up -0.19  
RGS7 2.05 1.03 1.18 up 1.66 -1.18 down at P9 0.19  
NRP1 2.05 1.42 1.31 up 1.80 1.18 up 0.12  
RGN 2.06 1.80 -1.39 up at P1 and down at P2 2.43 1.57 up -0.18  
RNF43 2.06  absent at P1/P2 1.48 2.19 up 0.28  
AMH 2.06 -1.31 1.28 Down at P1 and up at P2 1.96 1.28 up 0.05  
NR1H4 2.07 1.79 1.21 up 1.77 -1.18 down at P9 0.14  
GPR137B 2.07 1.25 1.22 up 1.74 1.08 up 0.16  
TXNDC5 2.07 1.05 1.35 up 1.92 1.43 up 0.07  
SOCS2 2.07 -1.18 -1.02 down 1.95 1.10 up 0.06  
CTTNBP2 2.08  absent at P1/P2 1.87 1.01 up at P9 0.10  
UGCG 2.08 1.38 1.31 up 1.76 1.20 up 0.15 a 
PEX5L 2.08  absent at P1/P2 1.80 1.07 up 0.14  
CCDC80 2.09 1.17 1.16 up 1.73 1.25 up 0.17  
KIAA1199 2.09  absent at P1/P2 1.60 2.66 up 0.24  
ZNF467 2.09 -1.10 -1.10 down 1.88 1.49 up 0.10  
GULP1 2.09  absent at P1/P2 1.95  absent at P9 0.06  
TGFA 2.09 -1.08 1.14 Down at P1 and up at P2 1.82 1.25 up 0.13  
SLC38A1 2.09  absent at P1/P2 2.01 1.48 up 0.04  
HAO2 2.09 2.07 1.30 up 2.24 1.28 up -0.07  
SYK 2.09 -1.44 1.48 Down at P1 and up at P2 1.71 1.62 up 0.19 c 
CRIP2 2.10 1.61 1.15 up 2.07 1.56 up 0.01  
LTBP1 2.11 1.24 -1.15 up at P1 and down at P2 1.72 1.10 up 0.18 c 
LGI2 2.11  absent at P1/P2 1.85 1.31 up 0.13  
SEMA3B 2.11 4.34 2.85 up 1.64 1.75 up 0.22  
CDKN1A 2.11 -1.81 1.62 Down at P1 and up at P2 1.74 2.51 up 0.17  
RTP4 2.11  absent at P1/P2 2.19 1.24 up -0.04  
TMEM51 2.11  absent at P1/P2 2.02 1.88 up 0.04  
NDRG2 2.12 1.38 1.40 up 1.70 1.19 up 0.20  
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RERG 2.12  absent at P1/P2 1.97 1.22 up 0.07  
KCNMA1 2.12 1.19 1.26 up 1.87 1.38 up 0.12  
FCGR2B 2.12 2.22 1.88 up 2.30 1.27 up -0.08  
COL23A1 2.12  absent at P1/P2 1.77 1.22 up 0.16  
TSPAN7 2.12 1.29 1.20 up 1.85 1.30 up 0.13 c 
CD74 2.13 1.56 1.99 up 1.72 1.35 up 0.19 a 
CHST11 2.13  absent at P1/P2 1.81 1.18 up 0.15  
SLC1A5 2.13 1.18 -1.02 up at P1 and down at P2  -1.01 absent at P7 1.00  
TM2D2 2.13 1.13 -1.04 up at P1 and down at P2 1.89 1.09 up 0.11  
SMPDL3A 2.14 1.21 1.17 up 1.92 1.61 up 0.10  
FXYD1 2.14 1.13 1.19 up 1.75 -1.08 down 0.18  
TOB1 2.15 1.47 1.30 up 1.87 1.46 up 0.13  
MST4 2.16  absent at P1/P2 2.00 1.02 up 0.08  
FLRT3 2.16  absent at P1/P2 1.97 -1.02 down at P9 0.09  
CEBPA 2.17 -1.42 -1.19 down 2.05 1.13 up 0.05  
C16orf45 2.18  absent at P1/P2 2.16 2.12 up 0.01  
CLIP3 2.19 1.15 -1.01 up at P1 and down at P2 1.57 -1.12 down at P9 0.28  
IIGP1 2.20  absent at P1/P2 2.02  absent at P9 0.08  
PPARGC1B 2.20  absent at P1/P2 1.99 2.83 up 0.09  
KCNK1 2.20 1.21 1.18 up 2.60 1.88 up -0.18 a 
CDH1 2.20 -1.06 -1.07 down  4.15 absent at P7 1.00  
SLC7A8 2.20 1.11 1.32 up 1.70 1.23 up 0.23  
P2RX7 2.20 1.01 -1.00 up at P1 and down at P2 1.92  absent at P9 0.13  
PLXNB1 2.21  absent at P1/P2 1.98 1.92 up 0.11  
PNLIP 2.22  absent at P1/P2  1.70 absent at P7 1.00  
PKP2 2.22 2.98 1.67 up 2.00 1.38 up 0.10  
SEMA3D 2.23  absent at P1/P2 2.05 -1.11 down 0.08  
XDH 2.24 1.83 1.96 up  1.22 absent at P7 1.00  
GREB1 2.24  absent at P1/P2  -1.02 absent at P7 1.00  
EYA1 2.25 1.17 1.13 up 2.08 2.50 up 0.07  
SLIT2 2.25  absent at P1/P2 1.72 1.50 up 0.24  
PRLR 2.26 -1.31 1.79 Down at P1 and up at P2 2.12 1.50 up 0.06  
BCL11A 2.26  absent at P1/P2 1.65 1.58 up 0.27 c 
NR2F1 2.27 1.15 1.21 up 1.99 -1.27 down 0.12  
IQGAP2 2.27 -1.18 -1.07 down 2.49  absent at P9 -0.09  
IGDCC3 2.28 1.09 1.31 up 1.83 1.66 up 0.20  
CAPN5 2.28 1.10 -1.01 up at P1 and down at P2 1.66 1.19 up 0.27  
CYP17A1 2.28 1.23 -1.07 up at P1 and down at P2 2.12 1.19 up 0.07  
MKX 2.30  absent at P1/P2 2.53 1.05 up -0.10  
ITGB5 2.33 1.25 1.45 up 1.85 1.61 up 0.20  
KY 2.33  absent at P1/P2 2.23 3.05 up 0.05  
NELL2 2.34 1.04 1.29 up 1.40 1.46 up 0.40  
KCNT1 2.34  absent at P1/P2 2.30 1.99 up 0.02  
HLA-DMB 2.35 6.50 2.28 up 1.96  absent at P9 0.17  
SFRP1 2.35 1.07 1.47 up 1.80 1.23 up 0.23  
Svs5 2.36 2.10 1.83 up 1.63 1.84 up 0.31  
LIN7A 2.36  absent at P1/P2 1.89 1.06 up 0.20  
TES 2.37 5.01 1.40 up 2.03 -2.18 down at P9 0.14  
RBFOX1 2.37  absent at P1/P2 2.14  absent at P9 0.10  
CTSH 2.38 1.26 1.57 up 1.85 1.10 up 0.22  
ANGPT2 2.39 1.38 1.28 up 2.08 1.49 up 0.13  
SYBU 2.39  absent at P1/P2 1.93 1.25 up 0.19  
GABRA1 2.39 1.32 1.30 up 1.70 -1.09 down at P9 0.29  
GPC1 2.40 1.03 1.25 up 2.08 1.30 up 0.13  
FAM57B 2.40  absent at P1/P2 1.99  absent at P9 0.17  
IGF1 2.40 1.16 1.25 up 2.24  absent at P9 0.07  
DPF3 2.40 1.33 1.28 up 1.70 1.26 up 0.29  
TMPRSS13 2.40  absent at P1/P2 2.17 1.93 up 0.10  
OOEP 2.41  absent at P1/P2 1.73 3.24 up 0.28  
LEPR 2.41 -1.03 -1.24 down 1.56  absent at P9 0.35  
CAMTA1 2.42  absent at P1/P2 1.57 1.30 up 0.35  
THBS1 2.42 1.77 1.44 up  1.01 absent at P7 1.00  
NTSR1 2.43 1.05 1.36 up 2.02 1.28 up 0.17  
PAK3 2.43 1.37 -1.09 up at P1 and down at P2 2.16 -1.10 down at P9 0.11  
RASGEF1B 2.43  absent at P1/P2 2.01 1.33 up 0.17  
EPHA3 2.43 1.07 -1.01 up at P1 and down at P2  -1.07 absent at P7 1.00  
PPM1H 2.44  absent at P1/P2 2.21 2.05 absent at P7 0.09  
MDFIC 2.44 1.20 1.20 up 2.26 1.15 up 0.07  
ALDH3A1 2.44 1.26 -1.19 up at P1 and down at P2 1.84 1.22 up 0.25  
NLRP10 2.45  absent at P1/P2 1.74 1.09 up 0.29  
PBX3 2.45 1.17 1.31 up 2.06 1.36 up 0.16  
C13orf15 2.46 1.01 1.26 up 2.39 1.36 up 0.03  
STC2 2.46 1.25 1.47 up 1.87 1.16 up 0.24  
MIA 2.46 1.20 -1.00 up at P1 and down at P2  1.22 up 1.00 a 
FGF7 2.46 1.51 -1.05 up at P1 and down at P2 1.89 1.23 up 0.23 c 
DMRT3 2.46  absent at P1/P2 2.11 1.51 up 0.14  
SERPINF1 2.46 1.47 1.79 up 1.89 -1.12 down at P9 0.23  
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FGFR2 2.46 1.86 1.26 up 2.07  absent at P9 0.16  
GPD1 2.47 2.38 1.92 up 2.58 1.12 up -0.04  
TNNI1 2.48 1.29 1.48 up  1.42 absent at P7 1.00  
ZC3H4 2.48  absent at P1/P2 1.78 -1.10 down 0.28  
GMPR 2.53  absent at P1/P2 2.54 1.65 up 0.00  
RND3 2.53  absent at P1/P2 2.47 1.52 up 0.02  
NOBOX 2.55 1.43 -1.12 up at P1 and down at P2 1.39 9.08 up 0.46  
ROBO1 2.56 1.66 -1.06 up at P1 and down at P2 2.17 -1.19 down at P9 0.15  
EDA2R 2.56  absent at P1/P2 1.83 -1.04 down at P9 0.29  
CNTN4 2.56 2.09 1.31 up 2.10 1.22 up 0.18  
CELSR1 2.57 1.44 1.75 up 1.85 1.39 up 0.28  
KCND2 2.58 1.23 1.50 up 1.62 1.83 up 0.37  
PRMT8 2.59  absent at P1/P2 1.47 8.67 up 0.43  
ODZ2 2.59 1.13 1.72 up 2.13 1.51 up 0.18  
PIK3R1 2.59 1.32 1.14 up 2.23 1.14 up 0.14  
Aldh1a7 2.59 1.37 1.65 up 1.83 -1.15 down at P9 0.30  
GABRB3 2.61 1.31 1.36 up 2.19 3.02 up 0.16  
TGFB2 2.64 1.37 1.31 up 1.92 1.43 up 0.27  
MYOC 2.65 1.12 1.41 up  1.80 absent at P7 1.00  
FETUB 2.65  absent at P1/P2 2.18 2.22 up 0.18  
THRSP 2.65 1.63 -1.09 up at P1 and down at P2 1.79 1.85 up 0.33  
LSAMP 2.67  absent at P1/P2 1.87 1.06 up 0.30  
TESC 2.67  absent at P1/P2 2.75 1.93 up -0.03  
TTC39B 2.68 2.50 2.01 up 2.45  absent at P9 0.08  
SPEG 2.68 -1.67 1.56 Down at P1 and up at P2 2.29 1.53 up at P9 0.15  
FRAS1 2.69  absent at P1/P2 2.27 1.93 up 0.16  
VTN 2.71 1.13 1.20 up 1.94 1.93 up 0.28  
HTRA1 2.71 1.08 1.25 up 2.32 1.51 up 0.15  
MYBPC3 2.72 1.27 1.67 up 1.91 2.37 up 0.30  
KCNE1 2.72 -1.43 -1.47 down 2.32 -1.26 down 0.15 b 
SLC6A15 2.76 1.65 1.16 up 1.97 1.11 up 0.28  
CADPS 2.77 1.75 1.55 up 2.14 1.27 up 0.23 C 
KCNJ3 2.77 2.02 -1.09 up 2.68 1.21 up 0.04  
TRIM62 2.78  absent at P1/P2 2.51 1.41 up 0.10  
RCN1 2.79 1.19 -1.04 up at P1 and down at P2 1.62 1.27 up 0.42  
PIPOX 2.80 1.27 1.30 up 2.36 2.22 up 0.16  
HEY1 2.81 1.43 1.48 up 2.19 1.19 up 0.22  
SORL1 2.86 1.19 -2.16 up at P1 and down at P2 1.88 -1.42 down at P9 0.34  
NFE2 2.87 1.43 1.68 up 2.28 1.87 up 0.21  
MMP23B 2.87  absent at P1/P2 2.46 1.99 up 0.15  
EPHA4 2.88 1.88 1.15 up 2.13 1.29 up 0.26  
RPRM 2.90 2.83 2.04 up 2.52 2.43 up 0.13  
CHST8 2.95  absent at P1/P2 1.94 1.29 up 0.34  
BHLHE22 2.97  absent at P1/P2 2.16 1.19 up 0.27  
HSD17B1 2.98 -1.07 -1.02 down 2.60 1.50 up 0.13  
FHOD3 3.00 1.38 1.93 down 2.57 2.15 up 0.14  
CPNE8 3.01  absent at P1/P2  -2.05 absent at P7 1.00  
ENO3 3.01 1.27 1.66 up 2.00 1.45 up 0.34 c 
UNC13D 3.02  absent at P1/P2 2.57 2.34 up 0.15  
WIF1 3.02  absent at P1/P2 2.59 2.63 up 0.14  
PCDH9 3.03  absent at P1/P2 2.88 1.34 up 0.05  
LTBP3 3.06 1.15 -1.36 up at P1 and down at P2 2.87 1.30 up 0.06  
RBM47 3.09  absent at P1/P2 2.08  absent at P9 0.33  
ADCYAP1R1 3.12 -1.24 -1.64 down 2.30 2.16 up 0.26  
MRAP 3.16 1.75 1.44 up 2.14 1.47 up 0.32  
ZNF521 3.18  absent at P1/P2 2.09  absent at P9 0.34  
MMP15 3.18 1.47 1.31 up 2.09 1.48 up 0.34  
ASPH 3.20   2.93   0.08  
CADPS2 3.21   2.41 -1.29  0.25  
ZMIZ1 3.24  absent at P1/P2 3.60  absent at P9 -0.11  
PTGDS 3.24 -1.35 1.30 Down at P1 and up at P2 2.71 2.17 up 0.17  
CELA3B 3.26  absent at P1/P2 3.27 1.75 up 0.00  
NPPC 3.26 2.12 2.66 up 3.23 1.76 up 0.01  
KLKB1 3.28 2.84 1.98 up 2.84 1.48 up 0.14  
EPPK1 3.32  absent at P1/P2 2.53 1.77 up 0.24  
PCSK6 3.34 1.36 1.71 up 2.59 3.22 up 0.23  
NETO2 3.38  absent at P1/P2 2.68  absent at P9 0.21  
MID1 3.40 -1.16 -1.21 down  1.16 absent at P7 1.00  
RPS9 3.48  absent at P1/P2 1.30 1.08 up 0.63  
EGFL6 3.48  absent at P1/P2  2.05 absent at P7 1.00  
MYO1A 3.57  absent at P1/P2 2.52 2.64 up 0.29  
AQP5 3.57  absent at P1/P2 4.06 2.11 up -0.13  
CNGA1 3.63 -1.72 -3.83 down 2.26 1.80 up 0.38  
P2RY6 3.63  absent at P1/P2 2.59 1.30 up 0.29  
SEMA3A 3.64 1.45 -1.03 up at P1 and down at P2 2.85 1.05 up 0.22  
HLA-DRB1 3.64 2.48 2.44 up 2.64 3.77 up 0.27  
FABP3 3.65 1.53 1.34 up 3.40 1.61 up 0.07 c 
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SGPP2 3.94  absent at P1/P2 3.60 1.37 up 0.09  
HLA-DQA1 4.10 4.22 4.78 up 3.22 2.13 up 0.22  
PQLC1 4.20 1.85 1.96 up 2.98 1.58 up 0.29  
ANO4 4.28  absent at P1/P2 3.33 -1.08 down at P9 0.22  
DSG2 4.34 1.43 1.68 up 3.62 3.19 up 0.17 a 
HLA-DQB1 4.36  absent at P1/P2 3.40  absent at P9 0.22  
FBLN2 4.50 1.22 1.46 up 3.23 2.03 up 0.28  
KCNH1 4.64 1.11 1.13 up 3.99 1.63 up 0.14 c 
SPSB4 4.65  absent at P1/P2 4.17 1.84 up 0.10  
TCEA3 4.67 1.83 2.01 up 3.56 1.03 up 0.24  
APOC1 4.69 2.11 2.83 up 2.80 2.25 up 0.40  
BMP6 4.70 1.63 1.44 up 3.61 1.54 up 0.23 b 
TMEM178 4.75  absent at P1/P2 3.49 1.75 up 0.27  
HSPB8 4.76 2.77 1.65 up 3.44 1.72 up 0.28  
DSP 4.95 1.10 -1.12 up at P1 and down at P2 3.56  absent at P9 0.28  
BMPER 5.17  absent at P1/P2 3.49 1.09 up 0.33  
LRRN1 5.19 2.08 1.55 up 3.46 1.70 up 0.33  
KRT18 5.77 1.94 1.71 up 4.86 2.51 up 0.16  
PCDH8 6.26  absent at P1/P2 3.40 2.25 up 0.46  
KRT8 6.36 2.31 2.07 up 4.05 2.10 up 0.36  
CRABP2 6.55 2.28 4.63 up 8.00 9.15 up -0.22  
CCL17 7.71 1.20 2.33 up 6.44 -1.01 down at P9 0.16  
CFI 8.21 15.47 11.15 up 5.71 2.80 up 0.30  
PNMT 9.69 -1.46 1.30 Down at P1 and up at P2 4.40 -1.16 down at P9 0.55  
ZG16 9.89 1.03 -1.03 up at P1 and down at P2 6.90 2.92 up 0.30  
LECT1 11.62  absent at P1/P2 6.20 3.95 up 0.47  
 
KEY 
a = (Chip-Chip)-DMRT1 Binding to anywhere within the promoter. Peak called in 3 separate experiments (Murphy et al., 2010) 
b = (Chip-Chip)-DMRT1 Binding to anywhere within the promoter. Peak called in 2 separate experiments (Murphy et al., 2010) 
c = (Chip-Chip)-DMRT1 Binding to anywhere within the promoter. Peak called in 1 experiment (Murphy et al., 2010) 
d = ChIP-Seq- Enrichment at 10kb to 5' promoter region 
e = ChIP-Seq - Enrichment at intergenic regions 
f = ChIP-Seq - Enrichment at intronic regions 
g = ChIP-Seq - Enrichment at 3' regions 
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Table 3: DMRT1 binding sites characteristics identified by manual analysis of ChIP-Seq 
data. A. DMRT1 binding site characteristics. B. Top 31 DMRT1 targets grouped into five 
functional categories. 1 = Cell adhesion/ cytoskeletal regulation, 2 = RNA processing, 3 = 
protein processing/transport, 4 =DNA recombination/repair and 5 = homeostasis.  
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Table 4: Pathways and processes induced by differential gene expression profiles regulated 
through Dmrt1 in Sertoli cells and germ cells. A. Canonical pathways. B. Biological 
processed. 
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Table 5: Functional annotations for subset of genes derived from comparisons of Dmrt1-
null, Dmrt1-rescue and GCDmrt1KO gene expression profiles. A, B, and C, represent 
biological processes enriched in subset of genes comparing P1/P2 and P7 Dmrt1-null samples. 
D, E, F and G represent biological processes enriched in subset of genes comparing P7 Dmrt1-
rescue and P9 GCDmrt1KO samples. 
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Table 6: Manual analysis identifying genes important in specific spermatogenic processes 
and regulated entirely or partially by DMRT1 in a cell-specifically. Relative factor (RF) was 
the difference of one (1) minus the quotient obtained by dividing Dmrt1
-/-;tg
/Dmrt1
+/+
 fold 
changes by Dmrt1
-/-
/Dmrt1
+/+
 fold changes. RF≤ 0.4 = Not rescued, 0.5 ≤ RF≤ 0.7 = partially 
rescued and RF ≥ 0.8 = completely rescued. All genes with RF<1 were considered germ cell-
specific while those with RF = 1 were considered Sertoli cell specific. 
 
 
142 
 
 
143 
 
Table 7: DMRT1-direct targets identified by manual integration of ChIP-Seq and 
Microarray data.  
 
 
  
 
 
 
144 
 
 
 
 
 
Chapter 5: NANOS2 partially co-localizes and interacts with DMRT1 to 
modulate its transcriptional activity 
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Abstract 
The doublesex and mab-3 related transcription factor 1 (DMRT1) and nanos homolog 2 
(NANOS2) are both evolutionary conserved proteins implicated in germ cell development and 
maintenance. However, the molecular mechanisms involved are not fully appreciated for either 
protein. The current study provides evidence that NANOS2 and DMRT1 collaborate to regulate 
one or several steps in germ cell development. Co-immunoprecipitation experiments 
demonstrated that DMRT1 and NANOS2 can directly interact with one another. The potential of 
this interaction was supported by double immunofluorescence staining, which revealed 
occasional overlap of DMRT1 and NANOS2 cellular expression as indicated by confocal 
microscopy. Immunofluorescence analyses of Dmrt1-null mice revealed that NANOS2 protein 
was expressed in the absence of DMRT1 and suggested that NANOS2 is upstream of DMRT1. 
Global gene expression analyses from Nanos2-null mice from a previously published study 
revealed the expression of Dmrt1 along with other genes vital for germ cell development were 
up-regulated in the absence of Nanos2, validating the spatiality of Nanos2 relative to Dmrt1 and 
illustrating the absence of its evolutionary conserved repressive functions. These findings show 
that NANOS2 can interact with DMRT1 and regulate its activity. The finding, together with the 
known roles of NANOS2 and DMRT1 in germ cell development, suggests that the NANOS2-
DMRT1 interaction is needed to assure proper progression of germ cells through development.  
. 
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Introduction 
Differentiation of mammalian germ cells occurs early during embryonic development and 
involves the commitment of the sexually indifferent germ cells to either the male or the female 
pathway. Sex-specific differentiation of germ cells starts after they colonize the nascent genital 
ridge at about 10.5 days post coitus (dpc) in mice, and germ cells from both sexes maintain the 
capability to differentiate into either pathway until about 11.5 dpc [44]. Once committed, male 
germ cells are arrested in the G0/G1 phase of the cell cycle at 12.5 dpc and the female germ cells 
enter meiosis at 13.5 dpc, where they enter quiescence in the late diplotene stage [289]. 
Both extrinsic environmental signals and intrinsic germ cell factors determine the entry 
into meiosis. It is well established that the sex of germ cells follows the sex of the supporting 
cells that surround them, and thus the presence of granulosa cells favors the entry into meiosis by 
female germ cells, both of whose existence is dependent on the absence of SRY and SOX9 
expression in the bipotential gonad [26, 38, 156, 290-292]. Entry into meiosis of the embryonic 
female germ cells is favored by an intrinsic factor, retinoic acid (RA), known as the meiosis-
inducing factor and required in the RA signaling pathway [55, 56, 105]. Evidence show that a 
down-stream target of RA, a retinoic acid responsive gene, STRA8, is necessary for RA 
signaling pathway as its deletion prevents preleptotene spermatocytes in Stra8 knockout mice to 
enter meiosis [293, 294]. In contrast, differentiation and mitotic arrest of embryonic male germ 
cells is favored by the early expression of SRY and SOX9 during sex determination and the 
resultant differentiation of Sertoli cells, which produces CYP26b1; a P450 enzyme that oxidizes 
RA to an inactive metabolite. The importance of CYP26b1, a meiosis-inhibiting factor, was 
revealed in Cyp26b1-null mice, whereby embryonic male germ cells lacking this enzyme showed 
an elevated STRA8 expression that culminated in meiotic induction [54, 55]. This phenotype is 
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consistent to that reported in the Nanos2-null mice, in which STRA8 was elevated in embryonic 
male germ cells that led to initiation of meiosis [295]. This result was validated using female 
germ cells expressing exogenous NANOS2, which suppressed Stra8 expression and subsequent 
progress in meiosis [295]. These findings suggested that NANOS2 suppresses the expression of 
Stra8, which is up-regulated by RA signaling, to prevent meiotic entry by male germ cells; and 
thus acting as an intrinsic regulator of embryonic male germ cell differentiation [106]. 
 In addition to its role in embryonic germ cell differentiation, NANOS2, an evolutionary 
conserved zinc finger RNA binding protein expressed in germ cells, is also required for the 
maintenance of postnatal undifferentiated spermatogonia pool [105, 106]. In the postnatal mouse 
testis, NANOS2 is expressed only in types As and Apr spermatogonia; the subset of 
undifferentiated spermatogonia that comprise the “actual stem cell” pool with the ability to self-
renew [105-107, 109, 296]. It has been shown that NANOS2 favors self-renewal of 
undifferentiated spermatogonia than their differentiation. This is illustrated by the finding that 
male germ cells with a Nanos2 deletion initiate meiosis and STRA8 expression was up-regulated 
[295]. Like NANOS2, the transcription factor, DMRT1 is also essential for the development and 
maintenance of germ cells in the postnatal murine testis [50, 131, 133]. 
DMRT1 is a conserved transcriptional factor that is essential for postnatal testis 
differentiation. It is testis-specific and expressed both in Sertoli cells and in pre-meiotic 
spermatogonia [134]. Specifically, deletion of DMRT1 in undifferentiated spermatogonia favors 
premature switch from a normal mitotic differentiation program to a precipitated meiotic 
program that culminates in germ cells differentiating into spermatids [134]. These findings led to 
the conclusion that DMRT1 promotes spermatogonial differentiation by repressing the activation 
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of Stra8 through direct transcriptional regulation and ubiquitous inhibition of RA-dependent 
transcriptional activity [134]. 
While many excellent studies have contributed to our current understanding of DMRT1’s 
molecular characteristics and role in the testis, some important detail is missing. In particular, 
there is limited information on what regulates DMRT1 expression or activity in germ cells. 
Efforts have been placed on identifying the downstream targets of DMRT1 than on identifying 
upstream regulators that affect its transcriptional activity especially in germ cells.  
NANOS2 and DMRT1 are both regulators of male germ cell differentiation by regulating 
the mitotic to meiotic switch [134, 295]. These proteins may share a partial overlapping function 
since the deletion of DMRT1 in male germ cells did not induce uncontrolled meiosis [134]. This 
similarity in function raises the likelihood of a mechanistic link between NANOS2 and DMRT1 
in germ cells. In our present study, NANOS2 expression was unaffected in the absence of 
DMRT1 in both Sertoli cells and germ cells, whereas Dmrt1 mRNA expression was elevated in 
the Nanos2 null mice. Further analysis revealed that NANOS2 and DMRT1 interact with each 
other and a NANOS2 mammalian expression vector repressed the transcriptional activity of 
DMRT1 in in vitro experiments. This suggested that NANOS2 acts upstream of DMRT1 and 
serves as a potential regulator of DMRT1’s activity in undifferentiated germ cells. 
Materials and Methods 
Animals husbandry 
The generation of Dmrt1
-/-
 (Dmrt1-null) and Dmrt1
-/-;tg
 (Dmrt1-rescue) mice were 
reported elsewhere ([112] and Chapter 2). All animal procedures were approved by the 
Laboratory Animal Research Committee at the University of Kansas Medical Center and in 
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accordance with National Institutes of Health guidelines. Three animals each of Dmrt1
+/+
, 
Dmrt1
-/-
 and Dmrt1
-/-;tg
 mice at postnatal day 7 (P7) were examined in this study.  
Immunohistochemistry 
Testes from postnatal day (P7) mice were immersion-fixed in Bouin’s solution at room 
temperature for 24 h. Tissues were rinsed twice with 50% and 70% alcohol. Fixed testes were cut 
at the sagittal plane in half, processed and embedded in paraffin according to standard 
procedures. Five-micron (5 μm) sections were cut and mounted on slides. Five sequential 
sections on slide were analyzed per mouse by immunohistochemistry. Slides containing sections 
were cleared in xylene, rehydrated through graded alcohol series and heated in 10 mM sodium 
citrate buffer (pH 6.0) with microwaves (14 min at full power) for antigen retrieval. Sections 
were blocked using 10% normal goat or donkey serum (Zymed Laboratories Inc.) for 60 min at 
room temperature. For co-staining, primary antibody incubations were carried out overnight at 
4°C in blocking solution. The sections were immunostained with goat anti-NANOS2 and rabbit 
anti-DMRT1 antibodies. Goat polyclonal anti-NANOS2 antibody (sc-69190) was purchased 
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Rabbit polyclonal anti-DMRT1 
antibody was custom made by Covance Inc. (Denver, PA, USA) using a C-terminal peptide of 
DMRT1 and its reported elsewhere [130]. After washing with PBST, sections were incubated 
with fluorescent-labeled secondary antibody (Alexa FluorR 568 donkey anti-rabbit IgG, 
Molecular Probes Inc., Eugene; Alexa FluorR 488 donkey anti-goat IgG, Molecular Probes Inc., 
Eugene; Alexa FluorR 568 donkey anti-goat IgG, Molecular Probes Inc., Eugene; and Alexa 
FluorR 488 donkey anti-rabbit IgG, Molecular Probes Inc., Eugene) for 1 hour at room 
temperature. Samples were washed 3 times in PBST (5 min. each) and glass cover slides 
mounted using Fluoromount-G (Southern Biotechnology Associates Inc., Birmingham, AL). 
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Digital images were collected using fluorescent filters (200x and 400x) on a Nikon Eclipse 80i 
microscope (Nikon Inc., Instrument Group, Melville, NY), a Retiga 2000R fast camera and a 
QCapture software program (QIMAGING, Surrey, BC, Canada). Images were processed using 
Adobe Photoshop. 
Co-immunoprecipitation 
P7-P10 testes from Dmrt1
+/+
 and Dmrt1
-/- 
mice were homogenized, using a tooth 
polisher, on ice in cell lysis buffer (25 mM HEPES-KOH, pH 7.4, 250mM sucrose, 75mM β-
glycerophosphate, 1mM DTT,150 mM NaCl, 1 mM Na3V04, 1% Nonidet P-40, 2x complete 
protease inhibitor (Roche) containing 400 units/ml RNase out). Three hundred microliters 
(300uL) and 500uL of lysis buffer were used for total testis weight ≤20mg and ≥ 50mg, 
respectively. Whole testis extracts were collected by centrifugation at 10,000 xg for 10mins at 
4
o
C and supernatant were precleared in 75 uL of Protein A/G plus-agarose (Santa Cruz 
Biotechnology, Inc.); and then incubated with 2ug of rabbit anti-DMRT1 (Covance) or goat anti-
NANOS2 (Santa Cruz Biotechnology, Inc.) on a rotator for 2 h at 4
o
C. Forty microliters (40uL) 
of protein A/G agarose were added and incubated for 2h at 4 
o
C. Immunoprecipitates were 
collected by centrifugation at 1000 x g for 5mins at 4 
o
C and washed five times with wash buffer 
(25 mM HEPES-KOH, pH 7.4, 250mM sucrose, 75mM β-glycerophosphate, 1mM DTT, 350 
mM NaCl, 1 mM Na3V04, 1% Nonidet P-40, 2x complete protease inhibitor (Roche) containing 
400 units/ml RNase out). The agarose beads were boiled at 100
o
C in 40uL 2x SDS-PAGE 
loading buffer for 5mins. The eluents were run on a 12% acrylamide gel and analyzed by 
Western blot. Anti-DMRT1 was used to probe samples immunprecipitated with anti-NANOS2 
while anti-NANOS2 (sc69160) was used to probe samples immunoprecipitated with anti-
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DMRT1. Donkey anti-rabbit-HRP and Donkey anti-goat-HRP (Jackson Immuno Research) were 
used as secondary antibodies. 
Nanos2 cloning and other vectors 
Mouse Nanos2 transcripts were PCR-amplified with oligodeoxynucleotide primer sets engineered 
with Bgl II (TTGAGCGCAGATCTTAATGGACCTACCGCCCTTTGA) /Hind III (TTAAGCGGCTCG 
AGT TATCG CTTGACTCTGCGACC) and Hind III (TTGAGCG CAAGCTTATGGACCTACCG CC 
CT TTG A) / Xho I (TTAAGCGGCTCGAGTTATCGCTTGACTCTGCGACC) restriction endonuclease 
sites and double restriction digest performed using Bgl II / Hind III and Hind III / Xho I restriction 
enzymes, respectively. The cloning vectors, pcDNA3 (Invitrogen, Carlsbad, CA) and pCMV-Tag1 
(Agilent Technologies, Santa Clara, CA), were restriction digested with Hind III / Xho I and Bgl II / Hind 
III, respectively; dephosphorylated with calf intestinal phosphatase (New England Biolabs, Ipswich, MA), 
and ligated with the Hind III / Xho I and Bgl II / Hind III digested PCR products, respectively, using T4 
ligase (New England Biolabs, Ipswich, MA).  
Other expression vectors used for transient transfection include EF-FLAG-DMRT1, VP16-
DMRT1 and GAL4-VP16 that are all driven by a CMV promoter in the EF-FLAG-pLink, 
pKH68 and pBudCE4.1(Invitrogen, Grand Island, NY) mammalian expression vectors, 
respectively. The EF-FLAG-DMRT1 and VP16-DMRT1 expression vectors were gifts from Dr. 
Vivian Bardwell and the base vectors have been describe elsewhere [274, 297]. The VP16 
activation domain was generated by PCR using VP16 forward 2 (GCCGCTCG AGCC 
GAGGAG GACCTG AACATG GC) and VP16 reverse 2 (CCG GCT CGA GTC ACC CAC 
CGT ACT CGT CAA T) primers and VP16-mDMRT1 plasmid (Bardwell lab) as template. This 
PCR product was cloned into the XhoI site of pBudCE4.1 (Invitrogen) to give the plasmid VP-
16-pBudCE4.1. The Gal4 DNA binding domain was generated by PCR using Gal4 forward 
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(AGG CGG TAC CAG CTT GAA GCA AGC CTC CTG) and Gal4 reverse (CTC TCG GTA 
CCT CCA TGA TGG CGG CTC G) primers and pGBKT7 (Clontech) as template. The resulting 
PCR product was cloned into the KpnI site of the VP16-pBudCE4.1 vector to produce GAL4-
VP16-pBudCE4.1.  
Also, the reporter constructs used include 4X-IRE-promoter-Luc and 4X-DM-Luc 
generated by placing four copies of the binding sequences of DMRT1 upstream of a strong, 
constitutive SV40 promoter and a minimal promoter (TATA box) that drive luciferase 
expression in a pGL3-promoter (Stratagene, Agilent Technologies, Santa Clara, CA) and pLuc-
MCS (Stratagene, Agilent Technologies, Santa Clara, CA) plasmid reporter vectors, respectively. 
The control reporter was a pFR-Luc vector (Stratagene, Agilent Technologies, Santa Clara, CA), 
which contained five copies of upstream activation sequences (5X-GAL4-UAS) for the GAL4 
DNA binding domain and was placed in front of an SV40 promoter. Plasmid DNAs were prepared 
from overnight bacterial cultures using plasmid DNA miniprep columns according to the supplier’s 
protocol (Fermentas, Thermo Fisher Scientific, Inc., Glen Burnie, MD). All resulting clones were 
sequenced by GENEWIZ, South Plainfield, NJ.  
Cell preparation and transient transfection analysis 
Preparation and propagation of GC-1 spg (mouse spermatogonia cell line; ATCC #: CRL-
2053
TM
) were as described elsewhere and were cultured in Dulbecco’s modified Eagle’s medium 
(Cellgro Mediatech; Fisher Scientific, Pittsburgh, Pa.) supplemented with 10% fetal bovine 
serum[298]. For transient transfection, GC1 cells were plated at a density of 20,000 cells/well in 
24-well culture dishes (Costar, Corning, N.Y.) and transfected with 300ng total DNA and 0.6μl of 
TurboFect transfection reagent (Fermentas, Thermo Fisher Scientific, Inc., Glen Burnie, MD). Unless 
otherwise stated, GC1 cells were transfected with 200ng 4X-DM-Luciferase or 4X-IRE-
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promoter luciferase constructs along with 0-80ng of EF-FLAG-DMRT1 or VP16-DMRT1, 
FLAG-NANOS2-MYC or pCDNA3-NANOS2 and their base mammalian expression vectors. 
Transfection efficiency was controlled by including 20ng of phRL-TK (Promega Corp), which 
express Renilla luciferase from the hSV-TK promoter. For control experiments to determine 
specificity of NANOS2, GC1 cells were transfected with 200ng 5X-GAL-UAS-Luciferase, 20ng 
of phRL-TK and 0-80ng of GAL4-VP16, FLAG-NANOS2-MYC and their base mammalian 
vectors. Overall, Luciferase reporters with response element insert (4X-DM-Luc or 4X-IRE-Luc 
or 5X-GAL4-UAS-Luc) were co-transfected with a constant amount of expression vector (EF-
FLAG-DMRT1 or VP16-DMRT1 or GAL4-VP16) and increasing amounts of FLAG-NANOS2-
MYC into cultures of GC1-spg cells. Each transfection was performed in triplicates. Forty-eight 
hours after transfection, cells were lysed and assayed for both firefly and Renilla luciferase 
activities using the Dual-Luciferase reporter assay system (Promega Corp.), as described 
previously[138, 299]. The data are presented as the firefly/Renilla luciferase activity ratio of 4X-
DM-Luc (or 4X-IRE promoter Luc) in the presence of EF-FLAG-DMRT1 (or VP16-DMRT1) 
and with or without FLAG-NANOS2-MYC (or pCDNA3-NANOS2) constructs relative to the 
firefly/Renilla luciferase activity ratio of the promoter-alone construct. All transient transfection 
experiments were repeated at least three times. All plasmid DNAs were prepared from overnight 
bacterial cultures using a GeneJET
TM
 plasmid miniprep kit according to the supplier’s 
recommendations (Fermentas, Thermo Fisher Scientific, Inc., Glen Burnie, Md.).  
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Results 
Majority of genes involved in spermatogenesis showed opposite regulatory patterns in Nanos2-
null and Dmrt1-null mice 
There was significant evidence from the literature for an important interaction between 
NANOS2 and DMRT1 based on shared regulation of similar genes. To explore a potential link 
between DMRT1 and NANOS2, the gene expression changes were compared in embryonic 
Nanos2 knockout and P7 Dmrt1 mutant (Dmrt1
-/-
 and Dmrt1
-/-;tg
) testes ([300], Chapter 4). These 
genes were classified into a group of similar or opposite transcriptional change. Twenty-four (24) 
out of forty (40) genes examined including Dmrt1, Stra8, Dazl, Sox3, Sohlh2, Sycp1, Plzf, Taf7l, 
Lin28 and Ngn3 had expression patterns that were opposite in Nanos2-null and Dmrt1-null mice 
(Figure 1 and Table 1). For example, the expression of Dmrt1, Stra8, and Lin28 were up-
regulated when Nanos2 was deleted, whereas their expression were down-regulated in the 
absence of Dmrt1 (Figure 2). On the other hand, the expression of 16 genes including Dppa3, 
Dppa4, Piwi4, Morc, Gtsf1 and Emb had similar transcriptional change; which were either up-
regulated or down-regulated in both Nanos2-null and Dmrt1-null mice (Table 2). Also, whereas 
Dmrt1 expression changed significantly in embryonic Nanos2-null testes compared to the 
controls, Nanso2 expression was unchanged in Dmrt1-null testes. This suggested that NANOS2 
is potential regulator of Dmrt1 levels in germ cells and showed that NANOS2 is upstream of 
DMRT1. 
NANOS2 and DMRT1 form a stable interaction 
To explore potential interactions between DMRT1 and NANOS2, experiments were 
executed to determine if NANOS2 was a binding partner of DMRT1. To determine if physical 
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interaction can exist between these two proteins, in vitro methods that disrupted cellular barriers 
were employed. To this end, DMRT1 and NANOS2 were immunopreciptated from protein 
extracts of Dmrt1
+/+
 and Dmrt1
-/-
 P7 testes and the immunoprecitates analyzed for NANOS2 and 
DMRT1, respectively, using western blot analysis (Figure 2). Western blot analysis of anti-
DMRT1 precipitates probed with anti-NANOS2 revealed a major band of about 18kDa 
corresponding to NANOS2, which was exclusively detected in immunoprecipitates obtained 
from Dmrt1
+/+
 testes and absent in precipitates from Dmrt1
-/- 
testes (Figure 2A). Similarly, 
Western blot analysis of anti-NANOS2 precipitates probed with anti-DMRT1 revealed three 
major bands in the Dmrt1
+/+
 testes that were absent in Dmrt1
-/- 
testes (Figure 2B). One of the 
bands was about 41kDa and corresponded to the expected size of DMRT1, whereas the other two 
were located about 18kDa. It is likely that the lower bands are proteolytic products of the full-
length DMRT1 protein that are in a protein degradation complex, which also interacts with 
NANOS2. 
NANOS2 is localized at nuclear envelope and is upstream of Dmrt1 
There was little indication from the literature that NANOS2 and DMRT1 co-localized in 
the cell, given that DMRT1 is localized in the nucleus while NANOS2 was recently shown to 
localize in the cytoplasmic and nuclear compartments of HEK293T cells transfected with a 
NANOS2-MYC-expression vector [301]. To evaluate this possibility of co-localization and 
provide a hierarchical basis on the molecular mechanisms underlying observed interaction 
between NANOS2 and DMRT, immunofluorescence was used to localize NANOS2 in cells of 
postnatal day 7 (P7) testes, using sections from mice with and without DMRT1. In the Dmrt1
+/+
 
testes, NANOS2 was observed in the cytoplasm of germ cells juxtaposed to the nuclear envelope 
of the DMRT1-positive nuclei (Figure 3 A-C; arrowhead in Figure 3C). As in the Dmrt1
+/+
 mice, 
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NANOS2 was similarly expressed in testes from Dmrt1-null (Dmrt1
-/-
) mice, suggesting that 
NANOS2 is upstream of DMRT1 (Figure 3 D-F). This result validates observations that Dmrt1 
mRNA was induced in embryonic Nanos2-null testes and that Nanos2 mRNA did not change in 
the embryonic ovaries of female Dmrt1-null mice [137, 300]. Furthermore, immunostaining 
followed by confocal microscopy revealed that DMRT1 and NANOS2 are in close-proximity but 
did not completely overlap with each other (Figures 4C & 4I, arrowheads). As previously 
proposed NANOS2 was located in the cytoplasm and partially in the nucleus, where it 
juxtaposed to the nuclear envelope of the germ cell nuclei and partially co-localized with 
DMRT1.  
NANOS2 modulates DMRT1’s transcriptional activity in cultured cells 
To investigate whether NANOS2 can modulate DMRT1 transcriptional activity, transient 
transfection was used to measure the ability of NANOS2 (derived from an expression vector) to 
alter activity of co-transfected DMRT1, as measured by DMRT1’s ability to activate 
transcription from the two stated reporters (4X-DM-Luc and 4X-IRE-Luc) in immortalized GC1-
spermatogonia cells [274]. The 4X-DM-Luc reporter was generated by placing four copies of 
DMRT1 binding site in front of a TATA box minimal promoter, whereas the 4X-IRE- Luc 
reporter was generated by inserting four copies of DMRT1 binding site in front of a strong SV40 
promoter. In GC1 cells, co-transfection of a DMRT1 expression vector with the 4X-DM-Luc 
reporter or 4X-IRE-Luc reporter increased the basal activity by approximately 6-fold or 9-fold, 
respectively (Figures 5A and 5B). Co-transfection of increasing amounts of NANOS2 expression 
vector caused a dose-dependent decrease and increase in DMRT1-dependent transcriptional 
activity for the 4X-DM-Luc and 4X-IRE-Luc reporters, respectively (Figures 5A and 5B). To 
determine if the effect of NANOS2 was specific to DMRT1, co-transfection of a GAL4-VP16 
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and NANOS2 expression vectors with the 5X-GAL4-UAS-Luc reporter, showed that NANOS2 
had not effect on the GAL4-dependent transcriptional activity the reporter vector (5X-GAL4-
UAS-Luc; Figure 5C). Thus, the dose-dependent transcriptional activities illustrated by the 4X-
DM-Luc and 4X-IRE-Luc exemplifies the activating and repressive roles of DMRT1, 
respectively, with both roles modulated by NANOS2, suggesting that NANOS2 is a potential 
regulator of DMRT1’s in vivo functions in germ cells. 
Discussion 
The differentiation of postnatal germ cells in the mammalian testis is regulated by a 
diverse group of genes identified primarily from gene ablations studies in mice. These studies 
identified a number of genes that, when deleted, block germ cell development, including Dmrt1, 
Nanos2, Nanos3, Dazl, Gdnf, Stra8, Cyp26b1, Gfra1 and Sohlh1 [5, 50, 83, 105, 107, 134, 135, 
137, 295, 300, 302, 303]. Amongst these genes Nanos2, Dmrt1, Dazl, Sohlh1, Stra8 and 
Cyp26b1 are implicated in the mitotic-to-meiotic transition of germ cells and Nanos3, Nanos2, 
Gdnf , Gfra1, are required for the maintenance of spermatogonial stem cell population [55, 105, 
106, 134, 303]. Within this list are transcription regulators (DMRT1 and SOHLH1), translation 
regulators (DAZL, NANOS2 and NANOS3), a transmembrane receptor (GFRA1) and its ligand, 
GDNF, a neurotrophic factor, an unknown family protein (STRA8) and an enzyme (CYP26B1); 
all of which are vital to the production of a mature sperm. These genes regulate a sequential 
series of events that is important for inducing spatiotemporal expression of downstream target 
genes responsible for specific developmental changes. For example, GDNF secreted by Sertoli 
cells acts upstream to maintain expression of NANOS2 and their synergistic action is required 
for maintaining pluripotency of spermatogonia stem cells [105]. Likewise, DMRT1 and 
NANOS2 were both shown to act upstream of STRA8 and regulate meiotic entry of 
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spermatogonia [106, 134]. As a testis-specific transcription factor that is invaluable for testis 
differentiation, DMRT1 holds a vital position in this germ cell developmental pathway and this 
current study revealed functional and biochemical interactions between NANOS2 and DMRT1 
suggesting that they participate within the same pathway; and the gene expression / 
immunohistochemistry data showed that NANOS2 is upstream of DMRT1. This suggested that 
NANOS2 plays an important role in modulating the effects of DMRT1, a protein required for 
germ cell survival and development.  
NANOS2 belongs to the evolutionary conserved Nanos family that is intrinsic to the male 
germ cell and encodes an RNA binding protein containing a zinc-finger motif [304]. NANOS1 
and NANOS3 are the other two identified murine Nanos homologs that are expressed in the 
embryonic and adult brain and as well as in adult testis. In the testis, only NANOS3 and 
NANOS2 are expressed in germ cells were they protect germ cells from undergoing programmed 
cell death during migration into and after colonization of the male gonadal ridge, respectively 
[83, 305]. Although nanos2 is not implicated in meiosis or sex differentiation of germ cells in 
Drosophila melanogaster, it was shown to form a complex with pumilio, another RNA binding 
protein. Together, they repressed the translation of hunchback, cyclin B, and hid transcripts that 
results in embryonic polarity, mitotic latency and apoptotic suppression, respectively, by binding 
to the nanos-response element (NRE). The NRE (TTTGTTGTGCAAAATTGTACATAAGC-
CA) located at the 3′ untranslated region (UTR) of these target transcripts [306-309]. In the 
developing mouse gonad, ectopic expression of NANOS2 in female gonocytes and its normal 
expression in primordial male germ cells suppress entry into meiosis while promoting male-
specific differentiation [83]. In addition, NANOS2 was found to localize to P-bodies, which 
accumulate profusely in male gonocyte and are well-characterized RNA degradation sites [300]. 
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Furthermore, P-bodies have been shown to contain translational silent mRNAs, suggesting that 
NANOS2 not only promotes degradation of transcripts involved in meiosis but also sequesters 
other transcripts in a translation silent state within P-bodies during the development of the 
embryo. The sequestered transcripts can be later release from P-bodies and translated to support 
differentiation as the levels of NANOS2 declines after birth [300]. The deadenylation complex is 
associated with RNA degradation and in Drosophila melanogaster, the mRNA of hunchback 
was deadenylated with the help of nanos that resulted in translational repression without any 
change in the levels of the mRNA [310]. 
The relevance of NANOS2 in suppressing the proliferation and differentiation of 
spermatogonial stem cells was shown through studies in mice that overexpress NANOS2 and 
with a conditional Nanos2 deletion [107, 295, 311]. Characterization of Nanos2 conditional 
knockout mice, generated using a Tamoxifen-inducible chimeric Cre-ERT2, a fusion protein 
between a mutated ligand binding domain of the human estrogen receptor (ER) and the Cre 
recombinase, showed a gradual depletion of spermatogonial stem cells during spermatogonial 
cell cycles that was exacerbated with age and showed various degree of germ cell loss and 
complete loss at 8 and 12 weeks after birth, respectively [107]. The shift from undifferentiated to 
differentiated germ cells, followed by their complete loss, was associated with the loss of PLZF 
and GFRA1, two well-characterized markers of undifferentiated germ cells [107]. Likewise, the 
role of NANOS2 in spermatogonial stem cell maintenance was confirmed using gain-of-function 
experiments. The NANOS2-overexpressing testes were characterized by the accumulation of 
spermatogonia with diminished levels of NANOS3 or NGN-3 and elevated levels of PLZF and 
GFRA1 [107]. These results showed vital roles for NANOS2 in posttranscriptional regulation of 
undifferentiated spermatogonial pool based on existing evidence that its Drosophila homolog, 
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nanos, may function by impeding translation or assisting with the degradation of mRNA target 
[312, 313].  
The observed NANOS2 expression in Dmrt1
-/-
 mouse testes, the partial co-localization, in 
vitro interaction with DMRT1, and influence on Dmrt1 transcriptional activity have significant 
implications for the roles of DMRT1 and NANOS2 in germ cell development. NANOS2 
regulation of Dmrt1 was first implicated from global gene signatures of Nanos2-null mice. 
Several genes involved in germ cell development including Dmrt1 and Stra8 were up-regulated 
in the absence of NANOS2, whereas these genes were down-regulated when Dmrt1 was absent 
([300], Agbor, Unpublished). NANOS2 was expressed in the absence of DMRT1 in the Dmrt1
-/-
 
testis indicating that NANOS2 is upstream of DMRT1. This suggested that Nanos2 is at the top 
of a germ cell-specific developmental pathway, which includes genes like Dmrt1 that are 
required for germ cell maintenance and survival.  
Recent findings show that GDNF acts upstream of NANOS2, whereas STRA8 was 
downstream of NANOS2 and DMRT1 [105, 106, 134]. Thus, a possible signaling cascade would 
be initiated by GDNF produced in Sertoli cells and transported to germ cells were it acts through 
its receptor, GFRA1, to maintain the expression of NANOS2. NANOS2 expressed in P-bodies in 
germ cells represses the translation of Stra8 alone or interacts with DMRT1 in an unknown 
complex to repress Stra8 translation. Alternatively, it is also possible that DMRT1 and NANOS2 
employ two separate mechanisms to repress STRA8 expression. Our findings implicate 
NANOS2 in the regulation of DMRT1 and that loss of Dmrt1 does not disturb NANOS2 
expression, suggesting that DMRT1 is downstream of NANOS2. The studies suggest a pathway 
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involving the sequential use of GDNF, NANOS2, and DMRT1 to the control of germ cell 
development.  
It was also observed that NANOS2 partially colocalized with DMRT1 in vivo, and co-
immunoprecipitation showed DMRT1 and NANOS2 interact. It is uncertain however if the 
interaction is direct or within a larger complex. In addition, transient transfection studies 
revealed DMRT1 and NANOS2 functionally interact in situ. These findings support the 
postulation that there is a possible mechanistic link between DMRT1 and NANOS2 due to their 
similarity in the regulation Stra8 expression and other shared genes involved in postnatal germ 
cell development [134]. Given that NANOS2 interacts with the CCR-NOT complex and is 
thought to regulate the deadenylation-mediated RNA degradation in P-bodies provides a possible 
mechanism by which NANOS2 regulate the posttranscriptional Dmrt1 message or its translation 
[314].  
Both NANOS2 and DMRT1 are evolutionarily conserved with prominent expression in 
male germ cells. Nanos2 expression is also expressed in the brain with no known function while 
Dmrt1 is testis specific but also expressed in Sertoli cells [130, 302, 305]. Since NANOS2 can 
activate DMRT1 on one promoter and repress it on another, it cannot be doing so by regulating 
the same RNA. A possible mechanism of interaction will be dependent on the identification and 
characterization of a murine homolog of nanos response element, which was vital in the 
repression of hunchback in Drosophila melanogaster. These short cis-acting regulatory elements 
were found to be sufficient in mediating the repressive action of nanos on hunchback and bicoid. 
These regions located in the 3′ untranslated region (UTR) of the gene acted as independent 
functional units that were active irrespective of the sequence context and relative position within 
the 3′ UTR [315]. The nanos response element consensus sequence was found to be similar 
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between bicoid and hunchback and arranged in two-half homologous regions. The first half was 
made-up of GUUGU (or GTTGT) nucleotides while the second was comprised of AUUGUA (or 
ATTGTA) nucleotides [315]. Preliminary analysis of the 3′ UTR region of Dmrt1 revealed 
nucleotides at positions 1335-1342 (TTTGTTGT) and positions 1604-1610 (AATTGTA) that 
were homologous to the independent functional units of NRE identified in bicoid and hunchback. 
Two polyadenylation sites of 9 (positions: 2187-2195) and 12 (positions: 1540-1551) nucleotides 
were identified in the 3′ UTR of Dmrt1. The TTTGTTGT conserved consensus sequence was 
located 212 bases downstream of the stop codon (position 1124-1126), 205 bases upstream of the 
first polyadenylation site (positions: 1540-1551) and 860bases upstream of the second 
polyadenylation site (positions: 2187-2195). Likewise, the AATTGTA consensus site was 
located 486 bases downstream of the stop codon, 53 bases downstream of the first 
polyadenylation site and 591bases upstream of the second polyadenylation site. Thus, knowing 
that most RNA binding sites are recognized as folded secondary structures facilitates the 
convergence of these conserved structural features into the correct spatial orientation that is 
recognized by Nanos2. However, the nature of this interaction awaits further characterization and 
may reveal vital knowledge on the role of NANOS2 on DMRT1 expression during germ cell 
development in the testis. 
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Figure 1: Expression changes of a group of genes that are differentially regulated by 
NANOS2 and DMRT1. The gray bars represent changes in male gonads lacking Nanos2 
collected at embryonic day 15.5 (E15.5) and evaluated by microarray. The dark bars represent 
microarray gene expression changes at P7 in mouse testis that were Dmrt1-deficient. 
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Figure 2: DMRT1 and NANOS2 Co-IP. P10 testis lysates from Dmrt1
+/+ 
and Dmrt1
-/-
 mice 
were immuno-precipitated (Imppt) with antibodies to either DMRT1 (A) or NANOS2 (B) and 
analyzed by Western blot analysis to detect NANOS2 (A) and DMRT1 (B). NANOS2 was 
observed in the DMRT1-imppt complex (A) and DMRT1 in the NANOS2-imppt complex (B). 
1= Sertoli cell nuclear extract (SC NE), 2, 3 and 4 = Input flow-through (FT) and 
immunoprecipitates from Dmrt1
+/+
 testes extract, respectively, 5, 6 and 7 = Input flow-through 
(FT) and immunoprecipitates from Dmrt1
-/- 
testes extract, respectively. 
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Figure 3: Immunolocalization of DMRT1 and NANOS2 in postnatal day 7 (P7) mouse 
testis. Testis sections from Dmrt1
+/+
 (A-C) and Dmrt1 
-/-
 (D-F) mice were evaluated using 
fluorescently labeled antibodies against DMRT1 (green; A and D) and NANOS2 (red; B and E). 
Panels C and F show merged images. Arrowhead in panel C show partial interaction between 
NANOS2 in the cytoplasm and DMRT1 in the nucleus of germ cells in Dmrt1
+/+
 mice testis. 
Also note the expression of NANOS2 in the absence of DMRT1 (E). Final magnification for 
micrographs is x400. 
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Figure 4: Immunolocalization of DMRT1 and NANOS2 in postnatal day 7 (P7) mouse 
testis. Testis sections from Dmrt1
+/+
 (A-I) mice were evaluated using fluorescently labeled 
antibodies against DMRT1 (red; A ) and NANOS2 (green; B ) and counterstained with DAPI for 
nuclei (blue; D, E and F). Panels C, G, H and I show merged images. Arrowheads in panel C and 
I show partial interaction between NANOS2 in the cytoplasm and DMRT1 in the nucleus of 
germ cells in Dmrt1
+/+
 mice testis. Final magnification for micrographs is x600. 
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Figure 5: NANOS2 alters the activity of DMRT1. The effect of NANOS2 on DMRT1 and 
GAL4 transcriptional activity was evaluated by transient transfection of GC-1 cells with various 
luciferase reporters and expression vectors. A. Co-transfection of EF-FLAG-DMRT1, increasing 
amounts of FLAG-NANOS2-MYC and 4X-DM-Luc, which was generated by placing four 
copies of DMRT1-response element upstream of a TATA box (minimal promoter). B. Co-
transfection of VP16-DMRT1, increasing amounts of FLAG-NANOS2-MYC and 4X-IRE-Luc, 
which was generated by placing four copies of DMRT1-response element in front of an SV40 
promoter (strong and constitutive promoter). C. Co-transfection of VP16-DMRT1, FLAG-
NANOS2-MYC and 4X-DM-Luc (solid bars), and co-transfection of GAL4-V16, FLAG-
NANOS2-MYC and 5X-GAL4-UAS-Luc, generated by placing four copies of GAL4 upstream 
activation sequence (UAS) in front of an SV40 promoter (checkered bars). The ratio of firefly to 
renilla luciferase activities for each sample was made relative to the firefly/renilla values for the 
reporters’ transfected without expression vectors. Error bars represent standard error of means. 
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Table 1: Opposite gene expression changes of twenty-four (24) genes regulated by NANOS2 
and DMRT1 obtained from Nanos2
-/- 
and Dmrt1
-/- 
mice. 
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Table 2: Similar gene expression changes of sixteen (16) genes regulated by NANOS2 and 
DMRT1 obtained from Nanos2
-/- 
and Dmrt1
-/- 
mice. 
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Introduction 
DMRT1 is an evolutionary conserved transcriptional regulator required for postnatal testis 
development. The mechanism(s) associated with DMRT1 and the pathways it regulates are unresolved. 
Thus, the overall hypothesis was to elucidate pathways critical for Sertoli cell differentiation and 
germ cell growth and maintenance regulated by DMRT1 and its protein-binding partners using 
mouse models with different cell-specific amounts of DMRT1. To investigate this hypothesis, 
specific aims were proposed to identify biological pathways regulated by DMRT1 that were 
unique to Sertoli cells and germ cells. This goal relied on the identification of gene expression 
differences, direct targets and their associated biological processes. In addition, more light was 
shed on the regulation of the transcriptional activity of DMRT1 in germ cells with the 
identification of a germ cell-specific partner protein.  
The work in this dissertation uncovers many essential features of DMRT1 including cell-specific 
expression and physiological function in the testis (Chapter 2), importance during ES formation and 
organization (Chapter 3), distinct cell-specific pathways and direct targets (Chapter 4), and transcriptional 
and translational regulation in germ cells (Chapter 5), which provided new insights on biological 
processes modulated by DMRT1 during postnatal testis differentiation. The implications and follow-up 
experiments of these findings will be discussed in this chapter. 
Dmrt1
-/-;tg
 mice (aka Dmrt1-rescue)- a novel mouse model of Dmrt1-deficient germ cells and 
male infertility 
 The Dmrt1-rescue mice is a novel DMRT1-deficent germ cell mouse model generated by the 
return of DMRT1 to Dmrt1-null Sertoli cells using a Wt1-Dmrt1 transgene. Characterization of these 
mice revealed new functions modulated by DMRT1 in Sertoli cells including maintenance of testis weight 
and sperm progressive motility, Sertoli cell maturation, serum testosterone levels and seminiferous tubule 
integrity. Consistent with previous murine Dmrt1 deletion studies, these results supported roles for this 
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transcription factor in postnatal testis differentiation but not sex determination like in the Dmrt1-null 
mice, which were characterized by postnatal Sertoli cell defects and germ cell death but not XY sex 
reversal [50]. Specifically, the adult Dmrt1-null male mice were characterized by severe testis hypoplasia, 
disorganized seminiferous tubules, failed Sertoli cell differentiation, premeiotic germ cell death and 
sterility, without evidence of ectopic ovarian tissues or Mullerian duct-derived structures. Features like 
infertility, testicular hypoplasia, germ cell loss and no XY sex reversal were also present in male Dmrt1-
rescue mice. In contrast, the Dmrt1-null females had normal ovaries and were fertile [50]. This finding is 
consistent with our observations that overexpression of DMRT1 in pregranulosa cells did not cause XX 
sex reversal on a Dmrt1
+/+
 or Dmrt1
-/- 
background. The ovaries in these transgenic females developed 
normally and remained fertile in the presence of DMRT1 during gonadal development.  
Further characterization of Dmrt1-transgenic and Dmrt1-rescue mice, which express exogenous 
Dmrt1 transgene only in Sertoli cells, validated roles for this transcriptional regulator in postnatal testis 
differentiation. Specifically, testis size and sperm progressive motility were better in aging transgenic 
males and in Dmrt1-/- background, the transgene partially restored SC differentiation, tubule morphology 
and production of adherens junction proteins (Chapter 3). The transgenic studies suggest that more 
DMRT1 is expressed or the levels are maintained in aging mice that provided a better testis environment, 
which translated to a better germ cell niche and improved sperm quality. This hypothesis can be tested by 
setting up fertility experiments to determine fertilization success in 1.5- 2.5 year-old Dmrt1-transgenic 
(Dmrt1+/+;tg and Dmrt1+/+;tg+tg) and Dmrt1+/+ mice. Consistent with the above results, recent studies using 
different approaches arrived at the same conclusion for DMRT1 in the maintenance of a testis 
environment. Notably, cell-specific deletion of Dmrt1 in Sertoli cells resulted in a normal morphology at 
birth with normal expression of SOX9; but by P14, Dmrt1-null Sertoli cells started to differentiate into 
granulosa cells, as indicated by the expression of FOXL2, which is normally expressed in the ovary, and 
by P28, the majority of cells expressing SOX9 were lost while FOXL2 was strongly expressed by cells in 
the seminiferous tubule [135]. In the same study, similar changes were observed four weeks after Dmrt1 
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was deleted from adult mice, leading to the conclusion that loss of Dmrt1 causes Sertoli cells to be 
reprogrammed into cells with a granulosa-like or theca-like morphology accompanied with elevated 
expression of female-specific genes, enzymes and androgens. With the above findings, it is still unclear if 
DMRT1 regulates primary sex determination in mice, but invaluable during postnatal testis differentiation 
and sex maintenance; and it is essential to note that some factors may limit the actual function of DMRT1 
when Dmrt1 is deleted or forced expressed in cell-specific expression studies. 
Potential factors affecting role of exogenous DMRT1 
The strength of the Wt1 promoter and gene redundancy are two factors that may have restricted 
the function of the exogenous DMRT1. It has been shown that the presence or absence of expression of a 
gene product depends on the strength of the control promoter of interest and the levels of expression of a 
gene product is directly proportional to the strength of the promoter [316, 317]. In our study, DMRT1 was 
express from Wt1-Dmrt1 transgene and thus under the control of Wt1 promoter elements. Comparing the 
gene expression profiles of Dmrt1 and Wt1 from P6 through P10, as published in the dataset GSE926, 
which evaluated the global gene expression profiles during mouse postnatal testis development starting 
immediately after birth (P0) through the first wave of spermiation (P35) (Figure 1;[276]), showed that 
expression of Dmrt1 was about two-fold higher than that of Wt1 expression. However, knowing that in 
the testis, WT1 is expressed only in Sertoli cells and DMRT1 is expressed in both Sertoli cells and 
premeiotic germ cells provides an explanation for the difference in Dmrt1 and Wt1 expression levels. 
Germ cell proliferation adds to the number and level of germ cell-specific expression of DMRT1, whereas 
the levels in Sertoli cells are fixed once the number of Sertoli cells required to maintain spermatogenesis 
are determined at puberty, at about P12 in mice. Consequently, the Sertoli cell-specific Dmrt1 expression 
levels can be deduced to be comparable to the gene expression levels of Wt1 in Figure 1. The strength of 
the Wt1 promoter was previously tested and was used to direct expression of SOX9 in the Wt1-Sox9 
transgenic mouse model; and was found to be powerful and sufficient to produce levels of SOX9 that 
induced XX-to-XY sex reversal [39]. Consistent with this study, it is evident that Wt1 directed the 
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expression of an adequate amount of DMRT1 from the Wt1-Dmrt1 transgene, which did not induce sex 
reversal. This also suggested that transgenic DMRT1 is regulated like endogenous DMRT1 but the 
seminiferous tubule integrity in adult testes from Dmrt1-rescue mice were partially restored and different 
from those of mice models like the W
v
/W
v
 mice, which lack germ cells [190, 318]. It is likely that there is 
a delay in the action of the exogenous DMRT1 given that Dmrt1-null and Dmrt1-rescue mice lacked 
seminal vesicles at P42 but by P120 and above, seminal vesicles were fully formed only in Dmrt1-rescue 
mice (Chapter 1; supplementary Figure 1). Thus, transplantation experiments by transferring germ cell 
explants into Dmrt1-rescue testes will be required to determine the nurturing function of Sertoli cells in 
this DMRT1-deficient germ cell mice model and in the process validating or refuting the strength of Wt1 
promoter. In addition, an elaborate characterization of the Dmrt1-rescue at older ages (starting from P90) 
will be required to determine the full extent of restoration of tubule integrity directed by exogenous 
DMRT1. 
The effects of gene redundancy provided by other DM domain genes may be the obstructing 
factors, knowing that other DM domain proteins are expressed both in the embryonic ovaries and testes 
(DMRT4 and DMRT7) or only in the embryonic testes (DMRT3), may account for the normal sex 
determination and embryonic testis differentiation observed in Dmrt1-null, Dmrt1-rescue and Dmrt1-
transgenic mice [50, 319]. Similar studies on the functional ablation of Sox9 demonstrated the gene 
redundancy effect, whereby the specific deletion of Sox9 in the gonads did not induce XY-to-XX sex 
reversal until an additional deletion of a closely related gene, Sox8, occurred in the male gonads [38]. 
Thus, double murine deletion studies of Dmrt3 and Dmrt1, which are both testis-specific and neighbors 
on chromosome 9 in humans, will be required to finally include or exclude DMRT1 as a mammalian sex 
determining factor. 
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Phenotypic similarities between adult Dmrt1-rescue mice and mice models of Klinefelter’s 
syndrome  
The phenotype of P42 testes in Dmrt1-/-;tg mice resembles that of two mouse models (male 41, 
XXY and the 41, XX
Y
*) of human Klinefelter’s syndrome (47 XXY), with common phenotypic features 
including significant germ cell depletion by P7, small testes in adult mice with reduced seminiferous 
tubule diameter, Sertoli cell-only tubules, Leydig cell hyperplasia and reduced serum testosterone levels 
[211-215]. Thus a novel mouse model of infertility that shares characteristics with Klinefelter’s patients; 
who are characterized by the presence of a supernumerary X chromosome, endocrine deficiencies and 
testicular alterations; is generated by returning DMRT1 to Dmrt1-null Sertoli cells. Klinefelter’s 
syndrome results from the failure of sex chromosomes to segregate during meiosis. Chromosomal non-
segregation in meiosis can occur during differentiation of gametes, which leads to aberrant karyotypes 
resulting in different disease states as long as the alterations induced by the extra chromosomes are not 
lethal [320-322]. Giving that a delay in the function of DMRT1 is likely present in the Dmrt1-rescue 
testes as suggested by the presence of seminal vesicles at >P120 that were absent at P42, it will be 
worthwhile to investigate if the similarities to mouse models of Klinefelter’s syndrome are maintained at 
older ages. Nonetheless, more experiments will required to further characterize and determine if P42 
Dmrt1-/-;tg mice exhibit any cognitive, behavioral and metabolic defects like Klinefelter’s patients. 
Novel function in formation and organization of testis-specific adherens junction 
Although existing findings exclude Dmrt1 as a potential murine sex-determining factor or as a 
central gene required for early embryonic regulation of testis differentiation, further characterization of 
Dmrt1-rescue mice validated cell-specific function vital for postnatal testis differentiation. Our findings 
showed that Sertoli cell-specific return of DMRT1 modulate the expression of proteins required for the 
formation and organization of ES, a testis-specific adherens junction, as determined by identification of 
these structures on electromicrographs and by immunohistochemical expression of ES- adapter proteins 
ESPIN, NECTIN-2 and NECTIN-3 (Chapter 3). The NECTINS are immunoglobulin-like adhesion 
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molecules that interact with AFADIN, an actin filament-binding protein that connects NECTINS to the 
cytoskeleton. Three actin-based adherens complexes have be identified at the apical junctional 
specialization namely: the INTEGRIN-LAMININ, the NECTIN-AFADIN, and the CADHERIN-
CATENIN complexes [193]. The association and dissociation of the apical junctional specialization 
overlaps with the expression of these junctional complexes [323, 324]. This distinctive association in 
cell–cell interactions may be linked to the dynamic properties of the apical junctional specialization. The 
NECTIN-AFADIN complex links spermatid to the Sertoli cell through a heterotypic interaction between 
NECTIN-2, located exclusively on the Sertoli side of the apical ES and NECTIN-3, located on the 
spermatid side [240]. By binding to I-AFADIN, an F-ACTIN binding protein, the interactions with 
NECTIN-2 play vital roles in the organization and reorganization of the cytoskeleton during 
spermiogenesis, since the epithelial organization was totally disrupted in Afadin knockout embryonic 
ectoderm, suggesting that AFADIN regulates the functional state of NECTINS and contributes to the 
basic organization of cell–cell junctions [325-327]. Similarly, genetic mutation experiments showed that 
ESPIN constitute a family of actin bundling regulatory proteins with the capacity to alter the organization, 
dimensions, dynamics and signaling abilities of the actin cytoskeleton [328]. Furthermore, Nectin-2 
knockout induces abnormal development of the spermatid head resulting in misshaped nuclei, presence of 
mitochondria in the head, and a disorganized middle piece, while Nectin-3 knockout also induces sterility 
in the mouse [326, 329]. Thus, Afadin, Nectin-2, Nectin-3 and Espin mutation studies illustrate the 
importance of the above interactions in cytoskeletal framework and Sertoli cell-germ cell interaction; and 
our current findings directly implicate DMRT1 in the formation and/or organization of ES by may be 
regulating the assembly of the NECTIN-AFADIN complex. Two observations implicate Sertoli cells’ 
DMRT1 in the formation and organization of this cytoskeletal framework. First, ES structure was reduce 
and absent in Dmrt1-/- mice based on protein expression of NECTIN-2 and NECTIN-3, respectively, but 
induce in tubules of Dmrt1-/-;tg mice. Second, immunofluorescence evaluation of ESPIN showed weak and 
irregular signals in Dmrt1-/- tubules compared to the strong and regular signals in Dmrt1-/-;tg tubules. 
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Vinculin (VCL), an actin-binding protein important for adherens junction assembly [330-332], was found 
to be a direct target of DMRT1 and its expression was misregulated in Dmrt1-null testes ([136]; Chapter 
4). It is evident that DMRT1 modulates the formation and organization of cytoskeleton by regulating 
genes like Vcl, which facilitates the assembly of adherens junction proteins. Thus, identifying downstream 
targets, partner proteins and the pathways recruited by VCL at the ES will provide a cytoskeletal 
assembly pathway directed by DMRT1 in Sertoli cells.  
Regulated genes and DMRT1 targets 
With a desire to understand DMRT1 functions, mice expressing different cell-specific amounts of 
Dmrt1 were generated and their global gene expression profiles analyzed to elucidate the cell-specific 
functions directed by DMRT1 in Sertoli cells and germ cells. Evaluation of cell-specific differential 
expression revealed enrichment of genes involved in ubiquitination (Magek1, Mage11, MageB16, 
Trim71, Trim12, and Trim34), Piwi (P-element-induced wimpy testis)-interacting RNAs (piRNAs (Piwil2 
and Piwil4)) and expressed in exosomes (Cpne8, Ano4, Rps9, Cfi, Cadm1, Aqp5, Foxq1, H2-Aa, Hspb8, 
Tuba3a, Flbn2, Rarres1, Dsp, Piwil2, Krt18, Krt8, Gfra1, Crabp2, Dppa3) (Chapter 4); thus providing a 
platform to speculate on some of the cell-specific roles of DMRT1. It is well established that DMRT1 
regulates Sertoli cell differentiation and germ cell development and survival but the mechanisms that 
determine the cellular fate of proteins involved in these biological processes remains obscure.  
MAGE-cancer testis antigens 
One way by which the cellular fate of proteins can be determined is through ubiquitination, which 
is a conserved posttranslational protein modification required during cell proliferation, differentiation, 
programmed cell death or inflammation [333, 334]. Proteins are modified by the addition of ubiquitin 
molecules by the sequential action of three enzymes: ubiquitin-activating (E1), ubiquitin-conjugating (E2) 
and ubiquitin-ligase (E3) enzymes. The proteins tagged with ubiquitin are targets for proteins carrying 
ubiquitin-binding domains, which determine the cellular fates of the ubiquitinated proteins [335-337]. 
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Several genes encoding MAGE cancer testis antigens (MAGE11, K1, & B16) and TRIM E3 RING 
ubiquitin ligases (TRIM71, 12, & 34) were differentially expressed in our study (Chapter 4) and a recent 
report showing MAGE and TRIM proteins interact to mediate substrate ubiquitination, may provide a 
possible mechanism by which DMRT1 directs differentiation of Sertoli cells [288]. However, 
characterization of the protein-protein interaction between DMRT1 and MAGE/TRIM ubiquitination 
complex will be required to establish this posttranslational modification as a process regulated by 
DMRT1. 
Non coding RNA 
The quest to identify possible mechanisms utilized by DMRT1 to regulate postnatal testis 
development also revealed noncoding small RNAs. Small RNAs are vital because of their various 
biological functions as powerful transcriptional, translational and RNA stability regulators [338]. Small 
RNAs are classified into three groups based on their origin, modes of action and functions including small 
interfering RNAs (siRNAs), microRNAs (miRNAs) and piRNAs [339]. piRNAs are expressed during 
sperm production in the mammalian testis, where they interact with PIWI-family proteins like 
PIWIL1,PIWIL2 and PIWIL 4 [340-345]. This Piwi-family proteins are a subfamily of Argonaute 
proteins, previously shown as the essential constituents of the RNA-induced silencing complex (RISC) in 
siRNA-mediated pathway [343, 346, 347]. The actions of the PIWI proteins can be deduce from their 
association with RNA helicase like the Tudor-domain-containing family protein (TDRDs), which are 
suggested to be critical regulators of nuage (germinal granules) assembly involved in piRNA-mediated 
signaling pathway. TDRD8 (STK31) and TDRD9 have been demonstrated as interacting partners of 
PIWIL2, and PIWIL4, respectively, in the piwi pathway [346, 348, 349]. Similarly, MOV10L1 another 
RNA helicase, which is specific to germ cells and contain the complete conserved helicase motif, also 
interacts with PIWI proteins with a preference for the MILI-piRNA complex than the MIWI-piRNA 
complex. These interactions are postulated to retain the evolutionary trait in the germline and safeguard 
RNA in male germ cells against retrotransponsons, thus maintaining the genetic content of a cell [350, 
179 
 
351]. STK31 is expressed postmeiotically and its conserved helicase domain suggests that it may be 
important in reorganizing sperm chromatin during spermiogenesis [352]. Although the maintenance of 
germline stem cells was unaffected in Mov10l1-null mice, primary spermatocytes activated long-terminal 
repeat (LTR) and Long interspersed element 1 (LINE1) retrotransposons that culminated in cell death and 
male infertility [351]. Thus, STK31 and MOV10 L1 are indispensable for spermatogenesis. Results in our 
study showed that the message levels of Piwi2, Piwi4, Mov10L1 and Stk31 were significantly reduced in 
the Dmrt1-null and Dmrt1-rescue mice, when compared to Wild-type mice (Chapter 4). This study 
revealed that, in the context of wild-type mice, the expressions of Piwi2, Piwi4, Mov10L1 and Stk31 in 
testicular germ cells are dependent on the transcriptional activity of DMRT1 and provides a putative 
mechanism for DMRT1-dependent regulation of germ cell development and maintenance. 
Vesicular transport and exosomes 
Although Sertoli cells and germs cells are the major occupants of the testis, no channel for 
exchange of information between these cell types have been established. Exosomes or microvesicles are 
released by most cells under normal physiological conditions and this membrane transfer is being used by 
some cells for communication [353]. Epididymosomes are exosomes secreted in an apocrine manner and 
are derived from epididymal epithelium. Proteins associated with the epididymosomes like macrophage 
migration inhibitory factor (MIF) was identified to be transferred from exosomes to spermatozoa as they 
transit the epididymis [354]. The revelation that genes shown to be expressed in exosomes like Cpne8, 
Ano4, Rps9, Cfi, Cadm1, Aqp5, Foxq1, H2-Aa, Hspb8, Tuba3a, Flbn2, Rarres1, Dsp, Piwil2, Krt18, Krt8, 
Gfra1, Crabp2 and Dppa3 were down-regulated in Dmrt1-null and Dmrt1-rescue, when compared to 
Dmrt1-wild-types, suggests that exosomes might be the conduit for exchange of information between 
Sertoli cells and germ cells in the testis. However, more characterization and tracing experiments will be 
required to substantiate this hypothesis.  
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DMRT1 targets 
In combination with the global gene expression profiles, primary and downstream targets of DMRT1 
were identified using ChIP-Seq. The majority of targets identified were novel, as they were not detected 
in the previously published ChIP-promoter array analyses and may be because the majority of targets had 
DMRT1 binding sites located beyond the proximal promoter region. Characterization of these binding site 
sequences revealed two putative sequences with considerable similarities to the in vitro binding sequence 
and mab3 binding site. Direct targets with these binding sites included Boll, Gfra1 and Usp9y that are 
important for germ cell differentiation and male infertility [105, 277, 278]. Further functional 
analyses revealed cell adhesion and development, cell cycle regulation, protein processing and transport, 
RNA metabolism and transport, and energy metabolism, to be enriched amongst DMRT1-targets. Overall, 
these results identified novel targets and putative binding sites of DMRT1.These putative binding sites 
identified could be confirmed using EMSA and reporter gene activation along with mutated variants of 
the binding site sequences. 
Nanos2, a modulator of DMRT1 expression and function in germ cells  
DMRT1 is essential for male development and fertility yet how its activity is regulated; particularly in 
germ cells was a mystery until now. Our knowledge of what regulates DMRT1 expression is derived 
almost entirely from studies in Sertoli cells and therefore essentially nothing was known on its regulation 
in germ cells. 
Controversy on the exact role of DMRT1 in mitotic to meiotic transition 
NANOS2 is an evolutionary conserved zinc finger RNA binding protein that is expressed in germ 
cells and required for maintenance of undifferentiated spermatogonia [105, 106]. In mouse testis, 
embryonic germ cells start expressing NANOS2 at 13.5 dpc and postnatal germ cell expression is 
restricted to types As and Apr spermatogonia; the subset of undifferentiated spermatogonia that includes 
the “actual stem cell” pool with the ability to self-renew [105-107, 109, 296]. NANOS2 favors the 
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maintenance of an undifferentiated spermatogonial germ cell pool and thus hinders differentiation by 
suppressing synthesis and expression of retinoic acid (RA) and STRA8, respectively. Like NANOS2, 
DMRT1 was recently shown to repress meiosis by controlling the mitotic to meiotic transition of germ 
cells [134, 295], suggesting they may share a partial overlapping functions since the deletion of DMRT1 
in germ cells did not generate excessive meiosis by germ cells [134]. However, the current published role 
of DMRT1 as meiotic repressors is controversial based on available published and unpublished data on 
the transcript expression profiles of Dmrt1 and Stra8.  
It is evident that DMRT1 in male germ cells regulate the mitotic to meiotic switch but not by 
repressing retinoic acid (RA) and STRA8 expression as was recently depicted [134]. Based on available 
transcript expression profiles from postnatal mouse testis time course (P0-P56, GSE926 dataset; [276]), 
embryonic Nanos2-null testes [295, 300], P7 Dmrt1-null and Dmrt1-rescue testes (Chapter 4), P1 and P2 
Dmrt1-null [132], Dmrt1-null ovaries [137], and except for P9 cell-specific Dmrt1 knockout testes [134], 
the transcription activity of DMRT1 on Stra8 points to activation not repression. Analyses of the global 
gene expression profiles of the postnatal mouse testis from P0 through P56 (GSE926 dataset; Figure 2A) 
showed that the lowest gene expression levels for Stra8 were observed between P0 and P3 when Dmrt1 
levels were at about 33% of its maximum expression level. However, the gene expression levels of Stra8 
increased gradually with increasing Dmrt1 levels and attained its maximum level at P10 when Dmrt1 
levels were also at maximum. Dmrt1 gene expression levels peak at P6 and peak levels were maintained 
until P10. From P14 through P35, the gene expression levels of Stra8 decreased as Dmrt1 levels dropped, 
suggesting that the Stra8 message was not suppressed [276]. The dependence of Stra8 gene expression to 
the expression of DMRT1 has been studied using Dmrt1-null mice, where gene expression of testes from 
these mice at P1, P2, P7 and P9 or ovaries, showed that the levels of Stra8 were suppressed in the absence 
of Dmrt1 ([132, 134, 137]; Chapter 4). 
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Unfortunately, the above gene expression patterns were discarded in favor of STRA8 expression 
results obtained using Ngn3-Cre-mediated conditional deletion of Dmrt1 in germ cells [134]. Even though 
the message for Stra8 in the P9 mutant testes was not elevated in this study, the finding was overlooked; 
leading to the conclusion that DMRT1 is a repressor of STRA8 and thus meiosis. Several factors might 
have contributed to the misinterpretation of their findings. Conditional knockouts are limited by their 
penetrance as the TNAP-Cre employed in another cell-specific deletion of DMRT1 was limited by its 
poor Cre penetrance that resulted in partial deletion with a portion of germ cells positive for DMRT1. 
Thus, immunohistological analysis showed that deletion using the TNAP-Cre was leaky and nonspecific 
as DMRT1 was ectopically ablated in some Sertoli cells. Thus, TNAP-Cre cannot be used to correctly 
profile the cells without accounting for the effective deletion. Likewise, a significant number of 
spermatogonia that were DMRT1-positive were negative for the Ngn3-Cre transgene until several weeks 
after birth, which prevented analysis of early germ cell specific events [110, 174]. The restricted co-
expression of DMRT1 and NGN3 in prepubertal mice can be appreciated by immunofluorescence of the 
two proteins in P7 testes, which shows few dual-stained yellow cells [130]. Consequently, the activation 
of Stra8 by DMRT1 in those populations of germ cells with failed Dmrt1deletion in the study was 
misinterpreted.  
In addition, knowing that NANOS2 represses meiosis and consistent with the gene expression 
profiles of Dmrt1-null testes, the transcriptional activation of Stra8 by DMRT1 is favored by global gene 
expression profiles of embryonic day 17 (E17) testes from Nanos2-null mice, which showed up-
regulation of both the Stra8 and Dmrt1 gene expression levels [295, 300]. Our current findings that 
NANOS2 is upstream of DMRT1, partially co-localizes, interacts and modulates the transcriptional 
activity of DMRT1 in germ cells (Chapter 5) are exciting and provide valuable information required to 
establish the role of DMRT1 in the mitotic-to-meiotic transition by germ cells. It is likely that the levels 
of DMRT1 is suppressed and tightly regulated by NANOS2 in the undifferentiated spermatogonia (Asingle 
and Apaired), which inturn suppresses retinoic acid synthesis and the transcription of Stra8, a direct target 
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of DMRT1 (Figure 2B). As the spermatogonium proliferates and progresses in development, NANOS2 is 
suppressed while DMRT1 levels are elevated and sufficient to mediate the transcription of Stra8 and 
hence meiosis. Thus, we speculate that NANOS2 controls meiosis by suppressing DMRT1’s expression 
in undifferentiated spermatogonial stem cells. However, more transient transfection, knockdown and 
coimmunoprecipitation experiments will be required to elucidate the mechanism and additional factors 
involved in DMRT1-mediated activation of mitotic-to-meiotic transition. 
What are the putative mechanisms employed by NANOS2 to regulate the transcriptional activity 
of DMRT1? 
DMRT1 expression can be regulated at several different levels. Its synthesis may be 
suppressed, the synthesized protein may be inactivated or degraded in the cytoplasm and the 
protein can be mislocalized in the cytoplasm in the absence of specific nuclear localization 
signals (Figure 3). Existing literature on the translation regulator and RNA binding protein, 
NANOS2, and the observed interaction and functional findings between NANOS2 and DMRT1 
in this current study provide a platform to speculate on potential mechanisms by which NANOS2 
regulates the transcriptional activity of DMRT1 in germ cells. NANOS2 was previously shown 
to localize in the cytoplasmic and nuclear compartments of HEK293T cells transfected with a 
NANOS2-MYC expression vector [301]. Our current immunostaining of NANOS2 and DMRT1 
revealed partial co-localization with NANOS2 affixed to the nuclear membrane with DMRT1 in 
the nucleus. Furthermore, NANOS2 modulated the transcriptional activity of DMRT1 in 
transient transfection experiments using GC1 cells. Giving that nuclear localization of NANOS2 
has been shown, suggests that NANOS2 translocate to the nucleus either alone or tethered to a 
binding partner like DMRT1 during its translocation from the cytoplasm to the nucleus. Based 
on the transient transfection results and given that NANOS2 was localized to the nucleus, the 
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first possibility for the regulation of synthesis of DMRT1 by NANOS2 could be at the initiation-
step of transcription.  
Co-transfection of NANOS2 had two independent effects (activation and repression) on 
DMRT1 transcriptional activity, which was dependent on the promoter context. When the 
DMRT1 response elements were placed upstream of a constitutive SV40 promoter and co-
transfected with NANOS2 and DMRT1, the transcriptional activity of DMRT1 was up regulated 
as seen with the dose-dependent increase of luciferase activity with increasing NANOS2. This 
suggests that NANOS2 bound to DMRT1 on the promoter facilitates the recruitment of co-
activators, such as NCOA2 and NCOA4 identified as direct targets of DMRT1, with a variety of 
modification capabilities vital for gene transcription (Figure 3; I) ( [136]; Chapter 4). This 
possibility has been documented for other RNA binding proteins. For example, two members of 
the U2AF65 family of proteins, RBM39 and RBM 23, regulate gene transcription and alternative 
splicing mediated by steroid hormones. The RBM proteins co-activated the progesterone 
receptor in transient transfection assays and altered in a hormone-dependent manner the 
alternative splicing of a calcitonin/calcitonin gene-related peptide [355]. Suppression of DMRT1 
transcriptional activity was the alternative effect obtained when NANOS2 and DMRT1 were co-
transfected along with a minimal TATA box promoter that was downstream of the DMRT1-
response elements. In this instance, NANSO2 potentially aids in the recruitment of co-repressors 
which hinders the transcription of a gene (Figure 3; II). An example exists with the non-POU-
domain-containing, octamer binding protein (p54nrb) and PTB-associated RNA splicing factor 
(PSF) initially characterized to be vital factors for pre-mRNA splicing but now have a novel 
function. They are currently associated with co-repression of steroid receptors. The consensus 
binding motifs (RVxF) of protein phosphatase 1 (PP1) was shared by p54nrb and PSF, 
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suggesting that PP1 may regulate phosphorylation state of both co-repressors and thus their role 
in gene transcription. In the same study, changes in transcriptional suppression of p54nrb and 
PSF were associated to changes in protein interactions between p54nrb or PSF and 
transcriptional corepressors like Sin3A and histone deacetylase 1 [356]. 
The posttranscriptional and posttranslational functions of NANOS2 are well documented 
and it is conceivable these mechanisms are employed in the regulation of DMRT1 expression 
(Figure 3; III-V). NANOS2 was found to localized in P-bodies in the cytoplasm of germ cell and 
are known as sites of RNA degradation and storage, since NANOS2 co-localized with DCP2 and 
XRN, two proteins expressed in P-bodies [314]. Components of the CCR4-NOT deadenylation 
complex were the major proteins identified in NANOS2 immunoprecipitations suggesting that 
members of these protein complex are in vivo interacting partners of NANOS2 [314]. Using the 
in vitro deadenylase assay system, it was shown that NANOS2-interacting deadenylase complex 
had catalytic activity based on the finding that cleavage of poly (A) RNA substrates occurred 
only in NANOS2 immunoprecipitates [300]. Since NANOS2 promotes the degradation of 
NANOS2-interacting mRNAs by recruiting the deadenylation complex, it is possible that same 
mechansism is employed to regulate the synthesis of DMRT1 in germ cells (Figure 3; III). 
Furthermore, the CCR4-NOT complex has been shown to have other functions including 
transcriptional, post-transcriptional RNA regulation and protein ubiquitylation [357, 358]. For 
example, CNOT1 interacts with nuclear receptors while CNOT3 is involved in chromatin 
remodeling, both of which are vital transcription regulatory mechanisms [359, 360]. These 
strongly predict by extrapolation a vital role for NANOS2 in modulating DMRT1’s 
transcriptional activity. Moreover, CNOT4 has E3 ligase activity, putting the CCR4-NOT 
complex in the protein ubiquitylation/proteolytic cleavage pathways [361, 362]. Thus, 
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proteolytic cleavage can be utilized by NANOS2 for regulation of DMRT1 levels in 
undifferentiated spermatogonial stem cells (Figure 3; IV). Finally, phosphorylation provides a 
reversible modification by which NANOS2 can stabilize or destabilize the levels of DMRT1 in 
germ cells (Figure 3; V). This possibility is exemplified by the Cold-inducible RNA-binding 
protein (Cirp), which binds directly to a dual-specificity tyrosine-phosphorylation-regulated 
kinase 1B (Dyrk1b or Mirk) to inhibit its binding to cyclin-dependent kinase inhibitor 1B 
(Cdkn1b or p27) leading to reduced phosphorylation and destabilization of Cdkn1b [363]. 
Conclusion 
A cellular model is provided on the functions of DMRT1 in Figure 4, which summarizes the 
findings in this project. The first and second sections of this chapter was focused on the characterization 
of a novel Dmrt1-deficient germ cell mouse model of male infertility, revealing key cell-specific 
processes regulated by DMRT1 in Sertoli cells. The cell-specific processes include maintenance of sperm 
progressive motility and testis size, differentiation of Sertoli cells, gene dosage dependency, maintenance 
of androgen levels and formation and organization of ES. In the third section, the differential expression 
of genes involved in ubiquitination, vesicular transport and piRNA pathways, which were top biological 
processed functions derived from manual analysis were examined. This addressed possible mechanisms 
for Sertoli cell-germ cell communication, regulation of Sertoli cell differentiation and germ cell 
development and survival. The last section highlights the shortage of research on the regulation of 
DMRT1 activity in germ cells and provides the first findings on a putative factor, NANOS2, which 
regulated DMRT1 transcriptional activity in germ cells. These studies have supplemented the existing 
knowledge and provided better understanding of the role of DMRT1 in postnatal testis differentiation, and 
thus fulfilled overall hypothesis and specific aims of this dissertation. However, the project raised many 
questions on the cell-specific function of DMRT1, which will require further investigation. For example, 
fertility experiments will be required to determine if overexpression of exogenous DMRT1 in Dmrt1+/+ 
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mice maintains a better testis milieu and sustains better sperm quality. Next, transplantation of germ cell 
explants into Sertoli cells of Dmrt1-rescue mice will determine the nurturing function of DMRT1-rescued 
Sertoli cells and validate the strength of the Wt1 promoter. In addition, identification of downstream 
targets of VCL, binding partners or pathways involved will show a cytoskeletal assembly biological 
process directed by DMRT1 in Sertoli cells. Finally, more transient transfections, knockdown (RNAi), 
coimmunoprecipitation for NANOS2, DMRT1 and STRA8 will be invaluable in validating NANOS2 as a 
regulator of the transcriptional activity of DMRT1 in germ cells as well as confirming that DMRT1 
activates the mitotic to meiotic transition in premeiotic germ cells. 
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Figure 1: Time course for the expression of Wt1 and Dmrt1 during mouse postnatal 
testis development. Dataset GSE926 contains published global gene expression profiles 
collected at P0 through P35 during postnatal mouse testis development. Expression of Wt1 is 
highest between P3 and P10, whereas Dmrt1 levels are highest between P6 and P10. During this 
period of elevated expression for both transcripts, the level of Dmrt1 is about two-fold higher 
than the levels of Wt1. 
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Figure 2: Gene expression of Stra8 and Dmrt1 andputative mechanism of DMRT1-
activation of the mitotic to meiotic transition. A. Time course for the expression of Stra8 and 
Dmrt1 during mouse postnatal testis development. Dataset GSE926 contains published global gene 
expression profiles collected at P0 through P35 during postnatal mouse testis development. B. 
Putative mechanism of DMRT1 activation of the mitotic to meiotic transition of germ cells. 
NANOS2 regulate meiosis by suppressing DMRT1’s expression. 
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Figure 3: Model depicting potential mechanisms by which NANOS2 modulate the 
transcriptional activity of DMRT1 in germ cells. In the first situation (I), the translocated 
complex binds to the Dmrt1-response element placed in front of a constitutive SV40 promoter and may 
recruit a co-activator (J) and the general transcriptional machinery, which transcribes the gene. In the 
second situation (II), the NANOS2-DMRT1 complex instead recruits an unidentified co-repressor (F) to 
the TATA box minimal promoter region of Dmrt1, inhibits its transcription. In the third situation (III), 
NANOS2 bound to its unidentified mammalian binding partner (Z) and the CCR4-NOT deadenylation 
complex in the P-body, sequester posttranscriptionally modified Dmrt1 mRNA in the cytoplasm, where it 
is degraded resulting in mRNA decay or mRNA is silenced, preventing translation and stored temporally 
in P-bodies. Finally, in IV and V, NANOS2 bound to DMRT1 in the cytoplasm can recruit an ubiquitin 
protein complex (Y; in IV) or a kinase (Y; in V) that mediates the ubiquitination or phosphorylation of 
DMRT1, leading to proteolytic cleavage or inactivation, respectively. W is a transcription factor like 
SOX9 known to regulate transcription of Nanos2, J = co-activators (NCOA2, NCOA4 and PPARGC1B) 
and P = phosphate moieties. 
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Figure 4: Integration model of DMRT1 activity. A cell model was generated showing 
predicted locations, subcellular fractions (denoted by shape) and associated functions (denoted 
by color) of the identified DMRT1 target genes (determined by proximity to confirmed DMRT1 
binding sites). Some genes are represented multiple times, as they are located in different parts of 
the cell. The analysis identified unique functional correlations between target and regulated 
genes, indicated by the color scheme associated with targets (located in the cell) and the up- and 
down-regulated gene categories. 
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